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ABSTRACT 
The European Food Safety Authority (EFSA) was asked by the European Commission to deliver a scientific 
opinion on sterigmatocystin (STC) in food and feed. STC is a polyketide mycotoxin that shares its biosynthetic 
pathway with aflatoxins. Following an EFSA call for data, analytical results from 247 food and 334 feed samples 
were submitted. In food, analytical results on STC were reported to be all below the limit of detection or limit of 
quantification. In feed, only four quantified results were reported. Therefore, the EFSA Panel on Contaminants 
in the Food Chain (CONTAM Panel) concluded that the available occurrence data are too limited to carry out a 
reliable human and animal dietary exposure assessment. Acute oral toxicity of STC is relatively low, and liver 
and kidneys are the target organs. STC is mutagenic in both bacterial and mammalian cells after metabolic 
activation and forms DNA adducts. Tumourigenicity has been observed after oral, intraperitoneal, subcutaneous 
and  dermal  administration  resulting  in  hepatocellular  carcinomas,  haemangiosarcomas  in  the  liver, 
angiosarcomas in brown fat and lung adenomas. Since no exposure data were available, the margin of exposure 
approach  for  substances  that  are  genotoxic  and  carcinogenic  could  not  be  applied  for  STC,  and  thus  the 
CONTAM Panel could not characterise the risk for human health. Regarding animals, the Panel noted that STC 
is hepatotoxic in poultry and pigs, and nephrotoxic in poultry and toxic in several fish species. However, in the 
absence of exposure data for livestock, fish and companion animals, and given the limited knowledge on the 
adverse effects of STC, the CONTAM Panel could not characterise the risk for animal health. More occurrence 
data on STC in food and feed need to be collected to allow dietary exposure assessment. For food, methods with 
a limit of quantification of less than 1.5 µg/kg should be applied. 
© European Food Safety Authority, 2013 
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SUMMARY 
The European Commission asked the European Food Safety Authority (EFSA) to provide a scientific 
opinion on the risks for public and animal health related to the presence of sterigmatocystin (STC) in 
food and feed.  
STC is a polyketide mycotoxin that is produced by more than 50 fungal species, including Aspergillus 
flavus, A. parasiticus, A. versicolor and A. nidulans, of which A. versicolor is the most common 
source.  STC  shares  its  biosynthetic  pathway  with  aflatoxins.  A.  nidulans  and  A.  versicolor  are 
apparently  unable  to  biotransform  STC  into  O-methylsterigmatocystin,  the  direct  precursor  of 
aflatoxin B1 (AFB1) and G1 (AFG1). Consequently, substrates colonised by these fungi can contain 
high amounts of STC, while substrates invaded by A. flavus and A. parasiticus contain only low 
amounts of STC as most is converted into AFs. STC can occur in grains and grain-based products due 
to fungal infestation at the post-harvest stage. 
Analytical methods for STC in food and feed based  on liquid chromatography-mass spectrometry 
(LC–MS)  reach  the  lowest  limits  of  detection  (LOD).  However,  the  sensitivity  varies  between 
individual  matrices  and  whether  a  single  or  multi-analyte  method  is  applied.  So  far,  no  certified 
reference materials are available for STC. In addition, no proficiency tests for STC analysis in food or 
feed could be identified. 
In the literature, only limited information is available on the occurrence of STC in different foods and 
feed. Most of the earlier studies using methods with rather high LODs/limits of quantification (LOQ) 
report a high percentage of left-censored data (often 100 %) on food and feed. Two recent studies 
using  a liquid chromatography-tandem  mass  spectrometry  (LC–MS/MS)  method  with  an  LOD  of 
0.15 µg/kg and an LOQ of 0.3 µg/kg reported STC positive samples of bread and of grain intended for 
use as animal feed. While these data indicate that these methods are sufficiently sensitive to quantify 
STC in food and feed, the data were insufficient to use for a reliable exposure assessment. 
Moreover, STC has been occasionally reported to occur in green coffee beans, spices, nuts and beer. 
Contamination of cheese occurs particularly at the surface, following fungal spoilage during ripening 
and storage. Food processing (e.g. milling, bread and cheese making, roasting) can result in a decrease 
of  the  STC  concentration,  however  the  extent  depends  on  the  type  of  food  and  the  processing 
conditions. 
Following an EFSA call for data, analytical results from 247 food samples submitted by two Member 
States were reported to be all below the LOD or LOQ. The EFSA Panel on Contaminants in the Food 
Chain (CONTAM Panel) concluded that a reliable exposure assessment was not feasible for humans.  
The scarce information available suggests that absorption of STC is limited following oral exposure. 
STC  is  metabolised  in  the  liver  and  lung  by  various  cytochrome  P450  enzymes  into  different 
hydroxymetabolites and its reactive exo-epoxide that readily forms DNA adducts. Excretion of both 
conjugated parent STC and its hydroxylated metabolites occurs via bile and urine.  
There  are  insufficient  data  to  assess  the  rate  of  carryover  of  STC  into  milk  when  ruminants  are 
exposed to contaminated feed. Moreover, no information is available about the transfer of STC and/or 
its metabolites into other animal products such as meat and eggs. 
The acute oral toxicity of STC is relatively low with LD50 values varying between 120 and 166 mg/kg 
body  weight  (b.w.).  Liver  and  kidneys  are  the  target  organs  of  acute  toxicity.  Liver  lesions  are 
observed in rat, mouse, monkey and guinea pig and increase with dose and duration of exposure. They 
are defined as hepatocellular necrosis and haemorrhages. In the kidney, hyaline degeneration, tubular 
necrosis and haemorrhages were described in rats and/or vervet monkeys (Chlorocebus pyreguthreus) 
exposed  to  STC.  Results  from  in  vivo  and  in  vitro  studies  suggest  that  STC  may  have 
immunomodulatory activity, but firm conclusions cannot be drawn. Sterigmatocystin in food and feed 
 
EFSA Journal 2013;11(6):3254  3 
STC is mutagenic in both bacterial and mammalian cell assays after metabolic activation. It induces 
chromosomal damage both in vitro, upon metabolic activation, and in vivo in experimental animals. 
Tumourigenicity  of  STC  was  observed  after  oral,  intraperitoneal,  subcutaneous  and/or  dermal 
administration in the animal species tested (rat, mouse, Mongolian gerbils, monkey and fish). After 
oral  exposure,  premalignant  and  malignant  lesions  such  as  hepatocellular  carcinomas  (HCC), 
haemangiosarcomas  in  the  liver,  angiosarcomas  in  the  brown  fat,  lung  adenomas  and  incidental 
findings in other organs were reported. It is concluded that STC is genotoxic and carcinogenic.  
Despite the evidence on genotoxicity and carcinogenicity, only a limited tumourigenicity database was 
available for dose–response assessment. From the data available on haemangiosarcomas in the liver of 
male rats, a benchmark dose for a response of 10 % extra risk (BMD10) of 0.36 and a lower 95 % 
confidence limit for a benchmark response of 10 % extra risk (BMDL10) of 0.16 mg STC/kg b.w. per 
day were calculated. A comparison of the BMD10 of STC for the occurrence of haemangiosarcomas 
and that  of  AFB1 for  the occurrence of  HCC  suggested  that  the carcinogenic  potency  of  STC is 
approximately three orders of magnitude lower than that of AFB1. 
Due to the absence of exposure data for the European population, the margin of exposure (MOE) 
approach  for  substances  that  are  genotoxic  and  carcinogenic  could  not  be  applied  for  STC  and 
therefore, the CONTAM Panel could not characterise the risk of STC for human health. 
Concerning feed contamination, following an EFSA call for data, analytical results from 334 feed 
samples were submitted by two Member States. Except for four samples, analytical results on STC 
were reported to be all below the LOD or LOQ. Based on the available data, the CONTAM Panel 
concluded that a reliable exposure assessment was not feasible for animals.  
The toxicity of STC in livestock, fish and companion animals remains largely unknown. In sheep, no 
signs of toxicity were observed in a feeding trial at the highest dose tested (16 mg STC/kg feed, 
estimated  as  equivalent  to  0.3  mg/kg  b.w.  per  day).  Only  limited  data  are  available  for  other 
ruminants, but a case report describes haemorrhages and bloody diarrhoea in cattle following exposure 
to STC. STC is hepatotoxic in poultry and pigs, and nephrotoxic in poultry. Toxicity of STC has been 
demonstrated in several fish species. Pathological alterations included haemorrhages and oedema of 
the gills and haemorrhages and eosinophilic infiltrations in the hepatopancreas. No data on adverse 
effects  of  STC could  be identified for other  animal  species.  In  the  absence  of  exposure  data  for 
livestock, fish and companion animals, and given the limited knowledge on the adverse effects of STC 
following the ingestion of contaminated feed, the CONTAM Panel could not characterise the risk of 
STC for animal health.  
The EFSA Scientific Committee has concluded that an MOE of 10 000 or more for substances that are 
genotoxic and carcinogenic is of low concern for public health. Based on the BMDL10 (0.16 mg 
STC/kg  b.w.  per  day)  and  an  MOE  of  10  000,  the  STC  concentration in  grains  and  grain-based 
products leading to an exposure of low health concern (0.016 µg/kg b.w. per day) would range from 
1.5 to 8 µg/kg. The available information on toxicity and exposure in farm and companion animals is 
insufficient to draw similar conclusions for feed. 
Since currently, due to the absence of exposure data, a risk characterisation is not possible for STC, 
the  CONTAM  Panel  recommends  that  more  occurrence  data  for  STC  in  food  and  feed  across 
European countries need to be collected. For food, methods with an LOQ of less than 1.5 µg/kg should 
be applied, whereas for feed, the available information is insufficient to make a recommendation. The 
development of suitable certified reference materials and/or proficiency tests to support analytical 
methodology should be encouraged. Sterigmatocystin in food and feed 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Sterigmatocystin is mainly produced by the fungi Aspergillus nidulans and Aspergillus versicolor. It 
has been reported in cereals, green coffee beans and cheese. Sterigmatocystin is a mycotoxin closely 
related to aflatoxins. 
AVAILABLE INFORMATION (NOT EXHAUSTIVE)  
In accordance with Article 36 of Regulation (EC) No 178/2002, a report ―Scientific information on 
mycotoxins and natural plant toxicants‖ has been produced following a grant agreement between the 
European  Food  Safety  Authority  (EFSA)  and  the  author(s)  of  the  report 
(CFP/EFSA/CONTAM/2008/01).  The  report  presents  information,  inter  alia,  regarding 
sterigmatocystin  in  feed  and  food  and  is  available  on  the  EFSA  website 
(http://www.efsa.europa.eu/en/scdocs/doc/24e.pdf)  
ISSUE 
There might be a possible risk for animal and public health, related to the presence of sterigmatocystin 
in  feed  and  food.  The  European  Commission  asks  EFSA  to  assess  on  the  basis  the  available 
information the risk for animal and public health in order to enable the European Commission and the 
competent authorities in the Member States to consider the need for a possible follow up including to 
fill the knowledge gaps. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Art. 29 (1) of Regulation (EC) No 178/2002, the European Commission asks the 
European Food Safety Authority to provide a scientific opinion on the risks for animal and public 
health related to the presence of sterigmatocystin in feed and food.  
The  assessment  should,  based  upon  the  available  information,  assess  if  the  presence  of 
sterigmatocystin in food and feed is a potential risk for public and animal health taking into account 
the toxicity of sterigmatocystin and the occurrence in feed and food. For the assessment of the risks 
related to the presence of sterigmatocystin in feed, the situation for the different farm animal species 
should be considered. For the assessment of the risks related to the presence of sterigmatocystin in 
food the situation for the specific (vulnerable) groups of the human population (e.g. high consumers, 
children, people following specific diets, etc.) should be considered. 
 Sterigmatocystin in food and feed 
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ASSESSMENT 
 
1.  Introduction 
Sterigmatocystin  (STC)  is  a  polyketide  mycotoxin  that  is  produced  by  several  fungal  species, 
including Aspergillus flavus, A. parasiticus, A. versicolor and A. nidulans, of which A. versicolor is 
the most common source. A recent assessment of fungi for potential STC biosynthesis has provided a 
comprehensive  list  of  55  fungal  species  within  the  genera  Emericella,  Aspergillus,  Chaetomium, 
Botryotrichum and Humicola that share the ability to produce STC (Rank et al., 2011). Previous 
reports that some Penicillium spp. produce STC have not been confirmed by this recent study. STC 
shares its biosynthetic pathway with aflatoxins (AF) (Sweeney and Dobson, 1999; see also Appendix 
A).  Wild-type  A.  nidulans  and  A.  versicolor  are  apparently  unable  to  biotransform  STC  into 
O-methylsterigmatocystin, the direct precursor of aflatoxin B1 (AFB1) and G1 (AFG1) (Sweeney and 
Dobson, 1999; Yu et al., 2004). Consequently, substrates colonised by these fungi can contain high 
amounts of STC, while substrates invaded by A. flavus and A. parasiticus contain only low amounts of 
STC as most is converted into AFs (Yu et al., 2004).  
A. vesicolor is able to grow on substrates with a low water activity (aw between 0.75 and 0.95) and in a 
temperature  range  between  4  and  40  °C,  with  an  optimum  for  toxin  production  at  temperatures 
between 23 and 29 °C (Betina, 1989).  
Grains and grain-based products have been found to contain STC due to fungal infestation at the post-
harvest  stage  (storage,  transport  and  processing).  STC  has  been  measured  incidentally  in  other 
products of plant origin such as green coffee beans, spices and beer. In addition, fungal spoilage and 
production of STC has been observed in cheese.  
Owing  to  the  structural  similarities,  AFs  and  STC  share  prominent  toxic  effects,  including 
genotoxicity and carcinogenicity (Miller and Trenholm, 1994; see Section 7.2.5). However, in contrast 
to AFs, only limited information on occurrence and toxicity of STC is available. 
1.1.  Previous assessments 
The International Agency for Research on Cancer (IARC) has assessed the carcinogenic potential of 
STC (IARC, 1976, 1987) and concluded that STC produced lung tumours in mice and liver tumours in 
rats following oral administration. The IARC noted that in rats, STC induced skin and liver tumours 
following its administration to the skin and sarcomas at the site of its subcutaneous (s.c.) injection. No 
case reports or epidemiological studies were available for evaluation by IARC and it was concluded 
that STC is possibly carcinogenic to humans (group 2B). 
The  California  Environmental  Protection  Agency  (1992,  2000)  has  evaluated  the  human  cancer 
potency of STC based on five datasets comprising liver tumours in male rats (Ohtsubo et al. 1978; 
Maekawa et al., 1979), hepatocellular carcinomas (HCC) in rats (sexes combined) treated by gavage 
and feeding (Purchase and van der Watt, 1970a), and liver carcinomas in male rats (Terao et al., 1978). 
A no significant risk level of 0.02 µg per day was derived as the intake associated with a lifetime 
cancer risk of 10
-5 or lower for a 70 kg body weight (b.w.) adult. 
The approach taken by EFSA to characterise the risk of substances that are genotoxic and carcinogenic 
is the margin of exposure (MOE) approach, in which no implicit assumptions about a ‗safe‘ intake 
(e.g. a no significant risk level) or a lifetime cancer risk are made (EFSA, 2005). 
1.2.  Chemistry 
STC  ((3aR,12cS)-3a,12c-dihydro-8-hydroxy-6-methoxy-7H-furo[3',2':4,5]furo[2,3-c]xanthen-7-one; 
C18H12O6, molecular mass 324.28 g/mol; CAS No 10048-13-2) is a polyketide mycotoxin structurally 
related  to  AFB1  (Figure  1).  STC  crystallises  as  pale-yellow  needles  with  a  melting  point  of Sterigmatocystin in food and feed 
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245-246 °C. It is methylated at the C8-hydroxyl group by methyl sulphate or methyl iodide. Methanol 
or ethanol in acid, form dihydroalkoxysterigmatocystin from STC (Lou et al., 1994; Versilovskis and 
De  Saeger,  2010).  Ultraviolet  (UV)  spectrum  (in  ethanol):  235  nm  (extinction  coefficient 
(ε) = 24 500), 249 nm (ε = 27 500), and 329 nm (ε = 13 100) (Cole and Schweikert, 2003). STC is 
characterised by a weak fluorescence (Maness et al., 1976). 
Sterigmatocystin  Aflatoxin B1 
 
 
 
 
 
 
 
 
 
 
Figure 1:   Chemical structures of sterigmatocystin and aflatoxin B1. 
STC is readily soluble in chloroform, as well as other organic solvents, such as methanol, ethanol and 
acetonitrile (Septien et al., 1993; Versilovskis and De Saeger, 2010). Septien et al. (1994) also showed 
the low solubility of STC in aqueous solutions (phosphate buffer) at different pH values.  
Septien et al. (1993) observed a stability of more than 95 % in chloroform at 4 °C and at -20 °C for 
30 days. No other data on stability of STC could be identified. 
2.  Legislation 
In order to protect public health, Article 2 of Council Regulation (EEC) No 315/93
4 stipulates that, 
where necessary, maximum tolerances for specific contaminants shall be established. Therefore, a 
number of maximum levels (MLs) for contaminants as well as natural plant toxica nts in food 
commodities are currently laid down in Commission Regulation (EC) No 1881/2006
5. To ensure 
agricultural productivity and sustainability, animal and public health, animal welfare and protection of 
the environment, maximum contents for undesirable substances in animal feed are laid down in the EU 
Directive 2002/32/EC of the European Parliament and the Council of 7 May 2002
6. While MLs for 
various mycotoxins were set for a number of food commodities and for  AFs in feedingstuffs, the 
occurrence of STC is not regulated so far under these or other Regulations within the European Union 
(EU).  
MLs for STC have been previously reported from the Czech Republic and Slovakia by the Food and 
Agriculture Organization (FAO) (FAO, 2004). However, both countries  withdrew their legislation on 
STC when becoming a member of the European Union. 
3.  Methods of analysis 
Analytical methods for STC have recently been reviewed by Versilovskis and De Saeger (2010). This 
includes  a  comprehensive  overview  of  chromatographic  methods  for  the  detection  of  STC  in 
foodstuffs, feed, dust, building and indoor air. STC reference standards can be obtained from several 
commercial suppliers. 
13C labelled STC is commercially available which could be used as an internal 
standard for mass-spectrometry based methods to compensate for analyte losses during extraction, 
                                                       
4  Council Regulation (EEC) No 315/93 of 8 February 1993 laying down Community procedures for contaminants in food. 
OJ L 37, 13.2.1993, p. 1–3. 
5  Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in 
foodstuffs. OJ L 364, 20.12.2006, p. 5–24. 
6  Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal 
feed. OJ L 140, 30.5.2002, p. 10–21. 
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stability  issues  during  analysis  and  matrix  effects.  No  certified  reference  materials  are  available. 
However,  Tanaka  et  al.  (2008)  reported  the  preparation  of  a  homogeneous  brown  rice  reference 
material containing STC. No proficiency tests for STC analysis in food or feed could be identified and 
so far only one thin-layer chromatographic (TLC) method has been officially validated
7. 
3.1.  Sample collection and storage 
Fungal  growth  and  mycotoxin  production  are  significantly  affected  by  crop  variety,  agronomic 
practices, weather conditions during growth and harvest, storage and processing conditions as well as 
toxigenic potential of individual mould species. Consequently, the distribution of mycotoxins in a lot 
of  agricultural  products  can  be  very  heterogeneous  if  fungal  invasion  occurs  post  harvest  during 
storage (‗hot spots‘). Therefore, sampling is the largest source of variability associated with mycotoxin 
test procedures and the most crucial step in obtaining reliable results (Köppen et al., 2010). The 
European Commission established sampling methods to be used for the official control of mycotoxins 
in  cereals  and  cereal-based  products,  dried  fruit,  dried  figs,  (ground)nuts,  spices,  milk  and  milk 
products (including milk products for infants), coffee and coffee products, fruit juices, cider and wine, 
apple products and apple juice, and baby food (Regulation 401/2006/EC
8). No specific research on 
sampling plans has been undertaken for STC, but the above-mentioned procedures provide a valuable 
guidance for sampling also for STC analyses.  
3.2.  Methods of analysis of sterigmatocystin 
3.2.1.  Sample preparation  
Methods for STC extraction from food and feed are mainly based on a mixture of acetonitrile (or 
methanol) and aqueous potassium chloride, but also chloroform and ethyl acetate were described as 
extraction solvents. For defatting of samples, n-hexane is applied while sample clean-up is performed 
by liquid–liquid extraction (mostly with chloroform). In addition, solid-phase extraction (SPE) on 
different  SPE  columns  has  been  described  (Versilovskis  and  De  Saeger,  2010).  Immunoaffinity 
columns are not available for STC clean-up. 
Liquid  chromatography-tandem  mass  spectrometry  (LC–MS/MS)  multi-mycotoxin  methods  that 
include STC are frequently based on a single extraction step for all investigated mycotoxins (e.g., 
acetonitrile/water mixture) followed by the direct analysis of the diluted crude extract (Sulyok et al., 
2007; Spanjer et al., 2008). This so-called dilute-and-shoot approach requires very sensitive analytical 
instruments and often suffers from considerable matrix effects. 
In the case of analysis of samples of the indoor environment, many different extraction methods are 
described, depending on the sample type (air, dust, mycelium, building materials). Several extraction 
solvents,  e.g.,  acetonitrile,  methanol/water,  dichloromethane/ethyl  acetate,  ethyl  acetate,  are  used, 
followed by defatting, filtration, centrifugation and/or evaporation steps (Tuomi et al., 2000; Engelhart 
et al., 2002; Delmulle et al., 2006; Bloom et al., 2007; Hintikka et al., 2009). 
3.2.2.  Instrumental techniques  
STC  detection  in  food  and  feed  extracts  is  performed  by  immunochemical  or  preferably  by 
chromatographic techniques. Table 1 summarises the characteristics and the limits of detection (LOD) 
of the different analytical methods.  
3.2.2.1.  Immunochemical methods 
Only a very limited number of enzyme-linked immunoassay (ELISA) methods have been described 
for STC, making use of either polyclonal (Morgan et al., 1986; Olson and Chu, 1993a) or monoclonal 
                                                       
7  AOAC Official Method 973.38 for sterigmatocystin in barley and wheat: AOAC Official Methods of Analysis, on-line 
edition, chapter 49. 
8  Commission Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods of sampling and analysis for the 
official control of the levels of mycotoxins in foodstuffs. OJ L 70, 9.3.2006, p. 12-34. Sterigmatocystin in food and feed 
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antibodies (Li et al., 1996). In wheat, the lowest reproducible concentration of STC that could be 
quantified was 31 µg/kg, with a working range up to 250 µg/kg (Li et al., 1996). 
3.2.2.2.  Chromatographic techniques 
a.  Thin-layer chromatography (TLC) with fluorescence detection (FLD) is commonly reported 
for STC analysis of extracts from different food and feed matrices with LODs ranging from 
2 to 140 µg/kg (Versilovskis and De Saeger, 2010). A validated official method is based on 
TLC with AlCl3 spraying. The limit of quantification (LOQ) was 30 µg/kg in maize and 
100 µg/kg in wheat and barley
7 (Stack and Rodricks, 1971, 1973). 
b.  Gas chromatography (GC) methods for STC determination are scarce with reported LODs at 
5 µg/kg in grains (Salhab et al., 1976) and 50 µg/kg in rice (Manabe et al., 1973).  
c.  High-performance  liquid  chromatography  (HPLC)  methods  for  STC  determination  are 
described as single analyte methods (Stack et al., 1976; Schmidt et al., 1981; Abramson and 
Thorsteinson, 1989; Scudamore et al., 1998a; Tanaka et al., 2007; Versilovskis et al., 2008b) 
as well as in multi-mycotoxin methods (Hurst et al., 1987; Tangni and Pussemier, 2007). 
Detection  is  performed  by  UV  (including  diode  array  detection,  DAD)  or  FLD.  HPLC 
methods are applied to extracts of different food, feed and grain dust matrices with LODs 
ranging  from  0.3  to  100  µg/kg  (Scudamore  et  al.,  1998a;  Tangni  and  Pussemier,  2007; 
Versilovskis et al., 2008b).  
d.  Liquid chromatography-tandem mass spectrometry (LC–MS/MS) methods with low limits of 
detection are described for detection of STC in different food and feed matrices. Scudamore et 
al. (1996) described the determination of STC at levels down to less than 5 µg/kg in cheese, 
bread and maize products by HPLC with atmospheric pressure ionisation mass spectrometric 
detection. For grains, a sensitive LC-electrospray positive ionisation (ESI
+)–MS/MS method 
was  developed  and  validated  for  STC  determination  with  the  lowest  validation  level  at 
0.5 µg/kg (Versilovskis et al., 2007). This LC–MS/MS method was modified and applied to 
the analysis of STC in cheese samples by Versilovskis et al. (2009) and reached the low 
detection limit of 0.03 µg/kg.  
STC has been included in several multi-mycotoxin liquid chromatography-mass spectrometry (LC–
MS)  methods  applied  to  extracts  from  mouldy  food  samples,  pistachios,  sweet  peppers,  food 
supplements, beer and cereal grains with LODs ranging from 0.4 to 10 µg/kg (Sulyok et al., 2007; 
Spanjer et al., 2008; Di Mavungu et al., 2009; Monbaliu et al, 2009; Martos et al., 2010; Zachariasova 
et al., 2010). 
Also for indoor environments and building materials, STC detection is mainly performed by use of 
single or multi-mycotoxin LC–MS/MS methods (Tuomi et al., 2000; Engelhart et al., 2002; Delmulle 
et al., 2006; Bloom et al., 2007; Hintikka et al., 2009; Vishwanath et al., 2011) with LODs ranging 
between 1 ng/mL fungal culture sample (Delmulle et al., 2006) and 6 ng/g dust sample (Hintikka et 
al., 2009). Sterigmatocystin in food and feed 
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Table 1:   Overview of characteristics and limits of detection of most important sterigmatocystin 
analytical methods in food and feed. 
Analytical technique  Method characteristics  LOD (µg/kg) 
ELISA  Screening (qualitative - semi-quantitative)    n.r.
(a) 
TLC  Screening (qualitative – semi-quantitative)  2–140 
GC  Confirmation (semi-quantitative – quantitative)  5–50 
HPLC with UV detection (including 
DAD) or FLD 
Confirmation (semi-quantitative – quantitative)   
LC-MS
(b)  Possible multi-analyte detection  0.3–100 
ELISA:  enzyme-linked  immunosorbent  assay;  TLC:  thin-layer  chromatography;  GC:  gas chromatography;  HPLC:  high-
performance liquid chromatography; UV: ultraviolet; DAD: diode array detection; FLD: fluorescence detection; LC–MS: 
liquid chromatography–mass spectrometry; LOD: limit of detection; LOQ: limit of quantification; n.r.: not reported. 
(a):  An LOQ of 31 µg/kg was reported by Li et al. (1996). 
(b):  LC–MS can be used for indoor environments analysis as well, with LODs reported in the range of 1 to 6 ng/mL or ng/g 
sample.  
 
3.3.  Concluding remarks 
Analytical methods for STC in food and feed based on LC –MS reach the lowest LODs. However, the 
sensitivity varies between individual matrices and whether a single or multi-analyte method is applied. 
So far, no certified reference materials are available for STC. In addition, no proficiency tests for STC 
analysis of food or feed could be identified. 
4.  Occurrence of sterigmatocystin in food and feed 
4.1.  Previously reported literature data on the occurrence of sterigmatocystin 
During the last 30–40 years only a limited number of surveys on the occurrence of STC in different 
foods were carried out. A recent review by Versilovskis and De Saeger (2010) described occurrence of 
STC in foodstuffs in general and in cheese in particular.  
The toxin has been reported in grains, nuts, green coffee beans, spices, beer and cheese. It should be 
noted that not all studies reported LOD and LOQ values, meaning that negative findings must be 
interpreted with caution. Appendix B gives further details on the studies, including the LODs and 
LOQs as far as reported. Whether unprocessed cereal grains are intended for food or feed use, remains 
often unclear and they are therefore discussed in a separate section. 
4.1.1.  Occurrence of sterigmatocystin in grains 
Appendix B (Table B1) gives an overview of published occurrence data in grains. The first surveys on 
the occurrence of STC have been carried out applying TLC as an analytical technique. In Europe such 
surveys were reported for Germany (Thurm et al., 1979), Poland (Szebiotko et al., 1981), the United 
Kingdom  (UK)  (Buckle,  1983),  Czechoslovakia  (Bartos  and  Matyas,  1983),  Bulgaria  (Petkova-
Bocharova et al., 1991) and Turkey (Ozay and Heperkan, 1989). Grains included maize, barley, wheat, 
oats and rye. STC was not found in most of the tested grain samples. However LODs and LOQs were 
high (≥ 15 µg/kg) or were not reported.  
In recent years, there has been significant progress in developing more precise analytical techniques. 
In particular, HPLC methods were applied for the determination of STC in various commodities. In 
the  UK,  four  surveys  have  been  carried  out  on  the  occurrence  of  STC  in  grains  using  HPLC. 
Scudamore and Hetmanski (1995) found STC in 8 (17 %) out of 46 samples of poorly stored cereals 
(wheat,  barley  and  oats). In  another  study,  Scudamore  et  al.  (1997)  monitored  the  occurrence  of 
mycotoxins in grains intended for use as animal feed, again using HPLC, with an LOD of 15 µg/kg. 
Out of 45 samples of barley and 50 samples of wheat, STC was found in one organically grown wheat 
sample at a concentration of 18 µg/kg. STC was not detected in any of the 122 samples of cereals 
(barley, maize, wheat, oats, rice and rye) using HPLC, with an LOD of 3 µg/kg and LOQ of 6 µg/kg Sterigmatocystin in food and feed 
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(MAFF,  1998).  Negative results  for  STC  were also  observed  in a  survey  by  the  Food  Standards 
Agency (FSA, 2002a), in which a total of 100 samples of rice were monitored.  
Using an LC–MS/MS method with an LOD of 0.15 µg/kg and an LOQ of 0.30 µg/kg, Versilovskis et 
al. (2008a) analysed 95 samples of different Latvian grains from 2006 (wheat, oats, ryes, barley and 
buckwheat samples) and 120 samples from 2007. STC was found in 14 % of the samples from 2006, 
with  concentrations  ranging  from  0.7  to  83  µg/kg.  In  35  %  of  the  samples  from  2007,  STC 
concentrations ranging from 1 to 47 µg/kg were found. The highest concentrations have been detected 
in wheat and barley, medium concentrations in buckwheat and quite low concentrations in oats and rye 
samples. In total, for both years 26 % of the 215 analysed samples contained STC above the LOD. 
Monbaliu et al. (2010) developed and validated a multi-mycotoxin LC–MS/MS method, accredited 
according to ISO17025, for the simultaneous detection of 23 mycotoxins, including STC, and used 
this method for the analysis of feed samples from Belgium. A total of 78 wheat and maize samples 
taken in 2008, intended for use as animal feed were analysed and STC was not found in any of the 
samples.  Among  367  additional  grain  samples  intended  for  use  as  animal  feed  from  the  period 
2008-2011, 11 samples of wheat, maize and barley showed STC concentrations between 6.9 and 
574 µg/kg. Co-occurrence with other mycotoxins was reported for all these 11 STC positive samples 
(i.e. above 4.75 µg/kg, the decision limit
9). In three maize samples, co-occurrence of STC (between 
7 and 574 µg/kg) with AFB1 (between 24 and 503 µg/kg) and aflatoxin B2 (AFB2) (between 4.3 and 
43 µg/kg) was observed (De Saeger, personal communication, 2012). 
In Russia, samples of wheat (n = 93), corn (n = 111) and barley (n = 146) intended for use as animal 
feed were sampled between 2006 and 2009 and analysed using ELISA (LOD/LOQ not reported). The 
percentage of samples above 100 µg/kg varied depending on the year between 0 and 21 %, 5 and 8 % 
and 0 and 23 % for wheat, corn and barley, respectively (Kovalenko et al., 2011). 
From North America, two reports describe the occurrence of STC in cereal grains using TLC. Scott et 
al. (1972) analysed 27 grain samples in Canada (wheat, oats, barley and rye) which were associated 
with lung problems in farmers and elevator operators from farm storage bins. The authors found STC 
in one (approximately 300 µg/kg) out of 20 wheat samples and no STC was found in the other grains. 
This was the first published report of STC occurring in an agricultural product. In the United States of 
America  (USA),  Stoloff  (1976)  reported  a  Food  and  Drug  Administration  (FDA)  survey  of 
457 samples of small grains over a two-year period in which STC could not be detected in any of the 
samples. No recent surveys on the occurrence of STC in North America could be identified. 
In Brazil, a total of 130 samples of maize were analysed (10 post-harvest and 120 stored for one year) 
using TLC, but the toxin was not found in any of the samples. The samples were collected from the 
region characterised by humid tropical weather, with hot and rainy summers and dry winters (Pozzi et 
al., 1995). Also in Brazil, Valente Soarez and Rodriguez-Amaya (1989) purchased 60 rice samples at 
random in retail stores and used a TLC method for the analysis (LOD = 15 µg/kg, LOQ = 35 µg/kg). 
STC was not detected in any sample. 
Several Japanese studies determined STC in brown rice samples. Sugimoto et al. (1977) investigated 
mycotoxin contamination of mould-infected brown rice during long-term storage in warehouses. They 
found STC in two samples of contaminated rice with levels of 50 and 450 µg/kg simultaneously with 
ochratoxin A (OTA) (430 and 230 µg/kg) and citrinin (1130 and 700 µg/kg). Takahashi et al. (1984) 
used TLC to study brown rice grains, infected by A. versicolor, which had been stored in a warehouse 
for two to three years after harvest. They found that the concentration of STC in the milled rice plus 
bran fraction was in the range of 3800–4300 µg/kg. However, negative results for STC were obtained 
by Tanaka et al. (2007), who analysed 48 brown rice samples using HPLC-UV.  
                                                       
9  If no permitted limit has been established for a substance, the decision limit (CCα) is the lowest concentration level at 
which a method can discriminate with a statistical certainty of 1-α that the particular analyte is present (Commission 
Decision  2002/657/EC  of  12  August  2002  implementing  Council  Directive  96/23/EC  concerning  the  performance  of 
analytical methods and the interpretation of results. OJ L 221, 17.8.2002, p. 8-36). Sterigmatocystin in food and feed 
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Screening of maize samples used in poultry feed for mycotoxins was carried out in India. Out of 
50 samples,  three  samples  were  contaminated  with  STC  at  concentrations  varying  from  traces  to 
150 µg/kg (Devi and Polasa, 1982). In another Indian study, wheat, rice and maize samples were 
collected randomly and screened for different mycotoxins (Pande et al., 1990). Among 30 wheat 
samples, two were positive for STC with levels of 110 and 145 µg/kg, from 30 rice samples, three 
were positive with a concentration between 108 and 157 µg/kg and no STC was found in any of the 
22 maize samples analysed. 
Overall, the available information on the occurrence of STC in grains from the literature is scarce. The 
EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) summarised the STC occurrence 
data that were obtained with TLC, HPLC and LC–MS methods. Most of the earlier studies using 
methods with rather high LODs/LOQs report a high percentage of left-censored data (below the LOD 
or LOQ) (often 100 %). One recent study using an LC–MS/MS method with an LOD of 0.15 µg/kg 
and an LOQ of 0.3 µg/kg reported STC-positive samples of grains intended for use as animal feed (26 
%).  
4.1.2.  Occurrence of sterigmatocystin in food 
4.1.2.1.  Grain-based products 
As STC was found in stored grains, it can be assumed that it is present also in grain-based products. 
Appendix B (Table B2) gives an overview of published occurrence data in grain-based products. 
In the UK, Jarvis (1982) investigated 13 maize flour samples and 26 breakfast cereals (six maize 
based,  six  oats  based  and  14  wheat  based)  and  found  that  only  one  wheat-based  sample  was 
contaminated with STC at a level of 7 µg/kg. A later survey (MAFF, 1998) comprised a total of 
128 maize-based food samples, purchased from various retail outlets: breakfast cereals, maize oils, 
maize on the cob, maize-based thickeners, maize syrup, polenta, tacos, tinned sweet maize, popcorn 
and maize snacks. STC was determined by HPLC with an LOD of 3 µg/kg. The toxin was not detected 
in any of the 128 samples analysed.  
Stroka et al. (2004) analysed 85 grain-based products purchased from local food markets in northern 
Italy. The LOD and LOQ of the high-performance thin layer chromatography (HP-TLC) method were 
2 and 6 µg/kg for wheat flour, and 4 and 11 µg/kg, respectively, for rice. STC was not detected in any 
of the 85 samples.  
An LC–MS/MS method with an LOD of 0.15 µg/kg and an LOQ of 0.30 µg/kg was used in Latvia for 
the analysis of 29 samples of different types of bread purchased from the local supermarkets in the city 
Riga  (Versilovskis  and  Mikelsone,  2008).  STC  was  found  in  five  of  the  analysed  samples  at 
concentrations ranging from 2.4 to 7.1 µg/kg. In total, four out of the five contaminated samples 
contained whole grains as the main ingredient.  
In  Brazil,  Valente  Soarez  and  Rodriguez-Amaya  (1989)  purchased  130  samples  of  maize-based 
products  at  random  in  retail  stores  and  used  a  TLC  method  for  the  analysis  (LOD  =  15  µg/kg, 
LOQ = 35 µg/kg). STC was not detected in any sample. 
4.1.2.2.  Cheese 
Cheese is a susceptible product for mould spoilage. A. versicolor, a species known to produce STC, is 
frequently found on hard cheeses that have become infected with this species during production or 
ripening. The occurrence of STC in cheese has been reported in various publications and was recently 
reviewed comprehensively by Versilovskis and De Saeger (2010). 
In Europe, the first study on the occurrence of STC in cheese was conducted in France, where Lafont 
et al. (1979) reported the analysis of 235 cheese samples. STC was detected in three contaminated 
hard cheeses that contained 45, 125 and 330 µg/kg in the outer 2 cm layer. The toxin was not found in Sterigmatocystin in food and feed 
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the inner part of the same positive samples. STC was detected also in the outer layer (1–2 cm) of 
mouldy  cheese  with  concentrations  up  to  9000  µg/kg  in  the  Netherlands  (Northolt  et  al.,  1980; 
Northolt and van Egmond, 1982) and in Egypt, where 100 samples of hard cheese were analysed using 
TLC (Abd Alla et al., 1996; Metwally et al., 1997). From the 100 samples, 35 samples contained STC 
with a mean value of 24 µg/kg and a range between 10 and 63 µg/kg. In Czechoslovakia, among 
66 examined samples of hard cheeses taken from local retail shops, three samples were found positive 
for STC: two samples of Edam cheese contained 7.5 µg/kg and 17.5 µg/kg, one sample of Moravian 
Block contained 7.5 µg/kg (Bartos and Matyas, 1982). However, several other studies using TLC, 
HPLC or unreported methods did not detect STC in cheese in a total of 156 samples (Luck et al., 
1976; Nowotny et al., 1983; MAFF, 1987, 1998; Lopez-Diaz et al., 1996). 
Applying a more sensitive LC–MS/MS method, Versilovskis et al. (2009) analysed (entire) cheeses 
produced in Latvia (eight samples) and Belgium (13 samples). The LOD and LOQ of the method were 
0.03 and 0.1 µg/kg, respectively. STC was quantified in 2 out of 13 Belgian cheese samples with 
concentrations of 0.52 µg/kg and 1.23 µg/kg. In four of the eight Latvian cheese samples, STC was 
detected above the LOD, but below the LOQ. 
The distribution of STC over surface, rind layer and two cheese layers in six Gouda cheeses (at ages of 
2-8 months) as well as the stability of STC in two Gouda cheeses (at ages 6.5 and 8 months) at three 
different storage temperatures (freezer (–18 °C), refrigerator (+4 °C) and warehouse (+16 °C)), was 
studied by van Egmond et al. (1982). The authors found that STC contents of the various layers 
decreased rapidly from the outside to the inner layers. The greater part of A. versicolor mycelium and 
STC were present in the rind layers to a depth not greater than 6 mm. Small amounts of STC could be 
found in edible parts of the investigated Gouda cheeses. It was uncertain whether STC found in inner 
layers had been formed in this layer itself or had migrated from the outside into the inner parts. STC 
was  stable  for  three  months  at  the  different  temperatures.  Earlier,  Engel  and  Teuber  (1980) 
investigated the formation and distribution of STC in cheese after inoculation with A. versicolor and 
A. nidulans and found that the toxin was exclusively located near the surface (within 8 mm). 
In summary, STC has been detected in the outer layer of mouldy cheese and the available data suggest 
that contamination of cheese occurs particularly at the surface, following mould infestation during 
ripening and storage. 
4.1.2.3.  Nuts 
Schroeder and Hein (1977) reported for the first time the occurrence of STC in tree nuts (pecans). 
They analysed 40 pecan nuts with a TLC method and found one positive sample. The contaminated 
sample had been purchased from a retail outlet.  
In a study of Jiménez et al. (1991), 168 samples of roasted nuts purchased from a Spanish retail market 
were investigated, including almonds, peanuts, hazelnuts, pistachio nuts, and sunflower seeds. The 
first three types of nuts were shelled whereas pistachio nuts had usually split shells and sunflower 
seeds were in-shell. Analysis was done by TLC. STC was not detected in any of the samples. In 
addition, negative results were obtained in the survey of the Food Standards Agency (FSA, 2002b) 
where  STC  was  not  detected  above  the  limit  of  quantification  (LOQ  =  10  µg/kg)  in  any  of  the 
20 samples of peanuts analysed.  
Negative results for STC were also reported from the analysis of 40 peanut samples (El-Maghraby and 
El-Maraghy, 1987) and 20 hazelnut and 20 walnut samples from Egypt (Abdel-Hafez and Saber, 
1993) and a total of 30 samples of six kinds of nuts for human consumption (almond, cashew nut, 
chestnut, hazelnut, pistachio nut and walnut) from Saudi Arabia (Abdel-Gawad and Zohri, 1993). 
However, Youssef et al. (2008) found the contamination with STC in a study of untreated, roasted, and 
roasted and salted peanuts (20 samples of each) prepared for human consumption using TLC. STC 
was detected in 15 % of roasted nut samples (12.2–16.8 µg/kg) and in 5 % of roasted and salted nut 
samples (12.2 µg/kg). Sterigmatocystin in food and feed 
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4.1.2.4.  Other products 
Coffee beans 
First results on STC in defective and mouldy coffee beans were reported at the 89
th Annual Meeting of 
the Association of Official Analytical Chemists (AOAC) in 1975. No STC was found in any of the 
15 samples from 12 different geographical sources (Stoloff, 1976). Several studies determined STC in 
green coffee beans: Purchase and Pretorius (1973) detected STC in one out of two samples with a 
concentration of 1 143 µg/kg by TLC in South Africa and De Palo et al. (1977) detected STC in one 
out of 502 samples in Italy with a concentration of 1200 µg/kg. More recently, STC was found in two 
out of 30 samples in Saudi Arabia with concentrations of 11 and 13 µg/kg (Bokhari and Aly, 2009). In 
the latter study a TLC method was used and the sample with the STC concentration of 11 µg/kg was 
co-contaminated with aflatoxin G2 (AFG2) (10 µg/kg).  
Fruits and vegetables 
Thurm et al. (1979) did not find STC in any of the 134 samples of fresh fruits (grapes, plums, apples, 
pears, bananas and oranges), sterilised fruits, fruit juices (apple juices, blackcurrant juice and cherry 
juice), green vegetables (including tomatoes) and sterilised canned vegetables in Germany. 
Beer 
In a study by Versilovskis et al. (2008b) on 26 Latvian beer samples (9 dark beers and 17 light beers) 
which were purchased from local supermarkets, HPLC-UV analysis was used with an LOD and LOQ 
of 0.26 µg/L and 0.68 µg/L, respectively. STC was found in two samples, namely one dark beer with a 
concentration of 7.8 µg/L and one light beer with a concentration of 4.0 µg/L.  
Spices 
There are two reports on the occurrence of STC in spices. The first is from India, where 15 different 
spices (turmeric, coriander, fennel, cinnamon, black pepper, cardamom, greater cardamom,  Indian 
cassia, ammi, cumin, chilli, yellow mustard, Indian mustard, garlic and clove) had been purchased 
(6 to 9 samples for each spice) from randomly selected major retail outlets (Saxena and Mehrotra, 
1989). The samples were not visibly mouldy and were analysed by TLC. STC was found in one out of 
nine fennel samples (142 µg/kg) and in two out of eight samples of black pepper (105 and 125 µg/kg). 
The second report is from Egypt, where a total of 24 different spices (5 samples each) were analysed 
by TLC (El-Kady et al., 1995). STC was detected in the crude extracts of three samples of red pepper 
(in a concentration ranging from 10 to 23 µg/kg), three samples of caraway (in a concentration ranging 
from 14 to 18 µg/kg), three samples of cumin (with an average concentration of 11 µg/kg) and one 
sample of marjoram (with a concentration of 17 µg/kg). In caraway and marjoram, STC co-occurred 
with AFB1 and AFB2.  
Other 
In Brazil, Valente Soarez and Rodriguez-Amaya (1989) purchased 45 cassava products and 61 dried 
bean  samples  at  random  in  retail  stores  and  analysed  them  by  TLC  (LOD  =  15  µg/kg, 
LOQ = 35 µg/kg). STC was not detected in any sample. 
4.1.2.5.  Concluding comments 
Overall,  the  available  information  on  the  occurrence  of  STC  in  food  other  than  grains  from  the 
literature is scarce and often involves old studies applying TLC methods. Considering the low number 
of available data, the CONTAM Panel summarised the STC occurrence data that were obtained with 
TLC, HPLC and LC–MS methods. Most of the earlier studies on grain-based products using methods 
with rather high LODs/LOQs report a high percentage of left-censored data (often 100 %). One recent Sterigmatocystin in food and feed 
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study using an LC–MS/MS method with an LOD of 0.15 µg/kg and an LOQ of 0.3 µg/kg reported 5 
STC-positive samples of bread out of 29.  
Moreover, STC has been occasionally reported to occur in green coffee beans, spices, nuts and beer. 
4.1.3.  Occurrence of sterigmatocystin in feed 
Grain contamination with STC has been reported above. From  many of these samples it remains 
unclear whether or not these grains were intended for human or animal consumption. Only a few 
studies investigated STC in feedstuff solely and the data are summarised in Appendix B (Table B3). 
In the UK, Buckle (1983) reported the analysis of feedstuffs (n = 811), hay (n = 157) and grass silage 
(n = 451) using TLC and reported one positive hay sample with a concentration below 40 µg/kg. 
Scudamore  et  al.  (1997)  analysed  221  samples  of  feed  ingredients  (rice  bran,  maize  gluten  and 
products, cottonseed meal, rapeseed, sunflower meal, olive pulp, palm products, soya, peas/beans and 
manioc) using HPLC, but STC was not detected. 
Scudamore  et  al.  (1998b)  tested  40  rice  bran  samples  used  in  animal  feed  for  the  presence  of 
20 mycotoxins  in  the  UK  using  HPLC  (LOQ  =  50  µg/kg).  No  STC  was  found  in  any  sample. 
Scudamore et al. (1998a) analysed STC with a multi-mycotoxin method for 22 toxins in 40 samples of 
maize  gluten  (LOD  =  100  µg/kg)  and  in  27  samples  of  other  maize  products  such  as  maize 
germs/brans, baby maize, maize meals, flaked maize and maize screens (LOD = 20 µg/kg). No STC 
was found in any of these feed samples. 
Feedstuffs for dairy cows were tested in 24 dairy farms in the Netherlands. The LOQ for STC was 
50 µg/kg. STC was not detected in silage  (n = 47), compound feeds (n = 72), ensiled by-products 
(pressed sugar beet pulp, brewer‘s grains, potato pulp) (n = 29), forages (fresh grass, dried grass, hay) 
(n = 13), and feed commodities (rapeseed /soy meal, maize gluten meal, cereals) (n = 8), although 
other  mycotoxins  were present  (Driehuis  et  al.,  2008a).  In  another  study,  Driehuis  et  al.  (2008b) 
reported  that  they  found  no  STC  in  140  maize  silages,  120  grass  silages,  and  30  wheat  silages 
produced in the Netherlands between 2002 and 2004. An LC–MS/MS method was used with an LOQ 
of 50 µg/kg. 
Monbaliu  et  al.  (2010)  used  a  multi-mycotoxin  LC–MS/MS  method,  accredited  according  to 
ISO17025, for the simultaneous detection of 23 mycotoxins and analysed four sow feed samples taken 
in 2008. All samples were contaminated with at least one mycotoxin, but STC was not found in any of 
the samples. Among 282 additional feed samples from the period 2008–2011, five mixed feed samples 
and  three samples  of  maize  silage  showed  STC  concentrations  between  8.6 and  17.2  µg/kg.  Co-
occurrence with other mycotoxins was reported for all STC-positive samples (i.e. above 4.75 µg/kg, 
the decision limit
9) (De Saeger, personal communication, 2012). 
In Russia, samples of soybean (n = 15), sunflower cake (n = 53), mixed feed for piglets 0-2 months 
old (n = 120), mixed feed for piglets 2-4 months old (n = 94), mixed feed for sows and fattening pigs 
(n = 64), ‗dry milk, whole milk substitute, protein-mineral-vitamin supplement‘ (n = 28), peas (n = 22) 
and bran (n = 18) were sampled between 2006 and 2009 and analysed using ELISA (LOD/LOQ not 
reported). The percentage of samples above 100 µg/kg varied depending on the year between 0 and 
50 %, 0 and 22 %, 3 and 18 %, 0 and 2 %, 0 and 8 % and 0 and 14 %, for soybean, sunflower cake, 
mixed feed for piglets 0-2 months old, mixed feed for piglets 2-4 months old, mixed feed for sows and 
fattening pigs and ‗dry milk, whole milk substitute, protein-mineral-vitamin supplement‘, respectively. 
No samples exceeded 100 µg/kg for peas and bran (Kovalenko et al., 2011). 
El-Shanawany et al. (2005) tested 40 Egyptian silage samples for mycotoxins using TLC and found 
STC in two samples.  Sterigmatocystin in food and feed 
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Vesonder and Horn (1985) reported the occurrence of 7750 µg STC/kg dairy cattle feed that was 
infected by A. versicolor in the USA in 1983. The feed consisted of maize, cottonseed and a protein 
mix. 
Overall, the available information in the literature on the occurrence of STC in feed other than grains 
is scarce. Most of the studies report a high percentage of left-censored data (often 100 %). However, 
these analyses were mostly conducted with methods with rather high LOD/LOQs. A recent study 
using an LC–MS/MS method reported 3 % of STC-positive samples of feed.  
4.2.  Occurrence of sterigmatocystin in food and feed: call for data 
In October 2010, EFSA launched a call for data on mycotoxins and phytotoxins, including STC, in 
food and feed. EFSA collected and evaluated the results reported from the analysis of 581 samples, 
including 247 food and 334 feed samples. It cannot be excluded that samples described in Section 4.1 
were also submitted to EFSA during this call for data. 
The data submission to EFSA followed the requirements of the EFSA Guidance on Standard Sample 
Description  for  food  and  feed  (EFSA,  2010a).  SAS  Enterprise  software  was  used  to  process  the 
submitted data. 
4.2.1.  Summary of data collected  
The origin of the 581 food and feed samples reported from three European countries is illustrated in 
Figure 2. The United Kingdom and Czech Republic provided, respectively, 53 % and 47 % of the 
analytical results on food, whereas the Netherlands and Czech Republic provided, respectively, 81 % 
and 19 % of the analytical results on feed (Figure 2). 
Figure 2:   Distribution of food and feed samples for which sterigmatocystin concentrations were 
reported to EFSA across European countries (CZ: Czech Republic; NL: the Netherlands; UK: United 
Kingdom). Sterigmatocystin in food and feed 
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The distribution of analytical results over the sampling years is illustrated in Figure 3. Almost 60 % of 
the analytical results on food were obtained in 2009 and 2010 while the remaining 40 % of the results 
were obtained in 2000. The results on feed samples were from 2003 (81 %) and 2010 (19 %). 
Figure 3:   Distribution of food and feed samples for which sterigmatocystin concentrations were 
reported to EFSA over the sampling years. 
 
4.2.2.  Occurrence data from food samples: data analysis  
Data were classified according to FoodEx, which is a food classification system developed by EFSA‘s 
Dietary Chemical Monitoring Unit in 2009 with the objective to simplify the link between occurrence 
and  food  consumption  data  when  assessing  the  dietary  exposure to  hazardous  substances (EFSA, 
2011a). FoodEx contains 20 main food groups (first level), which are further divided into subgroups 
having 160 items at the second level, 1 261 items at the third level and about 1 800 endpoints (food 
names or generic food names) at the fourth level.  
Data on STC in food were mainly reported in the food group ‗Grains and grain-based products‘ and 
only four samples were reported in the food group ‗Snacks, desserts, and other foods‘. Within the food 
group ‗Grains and grain-based products‘, bread and rolls represented almost 50 % of the results, 
followed by rice (40 %), grain milling products (6 %) and fewer than five samples for the remaining 
sub-groups (see Appendix C, Table C1). 
The analytical results on STC in food were obtained by LC–MS/MS (n = 117) or HPLC coupled with 
FLD (n = 130).  
The detection capabilities varied with the analytical techniques, the food matrices and the analysing 
laboratories. In the case of HPLC-FLD methods, the LOD varied from 2 to 3 µg/kg whole weight 
(median of 3 µg/kg whole weight), whereas for LC–MS/MS, the LOD was 5 µg/kg whole weight. The 
LOQs for the two analytical methods were reported as twice the LODs.  
All analytical results on STC in food were reported as either < LOD (47 %) or < LOQ (53 %). 
Therefore,  in  accordance  with  international  guidance  no  dietary  exposure  assessment  could  be 
performed based on this data set (GEMS/Food-EURO, 1995; WHO, 2009; EFSA, 2010b) and the 
CONTAM Panel concluded that the data are too limited to carry out a reliable human dietary exposure 
assessment.  Sterigmatocystin in food and feed 
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4.2.3.  Occurrence data from feed samples: data analysis  
Feed  was  classified  according  to  the  catalogue  of  feed  materials  specified  in  the  Commission 
Regulation (EU) No 575/2011
10 of 16 June 2011 creating the Catalogue of feed materials. Most of the 
results were reported for ‗Forages and roughage, and products derived thereof‘ (n = 130, 39 %) and 
‗Cereal grains, their products and by-products‘ (n = 123, 37 %) (Appendix C, Table C2). All results 
were obtained by LC–MS/MS with an LOD equal to 5 µg/kg. The LOQ was reported only for 19 % of 
the data and was equal to 10 µg/kg. All left-censored data in feed were reported as < LOD. All 
analytical results were reported as whole weight.  
Only four quantified results were reported in feed: two of unspecified forage and roughage (8 and 
8.9 µg/kg),  one  sample  of  lucerne  pellets  (28  µg/kg)  and  one  sample  of  cocoa  hulls  (14  µg/kg). 
Therefore, the CONTAM Panel concluded that the data are too limited to carry out a reliable animal 
dietary exposure assessment. 
4.3.  Food and feed processing 
4.3.1.  Food processing 
Several  studies  reported  on  the  changes  in  STC  content  in  food  during  food  processing  such  as 
milling, bread and cheese making and roasting. 
Takahashi et al. (1984) reported that most of STC in brown rice was removed in the milling process; 
however, it was not possible to remove the toxin completely. 
Versilovskis  and  Bartkevics  (2012)  tested  the  stability  of  STC  during  bread  making  using  a 
contaminated batch of wheat with an STC concentration of 83 ± 8 µg/kg. The flour obtained from 
wheat grains was used for whole-grain bread baking for 17 minutes at 200–220 °C. The mean content 
of STC in baked bread was 48 µg/kg, which was equivalent to 78 µg/kg in grains. Statistically there 
was  no significant  difference  between the results obtained  in  contaminated  grains  and the results 
obtained in bread baked from these grains and as such STC was found to be stable during the bread 
making process.  
Abd Alla (1994) added STC to milk and used this contaminated milk for cheese making. It was shown 
that the disappearance of STC from contaminated milk depends on the type of starter culture, the 
storage period and the type of milk. The same group showed also that during cheese processing, 80 % 
of the toxin present in milk was found in the curd and only 20 % was found in the whey, related to low 
solubility in aqueous media, according to the authors (Abd Alla et al., 1996; Metwally et al., 1997). 
The influence of roasting on the STC content was investigated by Bokhari and Aly (2009), who 
roasted coffee beans at 200 °C for 6–15 minutes using an electric oven. After 6 or 8 minutes, no 
decrease in STC content was found. Increasing the roasting time to 10–12 minutes reduced the STC 
concentration by 40 to 50 %, and after 15 minutes the STC concentration was reduced by 70 %. These 
data confirm earlier results reported by Stoloff (1976) on roasting at about the same temperature for 
20 minutes.  
In conclusion, food processing can result in a decrease of the STC concentration; however, the extent 
depends on the type of food and the processing conditions. 
4.3.2.  Feed processing 
No data could be identified on the fate of STC during feed processing. There is a lack of knowledge on 
the effects of grinding, milling, pelleting, steam conditioning, extrusion, expelling and micronisation, 
and other processes used in feed processing on STC concentrations. 
                                                       
10   Commission Regulation (EU) No 575/2011 of 16 June 2011 on the Catalogue of feed materials. OJ L 159, 17.6.2011, p. 
25-65. Sterigmatocystin in food and feed 
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5.  Food and feed consumption 
No food or feed consumption data were used in this opinion because no exposure assessment was 
possible.  
6.  Exposure assessment in humans and animals 
6.1.  Human exposure assessment of sterigmatocystin 
6.1.1.  Previously reported human exposure assessments 
No published human dietary exposure assessments could be identified. 
6.1.2.  Dietary exposure to sterigmatocystin 
Only limited STC occurrence data in food were submitted to EFSA by two European countries. All of 
the data were left-censored and only two food groups were covered. Therefore, the Panel concluded 
that these data are too limited to carry out a reliable human dietary exposure assessment.  
6.2.  Dietary exposure assessment of sterigmatocystin in animals 
Only limited occurrence data in feed were submitted to EFSA by two European countries and 99 % of 
the data were left-censored. Therefore, the Panel concluded that these data are too limited to carry out 
a reliable animal dietary exposure assessment. 
6.3.  Non-dietary exposure  
A. versicolor prevalent in the indoor environment can produce STC up to 1 % of its biomass (Nielsen, 
2003). A. versicolor is able to grow on very nutrient-poor materials such as concrete and plaster. STC 
and 11-methoxy-STC
11 were detected by HPLC-DAD and TLC with AlCl 3 staining, in each of five 
isolates of A. versicolor artificially inoculated on pine wood, wallpaper, gypsum board and chipboard 
(Nielsen et al., 1998). The concentrations of STC varied and could reach up to 23 µg/cm
2 in wallpaper 
samples. This is of concern in water-damaged buildings as large quantities of STC on the building 
materials can be present. 
Sample collection is a key step in the analysis of mycotoxins in buildings, but no harmonised sampling 
protocol  exist.  For  the  assessment  of  human  exposure,  only  the  mycotoxin-containing  particles 
(including  fungal  conidia)  that  can  become  airborne  are  of  interest.  Therefore,  a  combination  of 
surface, dust and air sampling is recommended (Nielsen, 2003; Polizzi et al., 2009). 
STC was detected in 2 out of 11 carpet dust samples collected from eight dwellings in northern 
Germany with visible mould growth and/or signs of indoor dampness. The analysis was done by 
means of LC–MS/MS and the concentrations ranged between 2 and 4 ng/g of dust (Engelhart et al., 
2002). 
Seventy-nine bulk samples of mouldy interior surfaces from Finnish buildings with moisture problems 
were analysed for 17 mycotoxins by means of LC–MS/MS. Collected building materials included 
wallpaper,  cardboard,  wood,  plywood,  plasterboard,  paper-covered  gypsum  board,  mineral  wool, 
plaster,  sand,  soil,  linoleum,  polyurethane  insulation,  pipe  insulation  and  paint.  The  mycotoxin 
analysis revealed that STC was the most prevalent mycotoxin in the buildings. It was detected in 
19 samples  (24  %)  and  in  concentrations  up  to  31  000  ng/g.  A.  versicolor  was  present  in  most 
STC-containing samples (Tuomi et al., 2000). 
The presence of STC in indoor environments was also confirmed by Bloom et al. (2007). Using LC–
MS/MS,  they  could  detect  STC  in  settled  dust  from  water-damaged  buildings  and  homes.  The 
mycotoxin was found in one out of eight samples at a concentration of 17 ng/g. It was also found in 
                                                       
11   Reported by the authors as 5-methoxy-STC. Sterigmatocystin in food and feed 
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25 of the 62 building materials in the range from 1.9 to 1 100 ng/g, and usually it co-occurred with two 
or  more  other  mycotoxins.  A  follow-up  study  by  Bloom  et  al.  (2009a) in  water-damaged  indoor 
environments in Sweden showed that STC was the third most frequently found mycotoxin in building 
materials (22 %) and the most common in cultures of airborne fungal particles (41 %). STC was 
detected in building material samples in the concentration range of 4.9–150 000 ng/g and in cultures in 
the range of 3.6–10 900 pg/cm
2. Settled dust was found to be free of STC. 
Another  investigation  carried  out  by  Polizzi  et  al.  (2009)  in  seven  water-damaged  buildings  in 
Belgium revealed the presence of one or more mycotoxins in 62 out of the 99 samples analysed by 
means of multi-mycotoxin LC–MS/MS analysis (Delmulle et al., 2006). The mycotoxins found were 
mainly roquefortine C, chaetoglobosin A and STC, but roridin E, OTA, AFB1 and AFB2 were also 
detected. STC was present in air samples (0.0034–1.77 ng/m
3) and in dust, wallpaper, and scraped 
mycelium (0.063–778 ng/cm
2). 
Ventilation systems of Finnish schools were examined for the presence of mycotoxins including STC. 
Only in one case was a small quantity of this toxin detected (2.7 pg/cm
2) in dust collected by wiping 
the supply air handling unit; however other mycotoxins including but not limited to beauvericin and 
verrucarol were also present (Hintikka et al., 2009). 
Bloom et al. (2009b) collected dust samples in New Orleans dwellings. The houses were contaminated 
with moulds because of the flooding after hurricane Katrina. The collected samples were analysed for 
the presence of mycotoxins by LC–MS/MS. STC was detected in two samples at concentrations of 
16 and 28 ng/g dust. Additionally, Aspergillus spp. were identified in these two samples. 
Vishwanath et al. (2011) focused on two relatively different indoor environments—inhabited houses 
and waste management units. The study was intended to estimate exposure to contaminants (including 
mycotoxins) through ingestion and/or inhalation of indoor dust. The samples of settled floor dust were 
collected  using  a  vacuum  cleaner  and  analysed  by  LC–MS/MS.  STC  was  detected  in  both 
environments at concentrations not higher than 45 ng/g in the waste units and 11 ng/g in the houses. 
It should be noted that the above-mentioned studies and contamination data, result from targeted 
sampling from buildings with clear visible mould growth and/or signs of indoor dampness or water 
damage.  Although  it  is  at  this  stage  impossible  to  quantify  human  STC  exposure  from  indoor 
environments, inhalation might lead to additional STC exposure. 
7.  Hazard identification and characterisation 
7.1.  Toxicokinetics  
7.1.1.  Absorption 
The absorption of STC was studied in a single vervet monkey (Chlorocebus pygerythrus) given a 
single oral dose of 100 mg 
14C-labelled STC (18.4 mg/kg b.w., purity 99.5 %, 0.145 mCi) (Steyn and 
Thiel, 1976). The maximal rate of absorption from the gastrointestinal system was not higher than 
30 % of the applied dose. In Sprague-Dawley rats, peak plasma levels were reached after 30 minutes 
following an oral bolus administration of 8 mg/kg b.w. of 
14C-STC (Walkow et al, 1985; details of the 
study are described below in Section 7.1.2). In this study the rate of absorption was not calculated, but 
plasma concentration-time curves showed significant differences between female and male rats in both 
age groups tested. The cumulative renal excretion varied between 7.3 and 10.3 % of the administered 
dose, suggesting a limited rate of absorption also in rats. 
7.1.2.  Distribution 
Kinetics of STC were studied by Wang et al. (1991) in 30 male Wistar rats orally treated with 
3H-STC 
(0.5  mCi/kg  b.w.  radioactive  purity  95  %).  The  highest  concentration  of  radioactivity  in  serum 
appeared three hours after treatment and the half-life was calculated to be 30 minutes. Radioactivity Sterigmatocystin in food and feed 
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was concentrated mainly in liver, stomach, kidney, duodenum and lung and to a lesser extent in body 
fat, muscle tissue, testis, bone and in rectum tissue. An initially high accumulation of radioactivity was 
also found in stomach, which is in accordance with acanthomatous changes seen in rats chronically 
exposed to STC (Purchase and van der Watt, 1970a) and gastric erosions observed in Mongolian 
gerbils treated orally with STC (Kusunoki et al., 2011). 
In a repeated dose study, male and female immature and mature Sprague–Dawley rats (n = 5 per group 
per sex and age group) were exposed to STC (8 mg/kg feed equally divided over 13 days). On the 
14
th day the rats received an oral bolus administration of 8 mg/kg b.w. of 
14C-STC (unknown purity) 
dissolved in wheat germ oil. The highest level of tissue radioactivity was found in mature males and 
the lowest in immature females. Significant age differences were demonstrated, with tissue levels in 
different organs varying between mature and immature males and to a lesser extent between mature 
and immature females (Walkow et al., 1985). 
7.1.3.  Metabolism 
Data on the biotransformation of STC are scarce. The few studies published to date indicate that phase 
I metabolism of STC comprises cytochrome P450 (CYP)-mediated formation of a reactive epoxide as 
well as mono- and dihydroxylation reactions. As phase II metabolites, a glucuronide of STC and of 
monohydroxy-STC have been reported, together with a sulphate conjugate of monohydroxy-STC and 
a  glutathione  (GSH)  adduct  of  a  monooxygenated STC.  However, the structure  of  most  of these 
metabolites is not completely identified and, in part, controversial, as outlined below. 
7.1.3.1.  Phase I metabolites 
The  most  conclusive  evidence  for  the  formation  of  a  reactive  STC  epoxide  was  obtained  by 
Essigmann  et  al.  (1979),  when  STC  was  incubated  under  cell-free  conditions  with  DNA  in  the 
presence  of rat  liver  microsomes.  Subsequent  isolation  and  degradation  of the  DNA  followed by 
HPLC analysis revealed the presence of a covalent adduct, which was purified and identified by 
nuclear  magnetic  resonance  spectroscopy  and  mass  spectrometry  as  1,2-dihydro-2-(N
7-guanyl)-1-
hydroxy-STC (see also Section 7.2.5). The same DNA adduct was formed when isolated rat liver was 
perfused with STC (Essigmann et al., 1980). From the chemical structure and stereochemistry of this 
adduct, it was concluded that an exo-STC-1,2-oxide, i.e. an epoxide of STC with the epoxide ring in 
trans position to the bulky rest of the molecule, was the metabolite that reacted with DNA. 
In  a  recent  study  using  recombinant  human  CYP1A1,  1A2,  2A6,  2A13,  and  3A4,  the  in  vitro 
metabolism of STC was investigated (Cabaret et al., 2010, 2011). O-Demethylation of STC was not 
observed with any of the five CYP isoforms. Three metabolites (M1, M2, M3) were detected by LC-
MS with electrospray ionization and tentatively identified by their mass spectra. To M1, the structure 
of  12c-hydroxy-STC  was  assigned.  M2  was  proposed  to  represent  1,2-dihydroxy-STC,  possibly 
resulting from the hydrolysis of STC-1,2-oxide. M3 was suggested to be the glutathione (GSH) adduct 
of STC-1,2-oxide. However, these structure assignments, particularly of M2 and M3, were questioned 
by Krol (2011), mostly because of discrepancies between the mass spectra and the proposed structures. 
As alternative metabolic pathways, which would be in better agreement with the mass spectra obtained 
by Cabaret et al. (2010, 2011), Krol (2011) suggested hydroxylation of STC at positions 9 and/or 11 
(see  Figure  1).  This  would  lead  to  catechols/hydroquinones  and  through  subsequent  oxidation  to 
electrophilic quinones capable of forming GSH adducts. However, this aromatic hydroxylation of STC 
is still not confirmed, and the exact chemical structures of M1, M2, and M3 have yet to be elucidated. 
It  should  be  noted  that  chemical  syntheses  of  STC-1,2-oxide,  its  hydrolysis  product  STC-1,2-
dihydrodiol and its GSH conjugate 1-hydroxy-2-(S-glutathionyl)-1,2-dihydro-STC have been reported 
(Baertschi et al., 1989; Raney et al., 1992), but this information has not yet been used for the rigorous 
identification of STC metabolites. 
The five human CYP isoforms used by Cabaret et al. (2010) differed in their ability to oxidize STC. In 
the absence of GSH, M1 was only generated by CYP1A1 and 1A2, and M2 only by CYP1A1. In the 
presence of GSH, M3 was only formed by CYP1A2 and 3A4. Evidence for the ability of individual Sterigmatocystin in food and feed 
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CYP isoforms to metabolically activate STC is available from several genotoxicity tests. For example, 
STC was more efficiently activated by human CYP3A4 than by CYP3A5 to DNA-damaging products 
in  two  Salmonella  typhimurium  tester  strains  (Yamazaki  et  al.,  1995).  In  the  same  test  system, 
experiments with lung microsomes of rats treated with various CYP inducers suggested that CYPs 
other than those of the CYP1A family activate STC (Shimada et al., 1992). In contrast, rat liver 
CYP1A1, 1A2 and 2B1 stably expressed in immortal Chinese hamster V79 cells activated STC to a 
potent clastogen as measured by the induction of micronuclei containing chromosome fragments, but 
not whole chromosomes (Ellard and Parry, 1993). Shimada et al. (1996) showed that human CYP1B1, 
which is widely expressed in extrahepatic tissues, does not activate STC in two S. typhimurium tester 
strains. However, an increased mutation frequency of STC was reported in Saccharomyces cerevisiae 
after transfection  of  rat  CYP2B1  (Black  et al.,  1992). The  capacity  to  activate  STC  to cytotoxic 
metabolites  was  essentially  similar  for  human  fetus-specific  CYP3A7  and  adult  CYP3A4  stably 
expressed in Chinese hamster lung cells (Hashimoto et al., 1995). 
7.1.3.2.  Phase II metabolites 
The first identified conjugate of STC was its glucuronide, isolated as a major metabolite from the 
urine and bile of a vervet monkey after oral administration of 
14C-labelled STC (Thiel and Steyn, 
1973; Steyn and Thiel, 1976). This metabolite released STC upon hydrolysis with ß-glucuronidase, 
showing that it was the glucuronide of parent STC and not of a hydroxylation product. STC has only 
one functional group suitable for glucuronidation, i.e. the hydroxyl group at C-8 (Figure 1). When the 
urine  of  rats  after  intraperitoneal  (i.p.)  injection  of  STC  was  analysed  for  metabolites  using  an 
immunosorbent method with polyclonal antibodies, STC glucuronide was the only conjugate observed 
(Olson and Chu, 1993a). Likewise, when STC was incubated with cultured primary epithelial cells 
from  the  trachea  of  pigs,  STC-8-O-glucuronide  was  the  only  conjugated  metabolite  detected  by 
LC-ESI-MS  (Cabaret  et  al.,  2010,  2011).  After  pre-treatment  of  the  cells  with  the  CYP  inducer 
ß-naphthoflavone,  two  additional  conjugates  were  observed  by  the  same  authors  and  tentatively 
identified as monoglucuronide and monosulfate of a  monohydroxylated STC. The exact chemical 
structures of these conjugates are as yet unknown. For a discussion of the GSH conjugate, see Section 
7.1.3.1. 
7.1.4.  Excretion  
The study of Walkow et al. (1985) showed that most of the orally given STC in Sprague-Dawley rats 
was eliminated in the faeces (64–92 %), and about 10 % via urine. The calculated elimination half-life 
in these Sprague-Dawley rats varied between 61.5 h in immature females and 130 h in mature male 
rats and the cumulative total elimination rate (urine and faeces) after 96 h exceeded 99 % in immature 
and mature males, and varied between 71.5 and 77.4 % in immature and mature females, respectively. 
The plasma concentration–time curves provided evidence of entero-hepatic recirculation. In contrast, 
Olson and Chu (1993b) found in Fischer rats treated i.p. with 1, 4, 8 and 16 mg STC/kg b.w. (n = 4 per 
group)  that,  within  24  hours,  only  3.1  %  of  the  administered  dose  was  recovered  in  urine.  This 
apparent difference from the study of Walkow et al. (1985) is probably due to the lack of appropriate 
standards in the ELISA method used by Olson and Chu (1993b), which might not detect conjugated 
STC.  
Urinary and biliary excretion of STC was also studied in one vervet monkey given orally 
14C-STC 
(Thiel and Steyn, 1973; Steyn and Thiel, 1976). The major fraction (50–80 %) of the oral dose was 
recovered in faeces within 48 hours.  
7.1.5.  Carryover into animal products 
The  carryover  of  STC  from  feed  to  milk  was  investigated  in  two  cows  exposed  via  feed  to 
approximately 5 to 10 mg STC per day for two weeks (van Egmond et al., 1978). No STC could be 
detected in milk (LOD of 1 µg STC/kg milk); based on this LOD the authors calculated that less than 
0.4 % of the STC was transferred to milk. As TLC was applied as the method of detection for STC 
residues in milk, potential metabolites of STC could not be identified. The CONTAM Panel concluded Sterigmatocystin in food and feed 
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that there are insufficient data to assess the rate of carryover of STC into milk. No information about 
the carryover of STC and/or its metabolites into animal products such as meat and eggs was identified. 
7.1.6.  Concluding comments 
The scarce information available suggests that absorption of STC is limited following oral exposure. 
STC  is  metabolised  in  the  liver  and  lung  by  various  cytochrome  P450  enzymes  into  different 
hydroxymetabolites and its reactive exo-epoxide that readily forms DNA adducts. Excretion of both 
conjugated parent STC and its hydroxylated metabolites occurs via bile and urine.  
7.2.  Toxicity in experimental animals 
7.2.1.  Acute toxicity 
LD50 values of STC in experimental mammals as reported in the literature are summarized in Table 2. 
STC has relatively low acute oral toxicity. Although STC is structurally related to AFB1, STC‘s acute 
toxicity is 10 or more times lower: Butler (1964) reported in male rats that the i.p. LD50 values for 
STC and AFB1 are 60 and 6 mg/kg b.w., respectively, and that the per os (p.o.) LD50 values are 166 
and 7.2 mg/kg b.w., respectively. Wong and Hsieh (1980) reported for AFB1 a p.o. LD50 in rats 
ranging  from  5.5  to  17.9  mg/kg  b.w.  The  accuracy  of  the  LD50  values  presented  in  Table  2  is 
questionable, since large volumes of solvent were used in order to overcome the problem of low 
solubility of STC without quantifying the influence of the volume of solvent and the unabsorbed STC 
on the oral LD50 (Purchase and van der Watt, 1969). 
Table 2:   LD50  values  of  sterigmatocystin  in  experimental  rats  and  monkeys  as  reported  in  the 
literature. 
Animal  Sex  Solvent  Route  LD50 
(mg/kg 
b.w.) 
95 % 
CI 
Reference 
Rat  M  Dimethylformamide  p.o.  166  113–224  Purchase and van der Watt (1969) 
Rat  M  Dimethylformamide  i.p.  60  46–77  Purchase and van der Watt (1969) 
Rat  F  Wheat germ oil  p.o.  120  92–155  Purchase and van der Watt (1969) 
Rat  M  Wheat germ oil  i.p.  65  37–109  Purchase and van der Watt (1969) 
Monkey  M  Dimethylsulphoxide  i.p.  32  15–70  Purchase and van der Watt (1970b) 
M: male; F: female; p.o.: per os; i.p.: intraperitoneal; b.w.: body weight; CI: confidence interval. 
 
The target organs of acute STC toxicity are liver and kidney. In rats treated with high doses, areas of 
necrosis in the liver and kidney were seen (Purchase and van der Watt, 1969). In the liver, STC causes 
degenerative changes and necrosis depending on the route of administration. In i.p.-treated animals, 
liver injuries are seen first in the periportal zone, while in orally treated animals lesions are localised 
around the central vein and are milder than when the same dose is applied i.p. Histopathological 
changes after administration of doses lower than the LD50 are focal necrosis affecting single cells or 
groups of cells together with the enlargement of some nuclei and the appearance of multiple nucleoli. 
At STC doses higher than the LD50 (150–200 mg/kg b.w., 95 % purity), severe periportal necrosis with 
haemorrhage in necrotic areas was described. In animals treated i.p. with high doses of STC, the 
peritonitis was so severe that it could have contributed to death. In the kidney, at doses between 10 and 
100 mg/kg b.w., STC causes cortical haemorrhage, hyaline casts in the collecting tubules and pyknotic 
nuclei in the tubular cells at the cortico-medullary junctions. There was also hyaline degeneration or 
necrosis  of  tubular  epithelial  cells.  At  doses  in  the  range  of  100–144  mg/kg  b.w.,  lesions  were 
accompanied  by  degeneration  and  necrosis  of  glomeruli  with  hyaline  thickening  of  the  basement 
membrane.  The  most  prominent  findings  at  doses  above  144  mg  STC/kg  b.w.  were  massive 
haemorrhage and necrosis. The degree of kidney damage was independent of the vehicle used to 
dissolve STC. 
Young animals are apparently more sensitive to STC toxicity than adults. A single s.c. injection of 
0.03 mL of 1 % gelatine suspension with 100, 50, 10, 5, 1 and 0.5 mg STC/kg b.w. was given to the Sterigmatocystin in food and feed 
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progeny of nine dams of CD2F mice within 24 hours after birth (Fujii et al., 1976). Most of the young 
mice died within five days after treatment. In the three highest dose groups almost all animals died. 
In  40-hour-old  chicken  embryos,  1.0  µg  STC/egg  caused  100  %  mortality  during  the  24-hour 
observation period (Vesely et al., 1982). When the same dose was given to five-day-old chicken 
embryos, there was no mortality, but all embryos died at a dose of 10 µg of STC/egg (Schroeder and 
Kelton, 1975). Another study reported an LD50 value for five-day-old chicken embryos of 14.9 µg per 
egg (Terao, 1983).  
Considering exposure of STC via the indoor environment, a recent study describes the effect of an 
intratracheally instilled single STC dose of 13 mg/kg lung weight on inflammation-associated gene 
transcription  in  lung  tissue  in  pathogen-free  white  Swiss  Webster  mice  sacrificed  4  or  12  hours 
afterwards (Miller et al., 2010). The results were compared with those of the control group instilled 
with  physiological solution  (five  animals per  group). There  were  no  histological  changes  seen in 
animals sacrificed four hours after STC treatment compared with controls, but in animals sacrificed 
12 hours after treatment mucus production was abundant, and bronchiolar and alveolar spaces and 
epithelium showed signs of inflammation with irregular thickened epithelium, mucus-like debris and 
alveolar  walls  that  appeared  oedematous.  In  animals  sacrificed  four  hours  after  STC  treatment, 
reverse-transcription  real-time  polymerase  chain  reaction  revealed  the  modulation  of  the 
inflammation-associated genes that was not so prominent 12 hours after treatment.  
In conclusion, the acute oral toxicity of STC is relatively low (range 120–166 mg/kg b.w.). Liver and 
kidneys are the target organs of acute toxicity. Hyaline degeneration was observed in the kidney and 
necrosis  and  haemorrhages  were  observed  in  the  liver  and  in  the  kidneys.  Following  inhalation 
(intratracheal installation) of STC, a non-specific but severe inflammatory response of the lung tissue 
was observed. 
7.2.2.  Repeated dose studies and subchronic toxicity 
Considering the previously observed hepatotoxicity of STC, van der Watt and Purchase (1970) studied 
the sequence of the timely appearance of liver lesions in male weanling Wistar rats (initial weight 
50 g; n = 16) exposed to the high concentration of 100 mg STC/kg feed (purity 95 %) for 16 weeks 
and sacrificed in pairs every other week starting after two weeks of exposure. After an exposure of two 
weeks, single cell necrosis and marked variations in the size of both nuclei and cells were observed, as 
well  as  few  necrotic  foci  without  inflammation  and  prominent  Kupffer  cell  proliferation.  After 
12 weeks  of  exposure,  foci  enlarged  and  were  macroscopically  visible  and  progressed  into  large 
hyperplastic  nodules surrounded  by  degenerating  and  necrotic  hepatocytes  (Purchase  and  van  der 
Watt, 1970b). In contrast to the observation of liver lesions following exposure to AFs, there was no 
massive bile duct proliferation observed after STC treatment. With continued feeding, first hepatic 
neoplasm was observed at 40 weeks, and at 50 weeks all surviving animals developed HCC. 
In a study with repeated intragastric dosing of STC (20 mg/kg b.w. every 14 days for 12 months, 
number of animals not reported) in vervet monkeys, histological liver changes were ascertained by 
liver biopsies performed at nine-week intervals for a period of 12 months (Purchase and van der Watt, 
1970b). After four to six months, the treatment caused icterus and chronic hepatitis. Continuing the 
treatment resulted in aggressive hepatitis with single-cell necrosis of hepatocytes, progressive growth 
of  the  fibrous  septa  and  disruption  of  the  lobular  architecture.  After  12  months‘  exposure,  large 
hyperplastic nodules, containing hepatocytes with pleomorphic nuclei, were observed throughout the 
liver. 
In guinea pigs (n = 10), oral treatment with STC (4.2 mg/animal for two weeks) caused diffuse fatty 
degeneration of hepatocytes and focal necrosis without any particular lobular distribution (Richard et 
al., 1978). In the necrotic foci, a proliferation of Kupffer cells and neutrophilic infiltration were seen. Sterigmatocystin in food and feed 
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7.2.3.  Reproductive and developmental toxicity  
Only one screening study (Schroeder and Kelton, 1975) on developmental toxicity was identified. 
STC was given to five-day-old chick embryos in the yolk sac of eggs at a dose of 5–7 µg/egg. Twisted 
feet were observed in the treated animals. The authors considered this finding as inconclusive as this 
condition may occur spontaneously. No further studies on reproductive and developmental toxicity of 
STC could be identified. 
7.2.4.  Immunotoxicity 
In an early study carried out in 1978 (Richard et al., 1978) it was shown that STC, given orally to 
guinea pigs for two weeks (4.2 mg/animal), induced a significant reduction of complement activity. 
Even if there was no significant effect on the total serum protein values in guinea pig serum, effects on 
α2- and β- globulins, which are a major component of complement, were noted. Apart from these 
effects, also significant weight loss and hepatotoxicity was observed. As components of complement 
are  produced  in  the  liver,  it  can  therefore  not  be  concluded  that  STC  has  a  specific  effect  on 
complement, or is specifically immunotoxic. 
Zhang et al. (2012) treated specific pathogen free Balb/c mice (n = 32) i.p. with STC dissolved in 
dimethylsulphoxide (DMSO)/saline at a dose of 3 mg/kg b.w. It was observed that tumour necrosis 
factor-alpha (TNF-α) levels as well as interleukin (IL)-12p35 levels were decreased in treated animals, 
whereas  IL-6  levels  were  transiently  increased  in  peripheral  blood  mononuclear  cells  (PBMCs) 
isolated from these animals. Concomitant analyses with peritoneal macrophages isolated from the 
same animals showed a significant decrease in the levels of all three cytokines, TNF-α, IL-6 and 
IL-12p35. The severity of these effects increased with time post administration (measured up to 24 h 
after  treatment).  The  authors  comment  that  such  an  impairment  of  the  host  defence  system  is 
comparable to the immunosuppressive effects discussed, for example, for trichothecenes (T-2 toxin), 
gliotoxin and other immunosuppressive mycotoxins. However, only one dose of STC was applied, 
hence no clear dose-response relationship could be assessed. Moreover, the study does not provide any 
information on effects of the treatment on any other possible target of STC toxicity, which would have 
been helpful in concluding on potential specific immunotoxicity of STC. 
Liu et al. (2012) showed that 24 h after a single i.p. STC administration to BALB/c mice (3, 30, 300 
and 3000 µg/kg b.w.), the percentage of FoxP3+ regulatory T cells (as well as the FoxP3 expression 
level)  are  significantly  increased  in  PBMCs,  the  spleen  and  the  thymus  (mainly  for  treatments 
≥ 30 µg/kg b.w.). Regulatory T cells expressing FoxP3 play a key role in immune homeostasis by 
suppressing  immune  responses  of  a  variety  of  immune  cells  (Schmidt  et  al.,  2012).  Increases  in 
regulatory T cells can result in suppressing an effective immune surveillance of carcinogen-induced 
tumours (Betts et al., 2007). The study by Liu et al. (2012) also reported a statistically significant 
decrease of plasmacytoid dendritic cells (pDCs) in the thymus and a significant increase of this cell 
population in the spleen at doses of 30, 300 and 3000 µg/kg b.w. pDCs populations in the thymus are 
involved in the induction of regulatory T cells (Hanabuchi et al., 2010; Martin-Gayo et al., 2010) but 
the overall effect of STC on pDC function remains to be elucidated. It should be noted that the study 
addresses effects after i.p. injection of STC at high concentrations and that there is no information 
provided on other effects of the treatment on any other possible target of STC, and this hinders the 
interpretation of these findings as specific immunotoxic effects. 
A series of papers on in vitro experiments with human peripheral blood lymphocytes and murine 
peritoneal macrophages showed that STC inhibited the expression and secretion of IL-12 (Xing et al. 
(2005) and Huang et al. (2002), cited in Zhang et al., 2012) and affected IL-2, interferon-γ and IL-4 
expression and secretion in murine spleen cells (Xing et al. (2005), cited in Zhang et al., 2012). In 
addition, Xing et al. (2005) demonstrated that STC reduced the expression of human leukocyte antigen 
(HLA) class I at the level of both RNA and protein. HLA-class I antigens have been associated with 
numerous immunological reactions and autoimmune diseases as well as with cellular apoptosis and 
development of neoplastic diseases, and the findings that STC can reduce HLA-1 expression suggest 
the immunomodulatory effects of STC. It should be noted, however, that these results were obtained Sterigmatocystin in food and feed 
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with rather high concentrations ranging between 0.5 and 2 mg/L, and that the relevance of these 
findings for the in vivo exposure remains to be elucidated. 
In  conclusion,  the  results  from  in  vivo  and  in  vitro  studies  suggest  that  STC  may  have 
immunomodulatory activity. However, firm conclusions cannot be drawn, as the in vivo data were 
difficult to interpret as specific immunotoxic effects. Moreover, the relevance of the in vitro data were 
difficult to interpret as these experiments were conducted with rather high concentrations of STC.  
7.2.5.  Genotoxicity  
Genotoxicity of STC has been tested in bacteria and mammalian cells in vitro and in rats ex vivo and 
in vivo. It was tested very often together or in comparison with other mycotoxins, especially with 
AFB1.  
In a large screening of 300 carcinogens and non-carcinogens by the standard S. typhimurium assay in 
the presence of rodent liver S9 mix, STC was approximately 10 times less mutagenic than AFB1 on a 
molar basis in the tester strains TA100, TA98 and TA1538 (McCann et al., 1975). The mutagenicity of 
STC in S. typhimurium was later confirmed in several studies by using a variety of tester strains in the 
presence  of  rodent  or  human  liver  microsomes  while  the  comparison  with  AFB1  did  not  give 
consistent results (Tang and Friedman, 1977; Kuczuk et al., 1978; Ueno et al., 1978; Wehner et al., 
1978; Mori et al., 1986). The report of McCann et al. (1975) implied that STC has similarly lower 
activities in base-pair and frame-shift mutagenesis as compared to AFB1. Mori et al. (1986) confirmed 
a  lower  activity  of  STC  for  frame-shift  mutations  but  showed  higher  levels  of  induced base-pair 
mutations as compared to AFB1. STC was also positive in the rec assay with Bacillus subtilis, in the 
presence of rodent S9 mix. In this test AFB1 exhibited a sharp dose dependency while STC was 
positive  only  in  limited  experimental  conditions  (i.e.  lowest  tested  doses  of  1–5  µg)  (Ueno  and 
Kubota, 1976).  
Baertschi et al. (1989) analysed the mutagenicity of metabolically activated (by human CYP enzymes) 
STC and AFB1 in the bacterial SOS-repair assay (using a S. typhimurium strain in which the umuC 
gene  is  linked  to  a  lacZ  reporter  gene  in  plasmid  pSK1002)  in  comparison  with  DNA  adducts 
generated in vitro in isolated calf DNA. The level of guanyl-N7 adducts was in the order AFB1 > STC 
(approximately 1.5 fold higher) while the order of the umu response was STC > AFB1. Therefore, the 
SOS  response  per  molecule  of  guanyl-N7  adduct  was  higher  for  STC  than  AFB1.  The  authors 
concluded  that  the  conformations  of  the  structurally  related  AFB1-  and  STC-induced  guanyl-N7 
adducts may prove to be significantly different in DNA thus accounting for the divergent biological 
responses. These findings were also confirmed by Krivobok et al. (1987), who tested STC with the 
SOS chromotest on Escherichia coli. 
STC induced a dose-dependent increase in mutation frequency (resistance to L-canavanine) in yeast 
expressing rat CYP2B1 (Black et al., 1992). 
Noda et al. (1981) showed induction of 8-azaguanine (8AG)-resistant mutations by STC in Chinese 
hamster ovary (CHO) cells which was greatly increased in the presence of liver microsomes from rats 
induced with phenobarbital. Reiners et al. (1983) showed that STC was weakly mutagenic at the 
hypoxanthine–guanine phosphoribosyltransferase (HPRT) locus in Chinese hamster lung V79 cells 
following activation by newborn mouse SENCAR keratinocytes used as a feeder layer.  
Morita et al. (1991) showed that STC induces 6-thioguanine (6TG)-resistant mutations in the mouse 
mammary carcinoma FM3A cell line in the presence of rat S9 fraction. FM3A cells had also been used 
by Umeda et al. (1977), who compared the mutagenicity of various mycotoxins. The induction of 
8AG-resistant mutations by STC was higher than that of AFB1 but only at highly cytotoxic doses. STC 
as well as AFB1 showed a weak induction of DNA single-strand breaks at high concentrations. In the 
same study STC induced high levels of chromosome aberrations. Sterigmatocystin in food and feed 
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DNA repair was measured in cultured DNA repair-deficient and normal fibroblasts derived from a 
xeroderma pigmentosum patient (XP-E) and a control person, respectively (Stich and Lashies, 1975). 
XP-E cells are defective in the nucleotide excision repair (NER), which plays a major role in the repair 
of  bulky  adducts.  The  cytotoxicity,  chromosome  breaking  activity  and  DNA  repair  synthesis 
(measured as unscheduled DNA synthesis (UDS)) of STC, was greatly increased in the presence of 
liver S9 fractions isolated from different species in both normal and XP-E fibroblasts. Owing to the 
defect in NER, XP-E cells responded to the activated STC and AFB1 with a lower level of UDS 
compared to normal cells, but higher levels of chromosomal damage and lethal effects.  
The induction of UDS was measured in metabolically competent primary hepatocytes from mice and 
rats exposed to STC (and other mycotoxins) by Mori et al. (1984). STC was clearly positive, inducing 
a high UDS response. A variety of STC-related compounds were also positive in a DNA repair test in 
a primary hepatocyte culture from rats (Mori et al., 1986). 
Crofton-Sleigh et al. (1993) showed that STC is positive in the micronucleus assay in the human 
lymphoblastoid TK
+/– MCL-5 cell line that constitutively expresses a relatively high level of native 
CYP1A1,  four  other  human  cytochromes  (CYP1A2,  CYP2A6,  CYP3A4  and  CYP2E1)  and 
microsomal epoxide hydrolase, carried as cDNAs in plasmids. Compared with AFB1 the numbers of 
micronuclei were similar or higher for STC. 
A potent induction of micronuclei was observed in V79 Chinese hamster cells genetically engineered 
to  express  rat  CYP2B1,  CYP1A1  or  CYP1A2  (Ellard  et  al.,  1991).  STC  induced  predominantly 
kinetochore-negative  micronuclei  consistently  with  the  induction  of  chromatid  breaks  (Ellard  and 
Parry, 1993). 
STC induces chromosome aberrations and sister chromatid exchanges (SCEs) in experimental animals 
in vivo. For example, STC induced increased SCE frequencies in bone marrow cells of female Swiss 
albino mice at all doses tested (0.06–6 mg/kg b.w.; i.p.) (Curry et al., 1984), and Ueda et al. (1984) 
found STC-induced chromosomal aberrations (chromatid breaks and gaps) in bone marrow cells in 
rats after the i.p. administration of 31.2 mg/kg b.w. 
In the fish species Oreochromis niloticus (Nile tilapia), STC (1.6 µg/kg, twice a week for 4 weeks) 
induced a significant decrease of body weight and an increase in the frequency of micronucleated red 
blood cells as well as chromosomal aberrations in the kidney (Abdel-Wahhab et al., 2005). 
In conclusion, STC is mutagenic in both bacterial and mammalian cells after metabolic activation. It 
induces chromosomal damage both in vitro upon metabolic activation and in vivo in experimental 
animals.  Various  studies  aimed  to  compare  the  genotoxicity  of  STC  and  AFB1.  However,  the 
uncertainty  regarding  their  actual  concentration  in  the  test  system,  the  efficiency  of  the 
activation/detoxification metabolic routes and the repair rate of induced lesions does not allow a direct 
comparison of the relative mutagenic potency of these mycotoxins.  
7.2.6.  Chronic toxicity and carcinogenicity 
The CONTAM Panel identified long-term carcinogenicity studies for STC in mice, rats, Mongolian 
gerbils, fish and monkeys.  
7.2.6.1.  Oral administration 
Mouse 
Two carcinogenicity studies on oral exposure in mice are available and details are summarised in 
Appendix D, Table D1. 
Pulmonary tumours (adenomas and/or adenocarcinomas) were the main finding in ICR white Swiss 
mice of both sexes (18 males and 10 females in the treatment group) exposed to STC-containing feed Sterigmatocystin in food and feed 
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(Zwicker et al., 1974). Commercially obtained STC was added at a concentration of 5 mg STC/kg to 
feed, corresponding to approximately 0.75 mg STC/kg b.w. per day using the default factor of 0.15 as 
recommended by EFSA (2012). The intermitted treatment lasted for 54–58 weeks in total (two weeks 
of treatment followed by two weeks of uncontaminated diet). In mice fed STC, the first pulmonary 
neoplasms were seen at 50 weeks of exposure. Cumulative tumour incidence (until 58 weeks) reached 
84 % (21/25) in the treatment group compared with 11 % (4/37) in the control group. The observed 
adenomas were mostly multiple, located deeply in the parenchyma without any obvious association 
with the airways. Adenocarcinomas occurred with much higher frequency in females (8/10) than in 
males (1/15). They were grossly described as large tan–white, firm raised masses which occasionally 
occupied the entire lobe. In the large tumours, central areas were necrotic, and these tumours invaded 
exclusively adjacent pulmonary tissue. There was a marked proliferation of large anaplastic epithelial 
cells with frequent mitotic figures. 
Enomoto et al. (1982) exposed female BDF1 mice to STC-containing feed at a concentration of 30 or 
120 mg STC/kg feed (unknown purity), corresponding to approximately 4.5 and 18 mg STC/kg b.w. 
per day using the default factor of 0.15 as recommended by EFSA (2012). However, the highest dose 
is an overestimation since the authors noted that the feed intake in this group was reduced. The control 
group consisted of 50 animals, and the low dose group of 55 animals which were exposed to a diet 
containing 30 mg STC/kg feed for 55 weeks. The third group of 55 animals were given a diet with 
120 mg STC/kg feed for 40 weeks, then a control diet for 4 weeks (to compensate for the poor intake 
of the STC contaminated feed) and then again the diet with 120 mg STC/kg feed for another 11 weeks. 
Five animals of each group were killed at week 43, 10 animals at week 68 and the remaining survivors 
at week 73. The reported cumulative tumour incidence can be summarised as follows: in the control 
group, 2 animals developed either a leiomyoma or leiomyosarcoma of the uterus. No other tumours 
were observed. In the low dose group, angiosarcomas in the liver were observed in 34 out of 53 
(64 %)  animals  and  hepatic  haemangioendotheliomas  in  14  animals  (26  %).  In  addition, 
angiosarcomas were observed in the brown fat (6 animals; 11 %), the ovary (1 animal) and the lung 
(1 animal). In the same dose group 10 animals also showed other tumours, such as lung adenoma (5), 
hepatocellular adenoma (1), HCC (1), papilloma of the oral cavity (1), leiomyosarcoma of the uterus 
(1) and leukaemia (1). In the high dose group, no angiosarcomas were observed in the liver, but four 
out  of  55  animals  (7  %)  had  developed  hepatic  haemangioendotheliomas.  Angiosarcomas  were 
observed in the brown fat (27) and in the ovaries (3). In this group 17 animals showed additional 
tumours,  such  as  lung  adenomas  (12),  hepatocellular  adenomas  (2),  sarcoma  of  the  uterus  (1), 
leiomyoma of the uterus (1) and squamous cell carcinoma of the auditory gland duct (1). The authors 
described  the  tumours  in  the  liver  and  the  brown  fat  as  typical  vascular  malignancies  based  on 
complementary  investigation  with  electron  microscopy.  In  summarising  their  results,  the  authors 
conclude that 72 % of the 104 STC-treated female mice surviving 43 weeks had one or more tumours. 
The first tumour appeared at week 43. No vascular tumours were observed in the control group and 
according to the authors this was the first report of vascular tumours in the brown fat in mice. 
Rat 
Five  carcinogenicity  studies  on  oral  exposure  in rats  are  available  and details  are summarised in 
Appendix D, Table D2. 
Among a series of toxicity studies from which data were reported in Section 7.2.2, Purchase and van 
der Watt (1970a) performed also a carcinogenicity study. STC in this experiment was produced by 
Bipolaris spp. on maize meal, and the purity was about 88 %. Starting at weanling age, three groups of 
rats were exposed via the diet for six months to STC at concentrations of 10, 20 or 100 mg/kg feed, 
corresponding to 0.5, 1 and 5 mg STC/kg b.w. per day using the default factor of 0.05 recommended 
by EFSA (2012). The authors calculated a daily intake of 0.15, 0.3 and 1.5 mg/rat. Thereafter, dietary 
concentrations were increased to 15, 30 and 150 mg/kg feed, respectively for another six months 
(corresponding  to  0.75,  1.5  and  7.5  mg  STC/kg  b.w.  per  day  using  the  default  factor  of 
0.05 recommended by EFSA (2012)). After these treatments, rats were placed on a normal diet until 
the end of the experiment at 123 weeks. Three other groups were given STC by gastric intubation at Sterigmatocystin in food and feed 
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doses  of  0.15,  0.3  or  1.5  mg/rat  (dissolved  in  0.5  mL  sunflower  seed  oil)  five  days  a  week  for 
52 weeks. One control group received sunflower oil five days a week for 52 weeks intragastrically, 
and another group received no treatment. Following dietary exposure to STC 0/9, 8/9, 10/10 and 3/3 
animals showed HCC at the starting doses of 0, 0.15, 0.3 and 1.5 mg/rat, respectively, whereas the 
respective  incidences  were  0/10,  4/10,  5/9  and  9/9  following  intragastric  administration  of  STC. 
Histological investigations showed all features of a typical HCC with necrosis in the centre of the 
tumour  mass.  The  amount  of  liver  fibrosis  varied  considerably,  but  there  was  no  evidence  of  a 
significant bile duct proliferation, as observed following exposure to AFB1. In eight rats with primary 
HCC, other tumours were observed in liver, uterus, ovary, spleen and omentum. Acanthotic changes 
were present in the stomach of 85 % of the STC-treated animals. 
In a study of Kempff et al. (1973) male Wistar rats were treated with STC (purity unknown) by gavage 
(20  mg/kg  b.w.)  once  a  week  for  48  weeks.  During  the  experimental  period,  four  animals  were 
sacrificed at approximately six week intervals (in total seven time points) to measure the activity of 
liver nuclear acid and alkaline DNase activity. After 48 weeks, nodular hyperplasia and foci were 
observed in the liver sections of these animals.  
A two-year carcinogenicity study was performed by Ohtsubo et al. (1978) in male Donryu rats (six 
weeks  old)  fed  A.  versicolor-contaminated  rice.  The  STC  concentration  in  mouldy  rice  was 
determined using gas–liquid chromatography, but the purity of STC was not reported. Three groups 
each  of  20  animals  were  given  0,  5  or  10  mg  STC/kg  feed,  respectively  for  up  to  101  weeks, 
corresponding  to  0,  0.25  and  0.5  mg  STC/kg  b.w.  per  day  using  the  default  factor  of 
0.05 recommended by EFSA (2012). The authors calculated an equivalent exposure dose of 75 or 
150 µg/rat, respectively for the two dose groups. The first animal with a tumour died after 66 weeks 
when in each of the two treatment groups the number of animals had declined from 20 to 13 animals 
and  in  the  control  group  from  20  to  17  (effective  group  size)  due  to  chronic  bronchopulmonary 
infection (bronchitis, bronchopneumonia, bronchiectasis and pulmonary abscess). In the high dose 
group the survival rate dropped steeply between days 71 and 86 weeks of feeding, and in the low-dose 
group between 86 and 100 weeks. A high percentage of animals had hepatic tumours in the low-dose 
(11/13; 85 %) and in the high-dose group (12/13; 92 %). Histological investigations classified the 
tumours in most cases as HCCs and in three cases as haemangiosarcomas. Tumours were in almost all 
cases  multiple  and  associated  with  hyperplastic  nodules  without  peritoneal  dissemination  and 
cirrhosis. Tumours were large and pulmonary metastases were seen in three rats of each treatment 
group. 
Terao  et  al.  (1978)  investigated  STC  carcinogenesis  in  male  Wistar  rats.  Rats  were  given  a  diet 
containing 10 mg STC/kg feed (n = 15) for 54 weeks, followed by an observation period of another 15 
weeks (total period 69 weeks). This concentration corresponds to a dose of 0.5 mg STC/kg b.w. per 
day using the default factor of 0.05 as recommended by EFSA (2012). The controls (n = 30) were 
given the basal diet only. Compared to the controls which did not develop any tumour, eight out of 15 
(53 %) animals developed HCC which were first observed after 54 weeks. No metastases were found. 
Maekawa et al. (1979) investigated hepatic changes in male ACI/N rats giving a diet containing 0.1, 
1.0 and 10 mg STC/kg feed and administered throughout their life. These concentrations correspond to 
doses of 0.005, 0.05 and 0.5 mg STC/kg b.w. per day using the default factor of 0.05 recommended by 
EFSA (2012). At the beginning of the experiment the rats were 11 weeks old and were divided into 
three experimental groups (n = 36 per group), and a control group receiving the basal diet (n = 12). 
The animals were treated and observed for a maximum of 122 weeks. Mean survival time varied from 
87  weeks  (highest  dose  group)  to  105  weeks  in  the  control  group.  However,  large  variation  in 
individual survival times was observed, and the animals suffered from multiple tumours. Tumours 
were observed in 7 out of 11 animals (64 %), 13 out of 27 (48 %), 6 out of 29 (21 %) and 10 out of 26 
(38 %) in the 0, 0.005, 0.05 and 0.5 mg STC/kg b.w. per day dose groups, respectively. Therefore a 
relationship of tumour incidence to the rat strain rather than to the STC exposure cannot be excluded. 
With respect to changes in liver tissue, one case (4 %) of an HCC in the 0.5 mg STC/kg b.w. per day 
dose group and three (12 %) and one (3 %) haemangiosarcomas in the 0.5 and 0.05 mg STC/kg b.w. Sterigmatocystin in food and feed 
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per day dose group, respectively, were observed. In addition, central necrosis and hyperplastic foci, 
which both exhibited a clear dose-dependent relationship, were observed in the liver. Hyperplastic foci 
consisted of normal or larger vacuolated or eosinophilic cells, not demarcated from surrounding cells 
and without disrupting the liver architecture. Hyperplastic nodules appeared only in the liver of three 
animals of the highest dose group.  
Other rodents 
Recent  literature,  particularly  from  Asian  countries,  where  STC  seems  to  be  a  common  food 
contaminant) focuses on the potential initiation or promotion of gastric cancers by STC. In particular, 
the co-exposure to Helicobacter pylori (one of the most common gastric infections) and STC was 
studied by Ma et al. (2003). STC was given with the diet at a concentration of 100 and 1000 mg/kg 
feed to Mongolian gerbils (n = 196, divided into 5 treatment groups) for a period of 27 months. In the 
presence  of  a  Helicobacter  pylori-infection,  dietary  STC  exposure  enhanced  the  development  of 
intestinal metaplasia of the gastric mucosa (Ma et al., 2003). Following the same hypothesis that STC 
could evoke gastric lesions and potential gastric carcinomas, Kusunoki et al. (2011) investigated the 
effect of a long-term administration of STC in aged Mongolian gerbils. To this end, male gerbils with 
an age of 75 weeks (approximately 50 % of the expected lifespan of 3 years recorded for Mongolian 
gerbils) were included in the study and allocated to three groups, i.e. controls (n = 11); the group 
receiving 0.1 mg STC/L drinking water (n = 7) and the group receiving 1 mg STC/L drinking water 
(n = 13).  STC  (>  98  %  purity)  was  administered  over  a  period  of  24  weeks  at  the  specified 
concentration in drinking water. The authors reported an exposure rate of 0.007-0.015 mg/kg b.w. for 
the lower concentration group (0.1 mg STC/L drinking water) and 0.088 – 0.132 mg/kg b.w. per day 
for the higher concentration group (1 mg STC/L drinking water). Histopathological investigations at 
the end of the exposure period showed an active gastritis in all treated animals (both groups) whereas 
the incidence of gastritis in the control animals was low (2 out of 11 animals). Erosions in the stomach 
were found in 7 out of 7 and 12 out of 13 animals, respectively, in the STC exposed gerbils, but in 
only 1 out of 11 animals of the control group. The incidence of hyperplastic polyps reached 71.4 % in 
the lower dose group and 61 % in the higher dose group. Intestinal metaplasia were found in all 
animals (100 %) of the low dose group, but only in 2 out of 13 animals (15.4 %) of the higher dose 
group    and  in  none  of  the  animals  (0  %)  of  the  control  group.  Immuno-staining  showed  a  high 
incidence of PCNA (proliferating cell nuclear antigen, a marker of cell proliferation), p53 (tumour 
suppressor gene, considered to be a marker for a transformation into a malignant tumour growth) and 
MDM2  (cellular  inhibitor of  p53)  in  the  affected  areas  of  the  gastric  mucosa,  interpreted  by  the 
authors as an indication for precancerous lesions. It should be noted that most of the effects, both 
histopathological changes and the impairment of cell cycle markers (immune-histochemistry) were not 
dose-dependent (Kusunoki et al., 2011). 
Non-human primates 
In 1975, the National Cancer Institute started a long-term study on 30 adult non-human primates 
(species not specified) treated orally once a week with STC at 1.0 and 2.0 mg/kg b.w. (corresponding 
to 0.14 and 0.29 mg/kg b.w. per day) dissolved in DMSO (Thorgeirsson et al., 1994) within a project 
initiated in 1961 to study chemical carcinogenesis in non-human primates. The report of Thorgeirsson 
et al. (1994) is one of several interim reports of this study which was still ongoing in the mid 1990s 
but for which no final report could be identified in the literature except another summary report of 
Schoeffner and Thorgeirsson (2000) indicating that the study may have been terminated in 1997. No 
specific unexposed control group was assigned to this experiment. Until 1994, 10 treated monkeys 
developed one or more malignant tumours, five in each STC exposed group. Tumours were located 
mostly  in  liver  (seven  HCC,  two  cholangiocarcinomas,  one  cholangiosarcoma).  One  monkey 
developed a kidney tumour (renal cell carcinoma). Some monkeys died with other diagnoses such as 
myocarditis, sepsis, toxic hepatitis, cirrhosis, bronchopneumonia, acute renal tubular necrosis, and 
necrotising colitis. The laparoscopy showed extensive liver damage in animals that survived (and were 
still treated) by the time the report was published. Sterigmatocystin in food and feed 
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Fish 
Carcinogenicity  of  STC  was  studied  in  rainbow  trout  (Salmo  gairdneri)  exposed  as  14-day-old 
embryos for one hour to an aqueous suspension of 0.5 mg/L STC or 0.5 mg/L AFB1 (Hendricks et al., 
1980). The authors reported that this treatment did not cause significant mortality but produced HCC 
after 12 months of observation. At this time point the incidence of HCC in STC-treated trout was 
13/100 and in AFB1-treated trout 53/100. The tumour incidence in STC-treated trout was not sex-
related, tumours were solitary and no tumour occurred in the control group.  
The carcinogenicity of STC was also studied in medaka (Orysiae latipes) (Terao, 1983). Hepatic 
tumours occurred in 29 % (2/7) of male and 72 % (8/11) of female fish fed with STC (5 mg/kg)-
contaminated feed for 24 weeks. 
7.2.6.2.  Non-oral administration 
Carcinogenicity  of  STC  has  been  demonstrated  in  rats  and  mice  after  i.p.,  s.c.  and  dermal 
administration (Dickens et al., 1966; Fujii et al., 1976; Purchase and van der Watt, 1973; Terao, 1978). 
Further details, including doses and tumour incidence are shown in Appendix D, Table D3.  
7.2.6.3.  Concluding comments 
In conclusion, tumourigenicity of STC was observed after oral, intragastric, i.p., s.c. and/or dermal 
administration in the animal species tested (rat, mouse, Mongolian gerbil, monkey and fish). After oral 
exposure,  premalignant  and  malignant  lesions  such  as  HCC,  haemangiosarcomas  in  the  liver, 
angiosarcomas in the brown fat, lung adenomas and incidental findings in other organs were reported. 
The CONTAM Panel concluded that STC is genotoxic and carcinogenic. 
7.2.7.  Combined effects of sterigmatocystin and aflatoxins  
STC and AFs can be produced by the same fungal species and share the same biosynthetic pathway 
and therefore combined effects of these mycotoxins are frequently discussed in the literature.  
Richard et al. (1978) investigated STC and AFB1 (4.2 or 0.01 mg/day, respectively) given orally alone 
or in combination to growing female guinea pigs (n = 10 animals per group) for two weeks. Weight 
loss was statistically significantly higher in all treated groups compared to controls, higher for STC 
given alone or in combination with AFB1 (P < 0.01) than for AFB1 alone (P < 0.05), but additive 
overall. The dose of STC was intended not to be lethal, but two animals died. Complement titre values 
were statistically significantly lower in the combined group than in the groups exposed to STC and 
AFB1 alone. Comparing the serum proteins of the combination with controls, the decrease in alpha-2-
globulin and β-globulin was statistically significant, although albumin increased. However, groups 
given STC and AFB1 alone did not differ significantly from the control except concerning alpha-2-
globulin. Additive effects were reported for alpha-2-globulin and β-globulin. Although the authors 
declared a synergism between STC and AFB1 in their combined effect on increasing blood serum 
albumin concentration (control: 2.3; STC: 2.4; AFB1: 2.6; and combination: 2.9 g/dL), the CONTAM 
Panel noted that this effect may still be indistinguishable from an additive effect, since the authors did 
not report the outcome of a statistical evaluation. Increased severity of hepatic lesions was not found 
in the combination group. Overall, this study does not give convincing evidence for a synergistic 
action of STC with AFB1 based on the high doses chosen and the sizes of the observed effects.  
In investigating the interaction between STC and AFs in poultry, a combination of STC (350 µg/kg 
feed) and AFB1 (100 µg/kg feed) in the diet was given to chicks from the first day after hatching for 
four  weeks, followed  by  a  four-week  recovery  period.  Decreased  body  weight  gain  and  a higher 
mortality rate was reported compared with control chicks kept on a mycotoxin-free diet, as was an 
increase in relative weights of various organs, particularly spleen (Abdelhamid and Dorra, 1993). 
However,  since no single  mycotoxin  group  was  included,  no  comment  on  synergistic  or  additive 
effects can be made. Sterigmatocystin in food and feed 
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Based on the limited data, the CONTAM Panel concluded that the combined effect of STC and AFB1 
in food and feed seems to be at most additive. 
7.3.  Adverse effects in livestock, fish and companion animals 
7.3.1.  Ruminants 
7.3.1.1.  Cattle 
Ingestion of feed accidentally contaminated with 7.75 mg STC/kg feed by dairy cattle resulted in 
bloody diarrhoea, loss of milk production and, in some animals, death. Those surviving were reported 
to resume milk production, and for the diarrhoea to stop, when switched to an alternative feed. No 
information on duration of exposure was reported for this study (Vesonder and Horn, 1985). In a small 
study with dairy cows (two animals in the exposure group and one in the control group), dietary 
exposure  to  approximately  5  to  10  mg  STC  per  animal  per  day  during  2  weeks  exerted  no-
observable-adverse health effects (van Egmond et al., 1978). 
7.3.1.2.  Sheep 
Nine female Austrian sheep (hybrid ‗Kärntner Bergschafe‘) of 65 kg b.w. and aged between three and 
four years were used in a feeding trial, with 3 sheep for control and 6 for STC exposure (Böhm and 
Sayed, 1994). STC was used in two different purities; crude STC which was the total A. versicolor 
culture including the growth medium, and purified STC which was the extracted STC from the A. 
versicolor culture. All six animals in the trial group were fed the following increasing amounts of 
crude STC over a total of 100 weeks: 2 mg STC/kg feed (consisting of 1 kg hay and 200 g barley per 
day) for six weeks, 3 mg STC/kg feed for the next four weeks, 6 mg STC/kg feed for another four 
weeks and then 12 mg STC/kg feed for another four weeks. Finally, the trial group was divided such 
that three sheep received 16 mg crude STC/kg feed and three sheep received 16 mg purified STC/kg 
feed for eight weeks. Six weeks after the start of the treatment, and thereafter every two weeks until 
the  end  of  the  trial,  blood  samples  were  analysed  for  haematological  (erythrocytes,  leucocytes, 
haematocrit,  haemoglobin)  and  biochemical  (aspartate  aminotransferase  (AST),  alanine 
aminotransferase  (ALT),  gamma-glutamyltransferase  (γ-GT),  glutamate  dehydrogenase  (GLDH), 
lactate dehydrogenase (LDH), urea, creatinine, calcium, magnesium, phosphor, total protein, albumin, 
glucose) parameters. In addition, biopsies of the liver were taken at the end of the STC exposure 
period. Finally, six months after the last exposure, all animals were killed and subjected to a post-
mortem histopathological examination. No significant differences were observed between the three 
control and the six treated animals, even when given the highest dose tested (16 mg STC/kg feed, 
equivalent to 0.3 mg/kg b.w. per day based on rough calculations).  
7.3.2.  Pigs 
Only one study with pigs could be identified (Kovalenko et al, 2011). This publication is apparently a 
summary  of  a  larger  trial  and  describes, in  addition  to  the  monitoring  of  feed  materials, feeding 
experiments with two groups of two months old piglets. Animals were given a naturally contaminated 
diet identified in the monitoring programme containing approximately 30 µg/kg feed (feed intake was 
not recorded). Clinical signs observed were decreased feed intake, depression, incidental diarrhoea and 
alteration in blood biochemical parameters such as transaminase values (ALT and AST), γ-GT and 
alkaline phosphatase were observed as well as increased concentration of bilirubin and urea.  Post 
mortem findings including severe alterations of the liver tissue with multiple, often large, necrotic 
spots. 
7.3.3.  Poultry 
During an STC feeding study, newly-hatched male Warren chicks (treatment group: n = 15; control: 
n = 10) received  normal  feed  for  3  days  and  on  day  4,  5  and  6  feed  contaminated  with  STC  in 
concentrations of 1.6, 1.6 and 0.8 g/kg feed, respectively. This resulted in 60 % mortality within eight 
days of feeding. The surviving chicks from this group were fed a control diet without STC for an Sterigmatocystin in food and feed 
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additional seven weeks. After this period, grey spots on the liver surface, an increase in the kidney 
mass, elevated serum alkaline phosphatase and decreased triglycerides were observed. Another group 
of chickens (n = 20) received a diet with an increasing STC concentration (control diet first week, 
20 mg STC/kg feed in the second week, 40 mg STC/kg feed in the third week and 50 mg STC/kg feed 
until seven  weeks;  equivalent  to  40,  61 and  73  mg/kg  b.w.  per  day  respectively  based  on  rough 
calculations). The chickens displayed after seven weeks, severe liver cirrhosis and fatty degeneration. 
In addition, cellular necrosis and intercellular inflammation were diagnosed, and b.w. gains and feed 
conversion rates were reduced in comparison with the control group. Serum biochemical parameters 
were  altered,  such  as  increased  AST,  γ-GT  and  creatine  kinase,  and  reduced  total  protein, 
triglycerides, and cholesterol in serum. However, ALT, LDH, GLDH, alkaline phosphatase, urea, 
creatinine and uric acid were not affected. Symptoms of anaemia were recorded in haematological 
findings (Sayed, 1993). 
Salam and Shanmugasundaram (1983) reported observations of adverse effects following a single oral 
dose of 50, 100, 250 or 500 µg STC/chick (n = 5 per dose group), but this study is poorly reported and 
as such it is not possible to draw any conclusions. Birds given 100 µg STC were reported to die on day 
two and histopathological examination showed fatty changes in the liver and in the distal tubules and 
glomerular endothelium of the kidneys, but these changes were not attributed to any dose level. 
In four published papers, Sreemannarayana et al. (1986a,b, 1987, 1988) report experimental data of 
repeated dose experiments for chicks with STC by i.p. injection.  
Five-day-old chicks were given 0.3 mg (36 birds) or 0.6 mg (44 birds) STC/kg b.w. in a single dose by 
i.p. injection. All dosed chicks had dull ruffled feathers after eight hours and greenish droppings were 
observed in the 0.6 mg/kg b.w. dose group after 12 hours; in this dose group decreased serum protein 
albumin and increased LDH and ALT were also noted (Sreemannarayana et al., 1986a). 
A group of 40 ten-day-old chicks were given 4.0 mg STC/kg b.w. by i.p. injection and compared with 
32  age-matched  birds  acting  as  controls  receiving  the  carrier  (olive  oil)  alone.  Deaths  occurred 
between 18 and 35 hours after dosing. Blood was collected from all chicks at 24 hours and from the 
16 surviving dosed chicks at 36 hours. The dosed birds had increased AST, ALT and LDH, and 
decreased serum albumin and total protein. Histopathological examination showed changes described 
by the authors as ‗mild to severe‘ in liver, pancreas, kidney and lymphoid tissue (Sreemannarayana et 
al.,1986b). 
An experiment was reported in which chicks (n = 32 per dose group), were given either the carrier 
alone (olive oil) or 1.0 mg STC/kg b.w. by single i.p. injection. The chicks were killed at 12 or 
24 hours. No histopathological effects were noted at 12 hours but changes in kidney were noted in 
those birds killed 24 hours post administration. Specifically, haemorrhage, foci of degeneration and 
necrosis  of  the  liver  were  observed,  and  the  kidneys  showed  tubular  degeneration  and  necrosis 
(Sreemannarayana et al., 1987). 
STC administered to male chicks of at least 100 g b.w. (n = 12) by i.p. injection at doses of 0.5 or 
0.7 mg STC/animal on days 11, 13, 15, 17 and 19 of age resulted in markedly reduced growth and also 
affected organ weights (Sreemannarayana et al., 1988). An increase in the relative size of the crop, 
proventriculus, gizzard, large intestine, kidney and pancreas and a decrease in the bursa of Fabricius 
were reported. Peritonitis was observed in the chicks given the high dose. In treated animals, the 
activity  of  serum  AST  and  the  number  of  granulocytes  in  blood  were  elevated.  STC  treatment 
decreased the concentrations of total serum proteins, albumin and potassium and the total number of 
white blood cells. It also decreased the concentration of dry matter, DNA, RNA and protein in liver, 
affected glycogen concentration, but had no effect on lipid concentration. A reduction in white blood 
cell  (WBC)  counts  of  21  and  29  %  was  observed  for  the  0.5  and  0.7  mg/animal  dose  groups 
respectively. In addition, there was a 40 and 56 % reduction in agranulocytes and a 46 and 66 % 
increase in granulocytes, respectively, when compared with control animals. STC caused necrosis at 
the periportal area of liver and liver haemorrhages. Hepatocytes were not clearly demarked and the Sterigmatocystin in food and feed 
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cytoplasm was eosinophilic with pyknosis and karyorrhexis. Degenerative changes were noticed in the 
epithelial  cells  of  bile  ducts.  In  the  high  dose  group,  kidneys  showed  haemorrhages  that  were 
subcapsular and interstitial. Proximal and distal tubules were degenerated, with pyknotic changes in 
tubular cells.  
In an in vitro study of the inhibitory effect of various mycotoxins and moulds on the movement of 
tracheal cilia from 1 day-old chicks, STC (Jesenská and Bernát, 1994) and extracts of A. versicolor 
(Pieckova and Jesenska, 1997) were among the most toxic mycotoxins in this trial. 
In conclusion, STC is hepatotoxic (necrosis, haemorrhage, cirrhosis and foci of degeneration of the 
liver) and nephrotoxic (tubular degeneration and necrosis) in poultry.  
7.3.4.  Fish 
Abdelhamid (1988) fed STC to carp for three weeks at dose levels of 0, 10, 50, 250 1250 µg/kg feed 
and reported a decreased growth rate and a decreased muscular protein content at all doses. The paper 
does not, however, report the number of fish per group, or relevant quantitative details. 
As discussed in Section 7.2.6, STC is carcinogenic to 14-day-old rainbow trout (Salmo gairdneri) 
embryos exposed for one hour to an aqueous suspension of 0.5 µg STC/L (Hendricks et al., 1980). 
In Egyptian Nile tilapia (Oreochromis niloticus) fish, oral treatment with STC (1.6 µg/kg b.w., twice a 
week for four weeks, n = 8) caused after three days darker coloration, unbalanced swimming and the 
death  of  25  %  (2/8)  of  treated  fish  (Mahrous  et  al.,  2006).  In  the  gills  of  STC-treated  animals, 
hyperplasia, lamellar oedema and haemorrhages were found. Haemorrhages were seen in branchial, 
hepatic and splenic tissues, and necrosis in hepatic and splenic tissue. In some cases, lesions included 
lysis of hepatocytes. STC caused also the appearance of eosinophilic granular cells and melanophores 
infiltrating the area of hepatopancreas. In this fish species the same dose statistically significantly 
increased chromosome aberrations (chromatid and chromosome breaks) in kidney tissues compared to 
controls (Abdel-Wahhab et al., 2005). 
In conclusion, toxicity of STC has been demonstrated in several fish species. Pathological alterations 
included haemorrhages and oedema of the gills and haemorrhages and eosinophilic infiltrations in the 
hepatopancreas.  
7.3.5.  Other animal species 
No  data  on  adverse  effects  of  STC  could  be  identified  for  other  farm  livestock  and  companion 
animals.  
7.4.  Observations in humans  
Various  studies  conducted  particularly  in  China  and  other  Asian  countries,  suggest  a  correlation 
between exposure to STC and the prevalence of gastric and liver cancer. For example, Lou et al. 
(1995) described that both the contamination rate and the content of STC in grains, were significantly 
higher in high incidence areas for gastric cancers than in a low incidence area in China. These findings 
have initiated a variety of further studies that are summarised in Sections 7.2.6.1 and 7.5. Comparable 
findings  were  reported  in  a  study  that  measured  the  concentration  of  STC  and  STC  adducts  in 
biological material of patients with liver and stomach cancer diagnosed in the Chinese Academy of 
Medical Sciences Cancer Hospital in Beijing, China, and in healthy volunteers (Tian et al., 1995). The 
concentration of STC was measured in 28 samples of cancerous and pericancerous tissues of patients, 
20 urine samples of patients and 10 of healthy persons and 14 blood samples of patients and 13 of 
healthy persons. Using indirect competitive ELISA with an LOD of 20 µg STC/kg, STC was found in 
the blood of 4 out of 13 patients (range 65–113 µg STC/kg) and in 1 (68 µg STC/kg) out of 14 healthy 
persons. In urine, STC concentrations were below the LOD in all samples tested. STC–DNA adducts 
were found in 14 out of 28 tissues of tumours collected from 12 patients. In a more recent paper, a 
study with 166 human patients, divided into 3 groups including controls (55 patients), patients with Sterigmatocystin in food and feed 
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liver cirrhosis (58 individuals) and patients with liver cancer (HCC) (53 individuals) is described 
(Hutanasu et al., 2011). In all patients, the concentration of STC in blood serum (measured by HPLC) 
was determined together with markers of liver function. STC was detected in 26.2 % of all samples, 
with a statistically significant (p < 0.001) higher prevalence in patients with liver cirrhosis and liver 
cancer. STC concentration varied between 0.01 and 0.005 ng/mL in blood in control subjects and 
reached values up to 2.02 ng/mL in blood and 9.39 ng/mL in urine in patients with HCC. In addition, a 
strong correlation between the presence of alfa-fetoprotein (a tumour marker) and STC was found in 
patients with liver cancer. The authors suggest that these findings may indicate a role of STC in the 
pathogenesis of liver cancer. 
As  tumour  formation  occurs  at  some  latency  after exposure to  a substance that is  genotoxic  and 
carcinogenic and co-exposure to other carcinogens cannot be excluded, the above-mentioned data do 
not  provide  conclusive  evidence  that  the  described  liver  and  stomach  cancers  have  indeed  been 
induced by dietary exposure to STC. 
The CONTAM Panel noted that these sparse data provide evidence of recent exposure of STC in the 
relevant  region  and  may  support  the  use  of  STC  concentration  and  DNA  adducts  in  blood  as 
biomarkers of recent exposure, but cannot inform on the risk of STC.  
7.5.  Modes of action 
The first observation of covalent binding of STC to DNA was made following incubation of calf 
thymus DNA with STC in the presence of phenobarbital-induced rat liver microsomes (Essigmann et 
al.,  1979).  Spectral  and  chemical  data  identified  the  adduct  as  1,2-dihydro-2-(N
7-guanyl)-1-
hydroxysterigmatocystin,  the  guanine  and  hydroxyl  moieties  being  in  a  trans  configuration.  The 
structure and stereochemistry of this adduct indicated that the exo-STC-1,2-oxide was the metabolite 
that reacted with DNA, and the quantitative yield of adducts indicated that this metabolite was a major 
product of the in vitro metabolism of STC. Formation of STC adducts was also detected when isolated 
rat livers were perfused with STC (Essigmann et al., 1980). A dose-dependent formation of DNA 
adducts of STC was found in the concentration range between 1 and 3 mg STC per liver. Male Fischer 
344 rats were administered STC i.p. and sacrificed 2 hours post-dosing (Reddy et al., 1985). A dose-
dependent  STC–DNA  adduct  formation  was  detected  in  the  rat  liver  over  a  27-fold  range  of 
administered STC (0.33–9 mg/kg b.w. i.p.). In addition, STC–DNA adducts, formed in rats given 
9 mg/kg b.w. i.p. were found to persist up to 105 days after treatment at a level of 0.5 % of the two-
hour value. The disappearance of STC–DNA adducts showed a triphasic profile: a first, rapid phase 
during 24 hours (t1/2 = 12 h), a second phase of slow decline from day 1 to 14 days (t½ = 7 days) and 
extremely slow decline from day 14 to day 105 post treatment (t½ = 109 days). In liver samples of 
male Fischer rats (three per group) treated with a single STC dose (1, 4, 8 and 16 mg/kg b.w., i.p.) and 
collected 24 hours after dosing, a linear dose–response relationship of STC–DNA adducts was found 
using ELISA and HPLC (Olson and Chu, 1993b).  
Reactions of the epoxides of AFB1 and STC with DNA were also analysed by Raney et al. (1992) by 
incubating calf thymus DNA with human liver microsomes. The rank order reported for the formation 
of N7-guanyl adducts by Baertschi et al. (1989) was confirmed. The yield of AFB1-induced N7 alkyl 
adducts was higher (approximately 4 fold) than that induced by STC and a correlation was observed 
with  the  number  of  revertants  measured  in  the  S.  typhimurium  TA98  strain  suggesting  that  the 
N7-guanyl adducts induced by STC and AFB1 have similar mutagenic potencies. The same pattern 
was seen with the products of AFB1 and STC oxidation by human liver microsomes (Raney et al., 
1992).  The  yield  of  epoxide-GSH  conjugates  and  other  oxidation  products  followed  the  order 
AFB1 > STC.  In  this  study  aflatoxin  Q1  (AFQ1;  detoxification  product)  was  the  most  refractory 
substrate and presented the lowest activity in the umu genotoxicity assay. It is important to note that 
several lines of evidence indicate that human CYP3A4 catalyzes the oxidation of AFB1 to both AFQ1 
and AFB1-8,9-oxide. Nothwithstanding that the unusually higher ability of STC to induce the SOS 
response as compared to AFB1 (Baertschi et al., 1989) might be due to DNA adduct-specific properties Sterigmatocystin in food and feed 
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(e.g. replication block), the detoxification of AFB1 to AFQ1, that is weakly genotoxic in the umu 
system on a molar basis (Raney et al., 1992), should be considered as an alternative explanation.  
The cytotoxicity of STC was studied in various mammalian cell lines (Bünger et al., 2004) showing a 
high degree of heterogeneity in the susceptibility to the toxic effects of STC. The primary mechanism 
of cell death in cultured cells is necrosis (Purchase and van der Watt, 1970b; Ueno et al., 1995). Cell 
death might be related to an impairment of mitochondrial ATP synthesis (uncoupling of oxidative 
phosphorylation) as described by Kawai et al. (1984). 
In  primary  kidney  epithelial  cells,  STC (2  mg/L)  completely  blocked  mitosis  and  caused  nuclear 
changes in 100 % of cells after 24 h of exposure (Engelbrecht and Altenkirk, 1972). The incorporation 
of 3H-thymidine into DNA was inhibited as well as that of 3H-uridine in RNA. The inhibitory effect 
of STC on liver RNA synthesis was confirmed in vivo in Wistar rats (n = 21) injected i.p. with 50 mg 
STC/kg b.w. and sacrificed ½, 1, 2, 3, 4, 16 and 48 hours after treatment (Nel and Pretorius, 1970). 
This treatment inhibited the incorporation of orotic acid in RNA in liver, with the maximum inhibition 
(60 %) one hour after treatment and recovery to the control values within four hours after treatment.  
In a more recent study, Xing et al. (2011) investigated the effects of STC on the cell cycle of human 
gastric epithelium cells (GES-1). They observed that STC arrested GES-1 cells at the G2 phase of the 
cell cycle and linked this observation to the individual cyclins and their regulation by MAPK and 
PI3K signalling pathways. These findings are in line with a previous study, demonstration that STC 
alleviated the normal p53-mediated cell cycle arrest that occurs for example as a consequence of DNA 
damage by induction of the p53 target gene MDM2 (Xie et al., 2000). 
Cell damage and necrosis exerted by STC could also be related to the induction of cellular oxidative 
stress. Male Wistar albino rats (n = 6) were fed A. versicolor-contaminated feed which contained toxin 
concentrations resulting in dose levels equivalent to approximately 0.2, 0.3, and 0.4 mg STC/kg b.w. 
per  day  for  30  days,  to  study  the  effects  of  STC  on  liver  cytochrome  P450-dependent 
monooxygenases,  as  well  as  on  the  production  of  reactive  oxygen  species  (ROS)  and  lipid 
peroxidation (Sivakumar et al., 2001). Since the two higher dose groups had shown more than 50 % 
mortality, the maximum tolerated dose of 0.2 mg/kg b.w. was used for further studies. This treatment 
significantly  increased  the  content  of  both  cytochrome  P450,  cytochrome  b5  and  their  related 
reductases along with the production of ROS, while the levels of reduced glutathione, ascorbic acid 
and α-tocopherol, and the thiol status declined. The activity of catalase was reduced, whereas the 
activities  of  the  enzymes  superoxide  dismutase  and  glutathione  peroxidase  were  increased. 
Histopathological changes included parenchymal cell degeneration and necrosis (without evidence for 
cellular apoptosis), and Kupffer cells proliferation. The authors concluded that STC may activate 
biotransformation  processes  in  liver  microsomes  and  suggested  that  lipid  peroxidation  should  be 
considered as a secondary mechanism of STC toxicity. The study did not provide information on 
oxidative DNA damage in STC-treated animals.  
In  conclusion,  the  genotoxicity  of  STC  is  likely  due  to  the  formation  of  DNA  adducts  that,  if 
unrepaired, increase the likelihood of mutation fixation. Moreover, most in vitro studies with purified 
DNA indicate that the level of induced N7-guanyl adducts is higher after AFB1 than STC exposure, 
supporting the view that AFB1 is a more potent liver carcinogen than STC. Various in vitro and in vivo 
investigations have demonstrated that STC exerts cytotoxicity, inhibition of cell cycle and mitosis, as 
well as an increased ROS formation and lipid peroxidation in vivo. Many of the in vitro assays have 
been conducted with rather high STC concentrations. Hence, the observed effects are of qualitative 
nature and their relevance for the assessment of the potential adverse effects of (low dose) dietary 
exposure to STC remains limited.  
7.6.  Dose–response assessment 
STC exhibits genotoxic effects in vitro, in vivo and ex vivo and carcinogenicity of STC has been 
demonstrated after oral, i.p., s.c. and/or dermal exposure in the animal species tested (Appendix D, Sterigmatocystin in food and feed 
 
EFSA Journal 2013;11(6):3254  38 
Tables D1, D2 and D3). The CONTAM Panel evaluated the dose–response effects of STC using data 
from available carcinogenicity bioassays using oral administration of STC as described in Section 
7.2.6.1 for mice, rats and monkeys and summarised in Table 3. 
The two identified carcinogenicity studies in mice were not suitable for dose–response analysis since 
dosing was discontinuous (Enomoto et al., 1982) or only one dose group was used (Zwicker et al., 
1974). The CONTAM Panel also noted that data in an unspecified monkey species were inappropriate 
for dose–response assessment since the authors did not report detailed tumour incidence for the two 
dose groups (see also Table 3). 
With the exception of the study by Maekawa et al. (1979), the available studies in rats were unsuitable 
for dose–response assessment. The studies either used discontinuous dosing (Purchase and van der 
Watt, 1970a (oral substudy)), exhibited a high portion of intercurrent mortality from non-neoplastic 
respiratory disease in both dose groups (Ohtsubo et al., 1978), or there was only one treatment group 
compared with a control group (Kempff et al., 1973; Terao et al., 1978). Furthermore, there was no 
clear dose-response relationship in the oral substudy by Purchase and van der Watt (1970a) and the 
study by Ohtsubo et al. (1978). A benchmark dose (BMD) analysis, conducted by the CONTAM Panel 
(Appendix E1) for the intragastric substudy by Purchase and van der Watt (1970a), showed a range of 
lower 95 % confidence limit for a benchmark response of 10 % extra risk (BMDL10) values from 
different  accepted  models  that  substantially  exceeded  one  order  of  magnitude  and  large 
BMD10/BMDL10  ratios  for  some  models,  indicating  that  the  data  are  not  informative  enough  for 
determining a reference point (EFSA, 2009, 2011b). 
The study of Maekawa et al. (1979) on hepatic changes in rats reported a dose-dependent incidence of 
liver tumours (Appendix D, Table D2). However, the Panel noted that these data did not provide an 
appropriate basis for risk characterisation since the study combined tumours of different origin (HCC 
and haemangiosarcomas and one tumour was not specified). The incidence of HCC (only one tumour-
bearing  animal  in  the  highest  dose  group)  could  not  be  reasonably  analysed  for  dose-response 
assessment. The Panel concluded that it was appropriate to conduct a BMD analysis on the incidence 
of haemangiosarcomas (zero tumour-bearing animals in the control and low dose group, one tumour- 
bearing animal at the mid dose group and three tumour-bearing animals at the high dose group) which 
is a relevant endpoint. The lowest BMDL10 value obtained from the fitted models was 0.16 mg/kg b.w. 
per day with a BMD10 of 0.36 mg/kg b.w. per day (Appendix E2). However, the Panel noted that the 
number  of  animals  with  haemangiosarcomas  made  up  only  11  %  (n = 4)  of  the  total  number  of 
tumour-bearing animals (n = 36) and that the overall tumour incidence in the control group was 64 %. 
Therefore, this BMD10/BMDL10 pair is based on a limited tumourigenicity database. A dose-response 
relationship was also observed for necrosis and hyperplastic foci and/or hyperplastic areas; these were 
not  subjected  to  dose-response  analysis  since  it  is  not  current  practice  to  use  such  data  in  risk 
characterisation of substances that are genotoxic and carcinogenic.  
In contrast to STC, dose-response assessment for AFB1 is based on the incidence of HCC (EFSA, 
2007). For AFB1, a BMD10 of 0.00041 mg/kg b.w. per day (0.41 µg/kg b.w. per day) with a BMDL10 
of 0.00017 mg/kg b.w. per day (0.17 µg/kg b.w. per day) were calculated for male Fischer rats, which 
was  the  most  sensitive  species  and  strain.  The  Panel  noted  that  haemangiosarcomas  were  also 
observed in the liver of animals exposed to AFB1 in the study of Ward et al. (1975).  
The CONTAM Panel compared the carcinogenic potency of STC and AFB1 by comparing the BMD10 
values. Whilst these BMD10 values are based on different tumour types, the Panel considered that they 
indicate that the carcinogenic potency of STC is approximately three orders of magnitude lower than 
that of AFB1. Sterigmatocystin in food and feed 
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Table 3:   Summary of studies on oral carcinogenicity of sterigmatocystin (details are provided in Appendix D, Tables D1 and D2). 
Strain 
Dose 
(mg/kg b.w. 
per day) 
Duration of 
the 
observation 
(weeks) 
Incidence of liver 
tumours (initial 
number of animals) 
Incidence of 
angiosarcomas in 
brown fat (initial 
number of animals) 
Incidence of lung 
neoplasia (initial 
number of animals) 
Incidence of 
unspecified 
tumours (initial 
number of 
animals) 
Reference 
Mouse               
ICR Swiss 
male  0  54-58      2/16 (19)    Zwicker et al. (1974) 
  0.75  54-58      12/15 (18)     
ICR Swiss 
female  0  54-58      2/21 (21)    Zwicker et al. (1974) 
  0.75  54-58      9/10 (10)     
BDF1  0  43/68/73  0
(e), 0
(b) and 0
(a)/50  0/50  0/50
(h)    Enomoto et al. (1982) 
  4.5  43/68/73  34
(e), 14
(b) and 1
(a)/55  6/55  5/55
(h)     
  18  43/68/73  0
(e), 4
(b) and 0
(a)/55  27/55  12/55
(h)     
Rat               
Wistar  0  123  0/9 (10)
(a)        Purchase and van der 
Watt (1970a) 
  0.5 + 0.75
(d)  123  8/9 (10)
(a)         
  1.0 + 1.5
(d)  123  10/10 (10)
(a)         
  5.0 + 7.5
(d)  123  3/3 (10)
(a)         
Wistar  0
(c)  123  0/10 (10)
(a)        Purchase and van der 
Watt (1970a) 
  0.5
(c)  123  4/10 (10)
(a)         
  1.0
(c)  123  5/9 (10)
(a)         
  5.0
(c)  123  9/9 (10)
(a)         
Donryu  0  101  0 and 0
(f)/17 (20)    0/17 (20)    Ohtsubo et al. (1978) 
  0.25  101  11 and 1
(f)/13 (20)    3/13 (20)     
  0.5  96  12 and 2
(f) /13 (20)    3/13 (20)     
 Sterigmatocystin in food and feed 
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Table 3:   Continued. 
Strain 
Dose 
(mg/kg b.w. 
per day) 
Duration of 
the 
observation 
(weeks) 
Incidence of liver 
tumours (initial 
number of animals) 
Incidence of 
angiosarcomas in 
brown fat (initial 
number of animals) 
Incidence of lung 
neoplasia (initial 
number of animals) 
Incidence of 
unspecified 
tumours (initial 
number of 
animals) 
Reference 
Wistar  0  69  0/30
(a)        Terao et al. (1978) 
  0.5  69  8/15
(a)         
ACI/N  0  121  0
(a) and 0
(f)/11 (12)        Maekawa et al. 
(1979) 
  0.005  121  0
(a) and 0
(f)/27 (36)         
  0.05  122  0
(a) and 1
(f)/29 (36)         
  0.5  118  1
(a) and 3
(f)/26 (36)         
Monkey               
Species not 
specified  0          1.5-80 %  Thorgeirsson et al. 
(1994) 
  0.14  12.3 years        5/15   
  0.28  11.5 years        5/15   
  0.14 or 0.28    7/30
(g)         
b.w.: body weight. 
(a):  hepatocellular carcinomas only; 
(b):  hepatic haemangioendotheliomas; 
(c):  intragastric, 5 days per week; 
(d):  dose first six months + dose second six months; 
(e):  angiosarcomas; 
(f):  hepatic haemangiosarcomas; 
(g):  hepatocellular carcinomas only, not differentiated by dose group; 
(h):  adenomas only. 
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8.  Risk characterisation  
8.1.  Human health risk characterisation 
To characterise the risk of substances that are genotoxic and carcinogenic, the MOE approach is the 
most appropriate procedure (EFSA, 2005; Barlow et al., 2006) and no health-based guidance value 
(e.g., a tolerable daily intake (TDI)) would be calculated. The occurrence results reported to EFSA 
were  all  left-censored  and  no  reliable  human  dietary  exposure  to  STC  could  be  calculated.  The 
absence of exposure data for the European population precludes the application of the MOE approach 
and therefore, the CONTAM Panel could not characterise the risk of STC for human health. 
8.2.  Animal health risk characterisation  
In the absence of exposure data for livestock, fish and companion animals in the EU and given the 
limited knowledge on the adverse effects of STC, the CONTAM Panel could not characterise the risks 
of STC for animal health. 
9.  Guidance for appropriate analytical performance to collect occurrence data in food 
and feed 
Since currently due to absence of exposure data for the European population, a risk characterisation is 
not possible for STC, the CONTAM Panel recommends to collect more occurrence data for STC in 
food and feed across European countries. 
The EFSA Scientific Committee has concluded that an MOE of 10 000 or more for substances that are 
genotoxic and carcinogenic is of low concern for public health (EFSA, 2005). For a BMDL10 of 
0.16 mg/kg b.w. per day, an MOE of 10 000 would be reached with an exposure of 0.016 µg/kg b.w. 
per day or less which would thus be of low concern for public health. Consumption of grains and 
grain-based products according to EFSA‘s comprehensive database ranges from 2.0 to 3.7 g/kg b.w. 
per day for average consuming adults. The STC concentration in grains and grain-based products 
resulting in an exposure of 0.016 µg/kg b.w. per day would range from 4.3 to 8 µg/kg grains and 
grain-based products.  
For average consuming toddlers, the consumption of grains and grain-based products according to 
EFSA‘s  comprehensive  database  ranges  from  5.9  to  10.5  g/kg  b.w.  per  day.  Therefore,  the  STC 
concentration in grains and grain-based products resulting in an exposure of 0.016 µg/kg b.w. per day 
would range from 1.5 to 2.7 µg/kg grains and grain-based products.  
Based on these considerations, the CONTAM Panel recommends that data on the occurrence of STC 
in food should be generated with methods with an LOQ less than 1.5 µg/kg. The available information 
on toxicity and exposure in farm and companion animals is insufficient to draw similar conclusions for 
feed. 
10.  Uncertainty analysis 
The EFSA Panel on Contaminants in the Food Chain concluded that the magnitude of the uncertainties 
due to the lack of exposure data precludes a risk assessment for STC in food and feed. 
The Panel therefore provided advice on the relative carcinogenic potency of STC and AFB1, and on 
the concentration of STC in grains that might lead to a dietary exposure considered to be of low 
concern for public health. There is considerable uncertainty in the BMD10/BMDL10 of STC used as the 
basis for this advice, due to the limitations in the available carcinogenicity studies. Sterigmatocystin in food and feed 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Background 
  Sterigmatocystin (STC) is a polyketide mycotoxin that is produced by more than 50 fungal 
species, including Aspergillus flavus, A. parasiticus, A. versicolor and A. nidulans, of which 
A. versicolor is the most common source.  
  STC  shares  its  biosynthetic  pathway  with  aflatoxins.  A.  nidulans  and  A.  versicolor  are 
apparently unable to biotransform STC into O-methylsterigmatocystin, the direct precursor of 
aflatoxin B1 (AFB1) and G1 (AFG1). Consequently, substrates colonised by these fungi can 
contain high amounts of STC, while substrates invaded by A. flavus and A. parasiticus contain 
only low amounts of STC as most is converted into AFs. 
  Grains and grain-based products can contain STC due to fungal infestation at the post-harvest 
stage. 
Methods of sampling and analysis 
  Analytical  methods  for  STC  in  food  and  feed  based  on  liquid  chromatography-mass 
spectrometry  reach  the  lowest  limits  of  detection  (LOD).  However,  the  sensitivity  varies 
between individual matrices and whether a single or multi-analyte method is applied. 
  So far, no certified reference materials are available for STC. In addition, no proficiency tests 
for STC analysis in food or feed could be identified. 
Occurrence and effect of processing  
  The  EFSA  Panel  on  Contaminants in the  Food  Chain  (CONTAM  Panel)  investigated the 
occurrence of STC in food and feed in the literature.  
o  The available information in the literature on the occurrence of STC in food and feed 
is scarce.  
o  Most  of  the  earlier  studies  using  methods  with  rather  high  LODs/limits  of 
quantification (LOQ) report a high percentage of left-censored data (often 100 %) for 
food and feed. 
o  Two  recent  studies,  using  a  liquid  chromatography-tandem  mass  spectrometry 
(LC-MS/MS) method with an LOD of 0.15 µg/kg and an LOQ of 0.3 µg/kg, reported 
STC positive samples of bread and of grain intended for use as animal feed. While 
these data indicate that these methods are sufficiently sensitive to quantify STC in 
food and feed, the data were insufficient to use for a reliable exposure assessment. 
o  STC has been occasionally reported to occur in green coffee beans, spices, nuts and 
beer.  Contamination of  cheese  occurs  particularly  at  the  surface,  following  fungal 
spoilage during ripening and storage.  
  Following an EFSA call for data, analytical results for 581 samples, including 247 food and 
334 feed samples, were submitted by three Member States. In food, analytical results on STC 
were reported to be all below the LOD or below the LOQ. In feed, only four quantified results 
were reported.  Sterigmatocystin in food and feed 
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  Food processing (e.g. milling, bread and cheese making, roasting) can result in a decrease of 
the STC concentration; however the extent depends on the type of food and the processing 
conditions. 
Exposure  
  The CONTAM Panel concluded that a reliable exposure assessment was not feasible either for 
humans or for animals, due to the high percentage of left-censored data (100 % for food and 
99 % for feed).  
Hazard identification and characterisation 
Toxicokinetics 
  The scarce information available suggests that absorption of STC is limited following oral 
exposure. STC is metabolised in the liver and lung by various cytochrome P450 enzymes into 
different hydroxymetabolites and its reactive exo-epoxide that readily forms DNA adducts. 
Excretion of both conjugated parent STC and its hydroxylated metabolites occurs via bile and 
urine. 
  There are insufficient data to assess the rate of carryover of STC from ruminants into milk 
when ruminants are exposed to contaminated feed, and no information is available about the 
transfer of STC and/or its metabolites into other animal products such as meat and eggs. 
Toxicity 
  The acute oral toxicity of STC is relatively low (range 120–166 mg/kg body weight (b.w.)). 
Liver and kidneys are the target organs of acute toxicity.  
  STC is hepatotoxic in rat, mouse, monkey and guinea pig. Incidence of hepatocellular necrosis 
and haemorrhages increase with dose and duration of exposure. 
  In the kidney, hyaline degeneration, tubular necrosis and haemorrhages were described in rats 
and/or vervet monkeys exposed to STC. 
  Results from in vivo and in vitro studies suggest that STC may  have immunomodulatory 
activity, but firm conclusions cannot be drawn. 
  STC is mutagenic in both bacterial and mammalian cell assays after metabolic activation. It 
induces  chromosomal  damage  both  in  vitro,  upon  metabolic  activation,  and  in  vivo  in 
experimental animals.  
  Tumourigenicity of STC was observed after oral, intraperitoneal, subcutaneous and/or dermal 
administration in the animal species tested (rat, mouse, Mongolian gerbils, monkey and fish). 
After oral exposure, premalignant and malignant lesions such as hepatocellular carcinomas 
(HCC), haemangiosarcomas in the liver, angiosarcomas in the brown fat, lung adenomas and 
incidental findings in other organs were reported. 
Adverse effects in livestock, fish and companion animals 
  In sheep, no signs of toxicity were observed in a feeding trial at the highest dose tested (16 mg 
STC/kg feed, estimated as equivalent to 0.3 mg/kg b.w. per day). 
  Limited data are available for other ruminants, but a case report describes haemorrhages and 
bloody diarrhoea in cattle following exposure to STC. Sterigmatocystin in food and feed 
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  STC is hepatotoxic in poultry and pigs, and nephrotoxic in poultry.  
  Toxicity  of  STC  has  been  demonstrated  in  several  fish  species.  Pathological  alterations 
included  haemorrhages  and  oedema  of  the  gills  and  haemorrhages  and  eosinophilic 
infiltrations in the hepatopancreas. 
  No data on adverse effects of STC could be identified for other animal species.  
Observations in humans 
  There  are  indications  of  an  association  between  STC  exposure  and  prevalence  of  gastric 
cancers in Asia, but so far these data are inconclusive.  
Mode of action 
  STC,  upon  metabolic  activation,  forms  N7-guanyl  DNA  adducts  which  are  likely  to  be 
responsible for the mutagenic effects.  
  STC  induces  cytotoxicity,  inhibition  of  cell  cycle  and  mitosis,  as  well  as  an  increased 
formation of reactive oxygen species and lipid peroxidation in vivo.  
Dose–response modelling 
  Despite  the  evidence  on  genotoxicity  and  carcinogenicity,  only  a  limited  tumourigenicity 
database  was  available  for  dose–response  assessment.  From  the  data  available  on 
haemangiosarcomas in the liver of male rats, a benchmark dose for a response of 10 % extra 
risk (BMD10) of 0.36 and a lower 95 % confidence limit for a benchmark response of 10 % 
extra risk (BMDL10) of 0.16 mg STC/kg b.w. per day were calculated.  
  A comparison of the BMD10 of STC for the occurrence of haemangiosarcomas and that of 
AFB1  for  the  occurrence  of  HCC  suggested  that  the  carcinogenic  potency  of  STC  is 
approximately three orders of magnitude lower than that of AFB1. 
Human risk characterisation 
  Due to the absence of exposure data for the European population, the margin of exposure 
(MOE) approach for substances that are genotoxic and carcinogenic could not be applied for 
STC and therefore, the CONTAM Panel could not characterise the risk of STC for human 
health. 
Animal risk characterisation 
  In the absence of exposure data for livestock, fish and companion animals, and given the 
limited knowledge on the adverse effects of STC, the CONTAM Panel could not characterise 
the risk of STC for animal health. 
Guidance for appropriate analytical performance to collect occurrence data in food and feed 
  Based on the BMDL10 (0.16 mg STC/kg b.w. per day) and an MOE of 10 000, the STC 
concentration in grains and grain-based products leading to an exposure of low health concern 
(0.016 µg/kg b.w. per day) would range from 1.5 to 8 µg/kg.  
  The  available  information  on  toxicity  and  exposure  in  farm  and  companion  animals  is 
insufficient to draw similar conclusions for feed. Sterigmatocystin in food and feed 
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RECOMMENDATIONS 
  More occurrence data on STC in food and feed across European countries need to be collected 
to allow assessment of dietary exposure. For food, methods with an LOQ of less than 1.5 
µg/kg  should  be  applied.  For  feed,  the  available  information  is  insufficient  to  make  a 
recommendation. 
  The development of suitable certified reference materials and/or proficiency tests to support 
analytical methodology should be encouraged. 
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Appendix A.   Biosynthesis of aflatoxins and sterigmatocystin 
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Figure A1: The aflatoxin and sterigmatocystin biosynthetic pathway (based on Yu et al., 2004). 
Abbreviations:  NOR:  norsolorinic  acid;  AVN:  averantin;  HAVN:  5-hydroxyaverantin;  OAVN:  oxoaverantin;  AVNN: 
averufanin;  AVF:  averufin;  VHA:  versiconal  hemiacetal  acetate;  VAL:  versiconal;  VERB:  versicolorin  B;  VERA: 
versicolorin A; DMSTC: demethylsterigmatocystin; DHDMSTC: dihydrodemethylsterigmatocystin; STC: sterigmatocystin; 
DHSTC:  dihydrosterigmatocystin;  OMSTC:  O-methylsterigmatocystin;  DHOMSTC:  dihydro-O-methylsterigmatocystin; 
AFB1: aflatoxin B1; AFB2: aflatoxin B2; AFG1: aflatoxin G1; AFG2: aflatoxin G2. Sterigmatocystin in food and feed 
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Appendix B.   Overview of previously reported literature data on occurrence of sterigmatocystin 
Table B1:   Overview of previously reported literature data on occurrence of sterigmatocystin in grains (indicating the final use (feed or food) if available). 
Commodity  Country of 
sampling  Year
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC  Descriptive statistics of numerical data (above LOD 
or LOQ) as reported by the authors (µg/kg)  Reference 
                Min
(b)  P50  Max  Mean 
Europe                         
Maize (for food)  Germany  n.r.  30  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Cereal grains (for food)  Poland  1975  12  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Szebiotko et al. (1981) 
Cereal grains (for food)  Poland  1976  37  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Szebiotko et al. (1981) 
Cereal grains (for food)  Poland  1977  62  TLC  n.r.  n.r.  98  n.r.  n.a.  n.a.  n.a.  Szebiotko et al. (1981) 
Cereal grains (for food)  Poland  1978  296  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Szebiotko et al. (1981) 
Maize (for food)  UK  n.r.  29  n.r.  n.r.  n.r.  93  > 10  n.a.  n.r.  n.r.  Jarvis (1982) 
Flake maize (for food)  UK  n.r.  2  n.r.  n.r.  n.r.  50  > 10  n.a.  n.a.  n.a.  Jarvis (1982) 
Cereals  (barley,  wheat, 
oats) (for feed) 
UK  1976–1979  523  TLC  20  n.r.  97  n.r.  n.r.  n.r.  n.r.  Buckle (1983) 
Wheat (for feed)  Czechoslovakia  1980–1981  24  TLC  n.r.  n.r.  96  traces  n.r.  n.r.  n.r.  Bartos and Matyas (1983) 
Barley (for feed)  Czechoslovakia  1980–1981  19  TLC  n.r.  n.r.  89  200  n.a.  400  n.r.  Bartos and Matyas (1983) 
Maize (for feed)  Czechoslovakia  1980–1981  16  TLC  n.r.  n.r.  87  50  n.a.  n.r.  n.r.  Bartos and Matyas (1983) 
Oats (for feed)  Czechoslovakia  1980–1981  10  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Bartos and Matyas (1983) 
Rye (for feed)  Czechoslovakia  1980–1981  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Bartos and Matyas (1983) 
Maize (for food)  UK  1987  20  n.r.  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1987) 
Maize (for food)  Turkey  1986  50  TLC  20  n.r.  80  20  n.r.  n.r.  n.r.  Ozay and Heperkan (1989) 
Maize (for food)  Bulgaria  1989–1990  n.r.  TLC  15  n.r.  100  n.a.  n.a.  n.a.  n.a.  Petkova-Bocharova et al. (1991) 
Cereals  (wheat,  barley, 
oats) (for feed) 
UK  n.r.  46  HPLC  n.r.  n.r.  83  n.r.  n.r.  n.r.  n.r.  Scudamore and Hetmanski 
(1995) 
Barley (feed ingredient)  UK  1992  45  HPLC  15  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Wheat (feed ingredient)  UK  1992  50  HPLC  15  n.r.  98  18  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Barley (for food)  UK  1997–1998  20  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Wheat (for food)  UK  1997–1998  20  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Oats (for food)  UK  1997–1998  21  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Rice (for food)  UK  1997–1998  21  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Rye (for food)  UK  1997–1998  20  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Maize (for food)  UK  1997–1998  20  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Long  grain  rice  (for 
food) 
UK  2000  25  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Easy  cook  rice  (for 
food) 
UK  2000  23  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Basmati rice (for food)  UK  2000  18  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Speciality  rice  (for 
food) 
UK  2000  16  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Brown rice (for food)  UK  2000  6  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) Sterigmatocystin in food and feed 
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Table B1:   Continued. 
Commodity  Country of 
sampling  Year
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC  Descriptive statistics of numerical data (above LOD 
or LOQ) as reported by the authors (µg/kg)  Reference 
                Min
(b)  P50  Max  Mean 
Europe (continued)                         
Short  grain  rice  (for 
food) 
UK  2000  6  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Flaked rice (for food)  UK  2000  3  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Ground rice (for food)  UK  2000  3  HPLC  3  6  100  n.a.  n.a.  n.a.  n.a.  FSA (2002a) 
Wheat (for food)  Latvia  2006  50  LC–MS/MS  0.15  0.30  82  0.7  n.r.  83  n.r.  Versilovskis et al. (2008a) 
Barley (for food)  Latvia  2006  10  LC–MS/MS  0.15  0.30  80  0.7  n.a.  25  n.r.  Versilovskis et al. (2008a) 
Oats (for food)  Latvia  2006  15  LC–MS/MS  0.15  0.30  100  n.a.  n.a.  n.a.  n.a.  Versilovskis et al. (2008a) 
Buckwheat (for food)  Latvia  2006  10  LC–MS/MS  0.15  0.30  80  0.7  n.a.  25  n.r.  Versilovskis et al. (2008a) 
Rye (for food)  Latvia  2006  10  LC–MS/MS  0.15  0.30  100  n.a.  n.a.  n.a.  n.a.  Versilovskis et al. (2008a) 
Wheat (for food)  Latvia  2007  20  LC–MS/MS  0.15  0.30  60  1  n.r.  47  n.r.  Versilovskis et al. (2008a) 
Barley (for food)  Latvia  2007  25  LC–MS/MS  0.15  0.30  56  1  n.r.  47  n.r.  Versilovskis et al. (2008a) 
Oats (for food)  Latvia  2007  25  LC–MS/MS  0.15  0.30  76  1  n.r.  25  n.r.  Versilovskis et al. (2008a) 
Buckwheat (for food)  Latvia  2007  25  LC–MS/MS  0.15  0.30  64  1  n.r.  47  n.r.  Versilovskis et al. (2008a) 
Rye (for food)  Latvia  2007  25  LC–MS/MS  0.15  0.30  68  1  n.r.  25  n.r.  Versilovskis et al. (2008a) 
Maize (for feed)  EU  2008  48  LC–MS/MS  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Monbaliu et al. (2010) 
Wheat (for feed)  EU  2008  30  LC–MS/MS  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Monbaliu et al. (2010) 
Grains  EU  2008-2011  367  LC–MS/MS  n.r.  n.r.  97  6.9  n.r.  574  n.r.  De Saeger, personal 
communication, 2012 
North America                         
Wheat (for feed)  Canada  1968  20  TLC  n.r.  n.r.  95  300  n.a.  n.a.  n.a.  Scott et al. (1972) 
Barley (for feed)  Canada  1968  2  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scott et al. (1972) 
Oats (for feed)  Canada  1968  3  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scott et al. (1972) 
Rye (for feed)  Canada  1968  2  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scott et al. (1972) 
Small grains  USA  n.r.  457  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Stoloff (1976) 
South America                         
Maize  Brazil  1991–1992  130  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Pozzi et al. (1995) 
Polished rice  Brazil  1985–1986  52  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Parboiled rice  Brazil  1985–1986  8  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Asia                         
Brown rice grains  Japan  n.r.  n.r.  TLC  n.r.  n.r.  n.r.  50  n.a.  450  n.r.  Sugimoto et al. (1977) 
Brown rice grains  Japan  1975  n.r.  TLC  n.r.  n.r.  n.r.  3 800  n.r.  4 300  n.r.  Takahashi et al. (1984) 
Brown rice grains  Japan  2005  48  HPLC-UV  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Tanaka et al. (2007) Sterigmatocystin in food and feed 
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Table B1:   Continued. 
Commodity  Country of 
sampling  Year
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC  Descriptive statistics of numerical data (above LOD 
or LOQ) as reported by the authors (µg/kg)  Reference 
                Min
(b)  P50  Max  Mean 
Asia (continued)                         
Maize for feed  India  n.r.  50  n.r.  n.r.  n.r.  94  traces  n.r.  150  n.r.  Devi and Polasa (1982) 
Wheat  India  1984–1986  30  n.r.  n.r.  n.r.  93  110  n.a.  145  n.r.  Pande et al. (1990) 
Rice  India  1984–1986  30  n.r.  n.r.  n.r.  90  108  n.r.  157  n.r.  Pande et al. (1990) 
Maize  India  1984–1986  22  n.r.  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Pande et al. (1990) 
UK: The United Kingdom; EU: European Union; USA: United States of America; n.r.: not reported; n: number of samples; TLC: thin-layer chromatography; HPLC: high-performance liquid 
chromatography; LC–MS/MS: liquid chromatography-tandem mass spectrometry; UV: ultraviolet; LOD: limit of detection; LOQ: limit of quantification; n.a.: not applicable; LC: left-censored 
data (values below the LOD or LOQ); Min: minimum; P50: 50
th percentile; Max: maximum. 
(a):  Year of sample collection;  
(b):  When only one quantified sample was available, the concentration is reported as the minimum. 
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Table B2:   Overview of previously reported literature data on occurrence of sterigmatocystin in food other than grains. 
Commodity  Country of 
sampling  Year 
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC 
Descriptive statistics of numerical 
data (above LOD or LOQ) as 
reported by the authors (µg/kg)  Reference 
Min
(b)  P50  Max  Mean 
Grain-based products                       
Europe                         
Maize flour  UK  n.r.  13  n.r.  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jarvis ( 1982) 
Maize-based breakfast 
cereals 
UK  n.r.  6  n.r.  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jarvis (1982) 
Oat-based breakfast 
cereals 
UK  n.r.  6  n.r.  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jarvis (1982) 
Wheat-based breakfast 
cereals 
UK  n.r.  14  n.r.  n.r.  n.r.  93  7  n.a.  n.a.  n.a.  Jarvis (1982) 
Breakfast cereals  UK  1997–1998  26  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Maize oils  UK  1997–1998  12  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Maize on the cob  UK  1997–1998  10  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Maize-based 
thickeners 
UK  1997–1998  13  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Maize syrup  UK  1997–1998  5  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Polenta  UK  1997–1998  12  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Taco  UK  1997–1998  5  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Tinned sweet maize  UK  1997–1998  12  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Popcorn  UK  1997–1998  12  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Maize snacks  UK  1997–1998  21  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Cereal-based products  Italy  2002  85  HP-TLC  2 - 4  6 - 11  100  n.a.  n.a.  n.a.  n.a.  Stroka et al. (2004) 
Rye bread  Latvia  n.r.  6  LC–MS/MS  0.15  0.30  83  2.4  n.a.  n.a.  n.a.  Versilovskis and Mikelsone (2008) 
Rye-wheat bread  Latvia  n.r.  9  LC–MS/MS  0.15  0.30  89  7.1  n.a.  n.a.  n.a.  Versilovskis and Mikelsone (2008) 
Wheat bread  Latvia  n.r.  14  LC–MS/MS  0.15  0.30  79  3.2  4.4  5.6  n.r.  Versilovskis and Mikelsone (2008) 
South America                         
Canned sweet maize  Brazil  1985–1986  32  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Maize flour  Brazil  1985–1986  27  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
White meal maize  Brazil  1985–1986  6  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Yellow meal maize  Brazil  1985–1986  18  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Instant yellow meal 
maize 
Brazil  1985–1986  13  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Popcorn  Brazil  1985–1986  15  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) Sterigmatocystin in food and feed 
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Table B2:   Continued. 
Commodity  Country of 
sampling  Year 
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC 
Descriptive statistics of numerical 
data (above LOD or LOQ) as 
reported by the authors (µg/kg) 
Reference 
Min
(b)  P50  Max  Mean   
Grain-based products                       
South America (continued)                       
Yellow maize grits  Brazil  1985–1986  7  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Dried white maize  Brazil  1985–1986  12  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Cheese                         
Europe                         
Cheese  France  n.r.  235  TLC  n.r.  n.r.  99  45  125  330  n.r.  Lafont et al. (1979) 
Cheese (Gouda and 
Edam) 
The Netherlands  1977–1978  39  TLC  5  n.r.  77  5  n.r.  600  n.r.  Northolt et al. (1980) 
Cheese   The Netherlands  n.r.  67  n.r.  n.r.  n.r.  73  Traces  n.r.  9 000  n.r.  Northolt and van Egmond (1982) 
Cheese  Czechoslovakia  n.r.  66  TLC  n.r.  n.r.  95  7.5  n.a.  17.5  n.r.  Bartos and Matyas (1982) 
Cheeses  Germany  n.r.  49  HPLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Nowotny et al. (1983) 
Cheese  UK  1987  20  n.r.  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1987) 
Cheese  UK  1997–1998  33  HPLC  3  n.r.  100  n.a.  n.a.  n.a.  n.a.  MAFF (1998) 
Manchego cheese  Spain  n.r.  12  TLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Lopez-Diaz et al. (1996) 
Cheese  Latvia  2008  8  LC–MS/MS  0.03  0.1  50  n.a.
(c)  n.a.  n.a.  n.a.  Versilovskis et al. (2009) 
Cheese  Belgium  2008  13  LC–MS/MS  0.03  0.1  77  0.52
(d)  n.a.  1.23  n.r.  Versilovskis et al. (2009) 
Africa                         
Cheese  South Africa  n.r.  42  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Luck et al. (1976) 
Cheese  Egypt  n.r.  100  TLC  n.r.  n.r.  65  10  n.r.  63  24  Abd Alla et al. (1996); Metwally et 
al. (1997) 
Nuts                         
Europe                         
Almonds  Spain  1986–1987  34  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jiménez et al. (1991) 
Peanuts  Spain  1986–1987  38  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jiménez et al. (1991) 
Hazelnuts  Spain  1986–1987  29  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jiménez et al. (1991) 
Pistachio nuts   Spain  1986–1987  32  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jiménez et al. (1991) 
Sunflower seeds  Spain  1986–1987  35  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Jiménez et al. (1991) 
Peanuts  UK  2000–2001  20  HPLC  n.r.  10  100  n.a.  n.a.  n.a.  n.a.  FSA (2002b) 
North America                         
Pecans  USA  1975  40  TLC  n.r.  n.r.  97  n.r.  n.a.  n.a.  n.a.  Schroeder and Hein (1977) 
Africa                         
Peanuts  Egypt  n.r.  40  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Maghraby and El-Maraghy 
(1987) 
Hazelnut  Egypt  n.r.  20  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Hafez and Saber (1993) Sterigmatocystin in food and feed 
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Table B2:   Continued. 
Commodity  Country of 
sampling  Year 
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC 
Descriptive statistics of numerical 
data (above LOD or LOQ) as 
reported by the authors (µg/kg) 
Reference 
Min
(b)  P50  Max  Mean   
Nuts                         
Africa (continued)                         
Walnut  Egypt  n.r.  20  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Hafez and Saber (1993) 
Untreated peanuts  Egypt  2004  20  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Youssef et al. (2008) 
Roasted peanuts  Egypt  2004  20  TLC  n.r.  n.r.  85  12.2  n.r.  16.8  n.r.  Youssef et al. (2008) 
Roasted, salted 
peanuts 
Egypt  2004  20  TLC  n.r.  n.r.  95  12.2  n.a.  n.a.  n.a.  Youssef et al. (2008) 
Asia                         
Almond  Saudi Arabia  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Gawad and Zohri (1993) 
Cashew nut  Saudi Arabia  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Gawad and Zohri (1993) 
Chestnut  Saudi Arabia  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Gawad and Zohri (1993) 
Hazelnut  Saudi Arabia  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Gawad and Zohri (1993) 
Pistachio nut  Saudi Arabia  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Gawad and Zohri (1993) 
Walnut  Saudi Arabia  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Abdel-Gawad and Zohri (1993) 
Other products                         
Europe                         
Green coffee beans  Italy  n.r.  502  n.r.  n.r.  n.r.  99.8  1200  n.a.  n.a.  n.a.  De Palo et al. (1977) 
Grapes and plums  Germany  n.r.  10  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Apples and pears  Germany  n.r.  10  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Bananas and oranges  Germany  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Sterilized fruits  Germany  n.r.  10  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Fruit juices  Germany  n.r.  52  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Apple juices  Germany  n.r.  12  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Blackcurrant juice  Germany  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Cherry juice  Germany  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Green vegetables  Germany  n.r.  10  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Tomatoes  Germany  n.r.  10  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Sterilized canned 
vegetables 
Germany  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Thurm et al. (1979) 
Dark beer  Latvia  n.r.  9  HPLC  0.26 µg/L  0.68 µg/L  89  7.8 µg/L  n.a.  n.a.  n.a.  Versilovskis et al. (2008b) 
Light beer  Latvia  n.r.  17  HPLC  0.26 µg/L  0.68 µg/L  94  4.0 µg/L  n.a.  n.a.  n.a.  Versilovskis et al. (2008b) 
Asia                         
Green coffee beans  Saudi Arabia  n.r.  30  TLC  n.r.  n.r.  93  11  n.a.  13  n.r.  Bokhari and Aly (2009) 
Fennel  India  1984–1986  9  TLC  n.r.  n.r.  89  142  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Black Pepper   India  1984–1986  8  TLC  n.r.  n.r.  75  105  n.a.  125  n.r.  Saxena and Mehrotra (1989) Sterigmatocystin in food and feed 
 
EFSA Journal 2013;11(6):3254  66 
Table B2:   Overview of previously reported literature data on occurrence of sterigmatocystin in food other than grains. 
Commodity  Country of 
sampling  Year 
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC 
Descriptive statistics of numerical 
data (above LOD or LOQ) as 
reported by the authors (µg/kg) 
Reference 
Min
(b)  P50  Max  Mean   
Other products                         
Asia (continued)                         
Turmeric   India  1984–1986  9  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Coriander  India  1984–1986  9  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Cinnamon  India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Cardamom  India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Greater cardamom  India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Indian cassia  India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Ammi  India  1984–1986  7  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Cumin   India  1984–1986  8  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Chilli  India  1984–1986  9  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Yellow mustard   India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Indian mustard   India  1984–1986  7  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Garlic  India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Clove  India  1984–1986  6  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Saxena and Mehrotra (1989) 
Africa                         
Green coffee beans  South Africa  n.r.  2  TLC  n.r.  n.r.  50  1 143  n.a.  n.a.  n.a.  Purchase and Pretorius (1973) 
Anise  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Black cumin  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Black pepper  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Caraway  Egypt  n.r.  5  TLC  n.r.  n.r.  40  14  n.r.  18  n.r.  El-Kady et al. (1995) 
Cardamom  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Chinese cassia  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Cinnamon  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Clove  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Coriander  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Cubeb pepper  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Cumin  Egypt  n.r.  5  TLC  n.r.  n.r.  40  n.r.  n.r.  n.r.  11  El-Kady et al. (1995) 
Eucalyptus  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Fennel  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Ginger  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Laurel  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Mastic  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Marjoram  Egypt  n.r.  5  TLC  n.r.  n.r.  80  n.r.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Nutmeg   Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Peppermint  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Red pepper   Egypt  n.r.  5  TLC  n.r.  n.r.  40  10  n.r.  23  n.r.  El-Kady et al. (1995) 
Rosemary  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) Sterigmatocystin in food and feed 
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Table B2:   Continued. 
Commodity  Country of 
sampling  Year 
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC 
Descriptive statistics of numerical 
data (above LOD or LOQ) as 
reported by the authors (µg/kg) 
Reference 
Min
(b)  P50  Max  Mean   
Other products                         
Africa (continued)                         
Safflower  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
Thyme   Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
White pepper  Egypt  n.r.  5  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  El-Kady et al. (1995) 
North America                         
Coffee beans  USA  n.r.  15  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Stoloff (1976) 
South America                         
Raw cassava flour  Brazil  1985–1986  33  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Roasted cassava flour  Brazil  1985–1986  9  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Seasoned and roasted 
cassava flour 
Brazil  1985–1986  3  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
Dried beans  Brazil  1985–1986  61  TLC  15  35  100  n.a.  n.a.  n.a.  n.a.  Valente Soares and Rodriguez-
Amaya (1989) 
UK: The United Kingdom; EU: European Union; USA: United States of America; n.r.: not reported; n: number of samples; HPLC: high-performance liquid chromatography; TLC: thin-layer 
chromatography; HP-TLC: high performance thin-layer chromatography; LC–MS/MS: liquid chromatography–tandem mass spectrometry; LOD: limit of detection; LOQ: limit of quantification; 
LC: left-censored data (values below the LOD or LOQ); n.a.: not applicable; Min: minimum, P50: 50
th percentile; Max: maximum. 
(a):  Year of sample collection. 
(b):  When only one quantified sample was available, the concentration is reported as the minimum. 
(c):  STC was detected in four samples above the LOD, but below the LOQ. 
(d):  Lowest quantified concentration. In one sample STC was detected but not quantified. 
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Table B3:   Overview of previously reported literature data on occurrence of sterigmatocystin in feed other than grains. 
Commodity  Country of 
sampling  Year 
(a)  n  Analytical 
method 
LOD 
(µg/kg) 
LOQ 
(µg/kg)  % LC 
Descriptive statistics of numerical 
data (above LOD or LOQ) as 
reported by the authors (µg/kg)  Reference 
Min
(b)  P50  Max  Mean 
Europe                         
Feedstuffs  UK  1976–1979  811  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Buckle (1983) 
Hay  UK  1976–1979  157  TLC  n.r.  n.r.  99  < 40  n.a.  n.a.  n.a.  Buckle (1983) 
Grass silage  UK  1976–1979  451  TLC  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Buckle (1983) 
Rice bran (feed ingredient)  UK  1992  40  HPLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Maize gluten and products (feed ingredient)  UK  1992  50  HPLC  40  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Cottonseed meal (feed ingredient)  UK  1992  21  HPLC  40  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Rapeseed (feed ingredient)  UK  1992  25  HPLC  25  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Sunflower meal (feed ingredient)  UK  1992  20  HPLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Olive pulp (feed ingredient)  UK  1992  5  HPLC  25  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Palm products (feed ingredient)  UK  1992  15  HPLC  40  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Soya (feed ingredient)  UK  1992  20  HPLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Peas/beans (feed ingredient)  UK  1992  15  HPLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Manioc (feed ingredient)  UK  1992  10  HPLC  25  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1997) 
Rice bran (feed ingredient)  UK  n.r.  40  HPLC  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1998b) 
Maize gluten (feed ingredient)  UK  n.r.  40  HPLC  100  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1998a) 
Maize products (feed ingredient)(maize 
germs/brans, baby maize, maize meals, flaked 
maize, maize screens) 
UK  n.r.  27  HPLC  20  n.r.  100  n.a.  n.a.  n.a.  n.a.  Scudamore et al. (1998a) 
Maize silages  The Netherlands  2002–2004  140  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008b) 
Grass silages  The Netherlands  2002–2004  120  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008b) 
Wheat silages  The Netherlands  2002–2004  30  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008b) 
Maize and grass silages   The Netherlands  2005  47  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008a) 
compound feeds  The Netherlands  2005  72  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008a) 
ensiled by-products  The Netherlands  2005  29  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008a) 
feed commodities  The Netherlands  2005  8  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008a) 
forage products  The Netherlands  2005  13  LC–MS/MS  n.r.  50  100  n.a.  n.a.  n.a.  n.a.  Driehuis et al. (2008a) 
Sow feed  EU  2008  4  LC–MS/MS  n.r.  n.r.  100  n.a.  n.a.  n.a.  n.a.  Monbaliu et al. (2010) 
Feed unspecified  EU  2008-2011  282  LC–MS/MS  n.r.  n.r.  97  8.6  n.r.  17.2  n.r.  Monbaliu et al. (2010) 
America                         
Dairy cattle feed (maize, cottonseed, protein mix)  USA  1983  1  TLC  n.r.  n.r.  0  7750  n.a.  n.a.  n.a.  Vesonder and Horn (1985) 
Africa                         
Silages  Egypt  n.r.  40  TLC  n.r.  n.r.  95  n.r.  n.r.  n.r.  n.r.  El-Shanawany et al. (2005) 
UK: The United Kingdom; EU: European Union; USA: United States of America; TLC: thin-layer chromatography; HPLC: high-performance liquid chromatography; LC–MS/MS: liquid 
chromatography–tandem mass spectrometry; LOD: Limit of detection; n.r.: not reported; LOQ: limit of quantification; LC: left-censored data (values below the LOD or LOQ); Min: minimum; 
n.a.: not applicable, P50: 50
th percentile; Max: maximum. 
(a):  Year of sample collection. 
(b):  When only one quantified sample was available, the concentration is reported as the minimum. Sterigmatocystin in food and feed 
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Appendix C.   Occurrence of sterigmatocystin in food and feed: call for data  
Table C1:  Distribution of 247 food samples across food groups
(a). 
Food group  n  LC  Mean UB
(b) (µg/kg) 
Grains and grain products       
Grains for human consumption  99  100 %  5.9 
Grain milling products  16  100 %  3.6 
Bread and rolls  119  100 %  5 
Breakfast cereals  5  100 %  3 
Fine bakery wares  2  100 %  3 
Pasta (raw)  2  100 %  3 
Snack food  4  100 %  3 
n: number of samples; LC: proportion of left-censored results; UB: upper bound. 
(a):  It cannot be excluded that samples described in Section 4.1 (Previously reported literature data on the occurrence of 
STC) were also submitted to EFSA. 
(b):  Lower bound means were equal to zero. Sterigmatocystin in food and feed 
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Table C2:  Distribution of 334 feed samples across feed groups
(a). 
Feed group  n  LC  Mean LB-
UB
(b) (µg/kg)  Max
(c) 
Cereal grains, their products and by-products   
Barley  39  100 %  5   
Maize  33  100 %  5   
Oats  2  100 %  5   
Triticale  4  100 %  5   
Wheat  45  100 %  5   
Forages and roughage, and products derived thereof   
Forage meal (grass meal, green meal)  2  100 %  5   
Forages and roughage, and products derived thereof 
(unspecified) 
127  98 %  0.1–5.1  8.9 
Lucerne (alfalfa)  1  0 %  28  28 
Legume seeds and products derived thereof   
Peas  1  100 %  5   
Sweet lupins  1  100 %  5   
Miscellaneous         
Starch  1  100 %  5   
Oil seeds, oil fruits, and products derived thereof   
Cocoa husks  2  50 %  7–9.5  14 
Linseed  2  100 %  5   
Palm kernel expeller  9  100 %  5   
Rape seed  5  100 %  5   
Sunflower seed  5  100 %  5   
Toasted soya beans  24  100 %  5   
Citrus pulp  9  100 %  5   
Other seeds and fruits, and products derived thereof  1  100 %  5   
Tubers, roots, and products derived thereof       
Potatoes  1  100 %  5   
Sugar beet  7  100 %  5   
Other feed  13  100 %  5   
n: number of samples; LC: proportion of left-censored results; LB: lower bound; UB: upper bound. 
(a):  It cannot be excluded that samples described in Section 4.1 (Previously reported literature data on the occurrence of 
STC) were also submitted to EFSA. 
(b):  .When only one value is shown, lower bound is zero and only upper bound is shown. 
(c):  Maximum values given only for feed groups with quantified results . 
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Appendix D.   Carcinogenicity of sterigmatocystin in rodents 
Table D1:   Carcinogenicity of sterigmatocystin in mice after oral exposure (feeding). 
Number of 
animals at 
beginning 
STC 
concentration 
in feed 
(mg/kg feed) 
Daily STC 
dose 
(mg/kg 
b.w.) 
Length of treatment 
(observation) in weeks 
Number of 
animals at end 
of experiment 
First 
appearance of 
tumours at 
week 
Organ 
Number of 
animals 
with 
tumours 
Type of tumour/ 
multiplicity if applicable
(b)  Reference 
ICR Swiss white, 3 weeks old, 11-16 g b.w. at start            Zwicker et al. 
(1974)  Male                 
19  0  0  n.a.  16  n.r.  Lung  2  2 pulmonary neoplasm   
18  5  0.75
(a)  54-58 wks, 
2 wks on + 2 wks off 
15  50  Lung  12  12 pulmonary neoplasm (incl. 1 
adenocarcinoma) 
 
Female                   
21  0  0  n.a.  21  n.r.  Lung  2  2 pulmonary neoplasm   
10  5  0.75
(a)  54-58 wks, 
2 wks on + 2 wks off 
10  n.r.  Lung  9  9  pulmonary  neoplasm  (incl.  8 
adenocarcinoma) 
 
BDF1mice, 5 weeks old, 0.016 kg b.w. at start              Enomoto et al. 
(1982)  Female                 
50  0  0  n.a. (43, 68 or 73 wks)  34  73  Uterus  2  1 leiomyosarcoma 
1 leiomyoma 
 
55  30  4.5
(a)  55 wks (43, 68 or 73 wks)  17  43  Liver  n.r.  14 haemangioendothelioma 
34 angiosarcoma 
1 HCC 
1 hepatocellular adenoma 
 
            Brown fat  6  6 angiosarcoma   
            Ovary  1  1 angiosarcoma   
            Lung  n.r.  1 angiosarcoma 
5 lung adenoma 
 
            Uterus  1  1 leiomyosarcoma   
            Other  n.r.  1 leukaemia 
1 papilloma of the oral cavity 
 
55  120  18
 (a)  40 wks + 4 wks control + 11 
wks (43, 68 or 73 wks) 
12  43  Liver  n.r.  4 haemangioendothelioma 
2 hepatocellular adenoma 
 
            Brown fat  27  27 angiosarcoma   
            Ovary  3  3 angiosarcoma   
            Lung  12  12 lung adenomas   
            Uterus  2  1 sarcoma 
1 leiomyoma 
 
            Auditory gland duct  1  1 squamous cell carcinoma   
STC: sterigmatocystin; b.w.: body weight; n.a.: not applicable; n.r.: not reported; HCC: hepatocellular carcinoma; wks: weeks. 
(a):  calculated using default values (EFSA, 2012); 
(b):  Some animals had multiple tumours. Sterigmatocystin in food and feed 
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Table D2:   Carcinogenicity of sterigmatocystin in rat after oral exposure. 
N of animals 
at beginning/ 
effective N 
Route of 
application 
STC 
concentration 
in feed 
(mg/kg feed) 
Daily STC 
dose (mg/kg 
b.w.) 
Purity (%) 
Length of 
treatment 
(observation) 
in weeks 
N of animals 
at end of 
experiment 
First 
appearance 
of tumours 
at week 
Organ 
N of 
animals 
with 
tumours 
Type of tumour/ 
multiplicity if applicable
(b)  Reference 
Wistar, weanling, 0.05 kg b.w. at start                  Purchase and 
van der Watt 
(1970a) 
10
(a)  Feeding  0  0  n.a.    9  –  –  0  – 
10
(a)  Feeding  10 + 15
c  0.5+0.75
(g)  88  26 + 26 (123)  9  42  Liver  8  8 HCC 
1 hyperplastic nodules 
1 invasive fibrosarcoma 
1 anaplastic mesenchymal 
tumour 
10
(a)  Feeding  20 + 30
c  1.0+1.5
(g)  88  26 + 26 (123)  10  42  Liver  10  10 HCC    
                Not specified    1 granulosa-cell tumour   
10
(a)  Feeding  100 + 150
 c  5.0+7.5
(g)  88  26 + 26 (123)  3  42  Liver  3  3 HCC 
1 osteogenic sarcoma 
 
                Omentum    1 rhabdomyosarcoma   
10
(a)  Intragastric 
5 days/week 
n.a.  0  n.a.  52 (123)  10  –  –  0  –   
10
(a)  Intragastric 
5 days/week 
n.a.  0.5
(i)  88  52 (123)  10  42  Liver  4  4 HCC  
2 hyperplastic nodules 
 
10
(a)  Intragastric 
5 days/week 
n.a.  1.0
(i)  88  52 (123)  9  42  Liver  5  5 HCC 
2 hyperplastic nodules 
 
10
(a)  Intragastric 
5 days/week 
n.a.  5.0
(i)  88  52 (123)  9  42  Liver  9  9 HCC 
1 mesenchymal tumour 
 
                Spleen  1  1 haemangiosarcoma   
Donryu, 6-weeks old, male, 0.12 kg b.w. at start                  Ohtsubo et 
al. (1978)  20/17
(d)  Feeding  0  0  n.a.  101 (101)  12  0  -  0  - 
20/13
(d)  Feeding   5  0.25
(g)  n.r.  101 (101)  3  66  Liver  11  1 haemangiosarcoma 
2 adenoma 
9 well differentiated HCC 
6 HCC with tubular pattern 
5 poorly differentiated HCC 
 
                Lung  3  3 metastasis   
20/13
(d)  Feeding  10  0.5
(g)  n.r.  96 (96)  0  66  Liver  12  2 haemangiosarcoma 
12 well differentiated HCC 
5 HCC with tubular pattern 
3 poorly differentiated HCC 
 
                Lung  3  3 metastasis   
Wistar, male, 4 weeks old                    Terao et al. 
(1978)  30  Feeding  0  0  n.r.  54 (69)  n.r.  n.r.  /  0  / 
15  Feeding  10  0.5
(g)  n.r.  54 (69)  n.r.  54  Liver  8  8 HCC   Sterigmatocystin in food and feed 
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Table D2:   Continued. 
N of animals 
at beginning/ 
effective N 
Route of 
application 
STC 
concentration 
in feed 
(mg/kg feed) 
Daily STC 
dose (mg/kg 
b.w.) 
Purity (%) 
Length of 
treatment 
(observation) 
in weeks 
N of animals 
at end of 
experiment 
First 
appearance 
of tumours 
at week 
Organ 
N of 
animals 
with 
tumours 
Type of tumour/ 
multiplicity if applicable
(b)  Reference 
ACI/N, 11 weeks old, male
(h)                    Maekawa et 
al. (1979) 
12/11
e  Feeding  0  0  n.a.  121 (121)  n.r.  58
(f)  Testis  4     
                Adrenal 
gland 
1     
                Others  4     
36/27
 e  Feeding  0.1  0.005
(g)  n.r.  121 (121)  n.r.    Testis  5     
                Adrenal 
gland 
1     
                Others  8     
36/29
 e  Feeding  1  0.05
(g)  n.r.  122 (122)  n.r.    Liver  1  1 haemangiosarcoma   
                Testis  2     
                Adrenal 
gland 
 
1     
                Others  3     
36/26
 e  Feeding  10  0.5
(g)  n.r.  118 (118)  n.r.    Liver  5  1 HCC 
3 haemangiosarcoma 
3 hyperplastic nodules 
 
                Testis  4     
                Adrenal 
gland 
2     
                Others  5     
STC: sterigmatocystin; b.w.: body weight; n.r.: not reported; N: number; HCC: hepatocellular carcinoma. 
(a):  Five male and five female rats. 
(b):  Some animals had multiple tumours. 
(c):  Dietary concentration first six months + dietary concentration second six months. 
(d):  Number surviving at time of appearance of first tumour. 
(e):  Number of rats surviving 58
th week except when autolysis at death was advanced. 
(f):  Not specified for which dose/control group. 
(g):  calculated using default values (EFSA, 2012). 
(h):  incidence of other histological changes in the liver at doses 0, 0.1, 1, 10: hyperplastic foci: 1,4, 9, 21; hyperplastic nodules: 0, 0, 0, 3. 
(i):   dose reported by the authors as mg/rat (administered 5 days per week; 0.5ml sunflower seed oil as dissolvent or given solely in controls) and converted to mg/kg b.w. based on information 
from feeding study conducted during the same series of experiments without correction for administration 5 days per week. Sterigmatocystin in food and feed 
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Table D3:   Overview of carcinogenicity studies of sterigmatocystin in rats and mice after intraperitoneal, dermal and subcutaneous treatment. 
Strain  Sex 
N 
Route of 
application 
Daily STC dose  Purity 
(%) 
Length of 
treatment 
(observation) 
(weeks) 
N of 
animals at 
the end of 
experiment 
First 
appearance 
of tumours 
(weeks) 
Organ  N of 
animals 
with 
tumours 
Type of tumour/ 
multiplicity if applicable
(b) 
Reference 
Mouse                       
CD2F1  M  s.c.    99.9  Single 
injection (52 
weeks) 
  n.r.        Fujii et al. 
(1976) 
  18    0 mg/kg b.w.      17    Lung  2  2
 papillary adenomas
(b)   
                Liver  1  1 hepatocellular adenoma   
  40    0.5 mg/kg b.w.      36    Lung  4  4 papillary adenomas   
                Liver  6  6 hepatocellular adenoma   
  15    1.0 mg/kg b.w.      14    Lung  3  3
 papillary adenomas
(c)   
                Liver  4  4 hepatocellular adenoma   
                Other  1  1 lymphoma   
  27    5 mg/kg b.w.      23    Lung  9  9 papillary adenomas
(d)   
                Liver  10  10
 hepatocellular adenoma   
  F            n.r.         
  18    0 mg/kg b.w.      18    /  0     
  34    0.5 mg/kg b.w.      34    Lung  1  1 papillary adenomas   
  22    1.0 mg/kg b.w.      22    Lung  2  2 papillary adenomas   
                Submaxillary 
gland 
1  1 adenoma
(e)   
  33    5 mg/kg b.w.      32    Lung  9  9 papillary adenomas
(c)   
                Liver  3  3 hepatocellular adenoma   
                Other  1  1 lymphoma   
Rat                       
NS  M                    Dickens et 
al. (1966) 
  6  s.c. 
twice/week 
0  n.a.  65 
(89) 
n.r.  /  Skin  1  1 sarcoma-like tumour   
  6  s.c. 
twice/week 
0.5 mg/rat  n.r.  24 
(65) 
n.r.  47  Skin  3  3 sarcomas   
                Liver    1 HCC 
1 cholangioma 
 Sterigmatocystin in food and feed 
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Table D3:   Continued. 
Strain 
Sex 
N 
Route of 
application  Daily STC dose  Purity 
(%) 
Length of 
treatment 
(observation) 
(weeks) 
N of animals 
at the end of 
experiment 
First 
appearance 
of tumours 
(weeks) 
Organ 
N of 
animals 
with 
tumours 
Type of tumour/ 
multiplicity if applicable
(b)  Reference 
Wistar 
M&F                   
Purchase and 
van der Watt 
(1973) 
  10
(a)  No 
treatment  No treatment  n.a.  70 (70)  10  /  /  0     
  10
(a)  Dermal 
twice/week  0 mg/rat in DMSO  n.a.  70 (70)  10  /  /  0    – 
  10
(a)  Dermal 
twice/week  0 mg/rat in acetone  n.a.  70 (70)  10  /  /  0    – 
  10
(a)  Dermal 
twice/week  1mg/rat in DMSO  99  70 (70)  10  40  Skin  10  4 papilloma 
6 squamous cell carcinoma 
 
                Liver  9  5 HCC 
4 hyperplastic nodules 
 
  10
(a)  Dermal 
twice/week  1 mg/rat in acetone  99  70 (70)  10  40  Skin  10  3 papilloma 
7 squamous cell carcinoma 
 
                Liver  7  7 HCC   
Wistar  M                    Terao (1978) 
  30  i.p. 
once/week  0 mg/kg b.w.
(f)  n.a.  23 (80)  27  /  /  0    – 
  40  i.p. 
once/week  4 mg/kg b.w.  n.r.  23 (80)  5  28  Liver  1  1 HCC   
                Peritoneum  20  20 mesothelioma   
NS: not specified; i.p.: intraperitoneal; s.c.: subcutaneous; STC: sterigmatocystin; b.w.: body weight; DMSO: dimethylsulphoxide; n.r.: not reported; n.a.: not applicable; HCC: hepatocellular 
carcinoma; N: number; M: male; F: female. 
(a):  five male and five female rats. 
(b):  All except one of the identified lung neoplasia was identified as papillary adenomas. Only one was identified as adenocarcinoma, however the dose and sex was not specified. Therefore the 
numbers shown for the study by Fujii et al. (1976) should be considered as the number of neoplasia. 
(c):  One animal with both lung and liver adenomas. 
(d):  Five animals with both lung and liver adenomas. 
(e):  In the submaxillary gland. 
(f):  Vehicle: dimethylformamide. Sterigmatocystin in food and feed 
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Appendix E.   Benchmark dose analysis 
The  details  of  the  benchmark  dose  (BMD)  analysis  applied  to  the  incidence  of  hepatocellular 
carcinomas (HCC) for the intragastric substudy reported by Purchase and van der Watt (1970a) and 
haemangiosarcomas reported by Maekawa et al. (1979) are presented in this Appendix.  
The  BMD/L  was  calculated  by  means  of  the  software  BMDS  v2.1.2  (US  EPA).  All  models  for 
dichotomous (quantal) data were selected for the analysis at the default benchmark response (BMR) of 
10 % extra risk advised by the EFSA guidance on the use of benchmark dose (EFSA, 2009). Models 
allowing  for  restrictions  were  run  only  when  the  fit  of  the  respective  unrestricted  models  would 
indicate their application after visual inspection of the dose-response data. 
 Since the BMDL is the lower 95 % one-sided confidence bound of the BMD and the BMDU is the 
upper  95  %  confidence  bound  of  the  BMD,  the  interval  BMDL/BMDU  represents  the  90  % 
confidence interval of the BMD. This provides a descriptive measure for the accuracy of the BMD, 
which for an acceptable BMD/L value should not be larger than one order of magnitude (EFSA, 
2009). 
E.1. BMD analysis of the incidence of hepatocellular carcinomas for the intragastric substudy by 
Purchase and van der Watt (1970a)  
Sterigmatocystin (STC) was administered by gastric intubation at doses of 0, 0.15, 0.3 or 1.5 mg/rat 
(dissolved in 0.5 mL sunflower seed oil) five days a week for 52 weeks. These doses correspond to 0, 
0.357, 0.714, 3.57 mg/kg b.w. per day (based on information from a feeding study conducted during 
the same series of experiments) after adjusting for the administration of STC on only 5 days per week. 
Reduced exposure for only 1 year was not adjusted for life-time exposure. 
Following intragastric administration of STC 0/10, 4/10, 5/9 and 9/9 animals showed HCC at these 
four dose groups, respectively (see Appendix D, Table D2). 
As shown in Table E1, a range of BMDL10 values from different accepted models was observed that 
substantially exceeded one order of magnitude. In addition large BMD10/BMDL10 ratios were obtained 
for some models. This indicates that the data are not informative enough for determining a reference 
point  (EFSA,  2009,  2011b)  and  the  BMD10/BMDL10  values  were  not  further  used  in  the  risk 
assessment. Sterigmatocystin in food and feed 
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Table E1: The benchmark dose and the 95 % benchmark dose lower confidence limit values for the 
incidence of hepatocellular carcinomas reported by Purchase and van der Watt (1970a) calculated for a 
benchmark response of 10 % extra risk when dosing sterigmatocystin intragastric for 52 weeks. 
Models  Restriction  N of 
parameters 
Minus Log-
likelihood 
P-
value  Accepted 
BMD10 
(mg/kg b.w. 
per day) 
BMDL10 
(mg/kg 
b.w. per 
day) 
Full model  na  4  12.91  –  –  –  – 
Null (reduced) model  -  1  26.29  -  -  -  - 
Probit  na  2  14.02  0.33  yes  0.21  0.13 
LogProbit  none  2  13.27  0.70  yes  0.16  0.020 
Logistic  na  2  14.18  0.28  yes  0.22  0.14 
LogLogistic  none  2  13.40  0.61  yes  0.15  0.016 
Quantal-Linear  na  1  13.05  0.96  yes  0.080  0.049 
Multistage Cancer
(a)  na  2  13.01  0.91  yes  0.089  0.050 
Multistage
 (a)  none  2  13.01  0.91  yes  0.089  0.047 
Weibull
   none  2  13.05  0.88  yes  0.095  0.0059 
Gamma  none  if  if  if 
R:0.87
(b) 
if 
R:yes
(b) 
if 
R:0.092
(b) 
if 
R:0.049
(b) 
b.w.: body weight; BMD10: benchmark dose for a response of 10 % extra risk; BMDL10: 95 % lower confidence limit of the 
benchmark dose with BMR = 10 % extra risk; na: not applicable, if: invalid fit; N: number 
(a):  two versions of the multistage model fitted the data with the same model; 
(b):  R: value obtained when fitting a restricted model. 
 
E.2. BMD analysis of the incidence of haemangiosarcomas reported by Maekawa et al. (1979)   
STC was administered via the diet at concentrations of 0, 0.1, 1 and 10 mg STC/kg feed. These 
concentrations correspond to doses of 0.005, 0.05 and 0.5 mg STC/kg b.w. per day using the default 
factor of 0.05 recommended by EFSA (2012). No haemangiosarcomas were observed in the control 
and the 0.005 mg STC/kg b.w. per day dose group, one (3 %) at the 0.05 mg STC/kg b.w. per day dose 
group and 3 (9 %) at the 0.5 mg STC/kg b.w. per day dose group (see Appendix D, Table D2). 
All dichotomous models satisfied the log-likelihood and the goodness-of-fit acceptability criteria when 
compared to the null model and the full model (Table E2). The BMD10 ranged between 0.36 and 
0.50 mg/kg b.w. per day and the BMDL10 between 0.16 and 0.34 mg/kg b.w. per day. The lowest 
BMDL10 of 0.16 mg/kg b.w. per day was obtained with the log-logistic model (see Figure E1) and was 
only slightly smaller than that obtained by the multistage model which resulted in the same linear fit as 
the two other multistage models and the Weibull and Gamma models (see Figure E2). Sterigmatocystin in food and feed 
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Table E2: The benchmark doses and the 95 % benchmark dose lower confidence limit values for the 
incidence  of  haemangiosarcomas  reported  by  Maekawa  et  al.  (1979)  calculated  for  a  benchmark 
response of 10% extra risk. 
Models  Restriction  N of 
parameters 
Minus 
Log-
likelihood 
P-
value  Accepted 
BMD10 
(mg/kg 
b.w. per 
day) 
BMDL10 
(mg/kg 
b.w. per 
day) 
Full model  na  4  13.65  –  –  –  – 
Null (reduced) model  -  1  16.50  -  -  -  - 
Probit  na  2  14.36  0.49  yes  0.48  0.33 
LogProbit  none  2  14.50  0.19  yes  0.50  0.28 
Logistic  na  2  14.40  0.48  yes  0.49  0.34 
LogLogistic  none  1  13.99  0.88  yes  0.36  0.16 
Quantal-Linear
(a)  na  1  14.03  0.86  yes  0.36  0.18 
Multistage Cancer
(a)  na  1  14.03  0.86  yes  0.36  0.18 
Multistage
(a)  none  1  14.03  0.86  yes  0.36  0.18 
Weibull
(a)  none  1  14.03  0.86  yes  0.36  0.18 
Gamma
(a)  none  1  14.03  0.86  yes  0.36  0.18 
b.w.: body weight; BMD10: benchmark dose for a response of 10 % extra risk; BMDL10: 95% lower confidence limit of the 
benchmark dose with BMR = 10 % extra risk; na: not applicable, N: number. 
(a):  the three versions of the multistage model and the Weibull and Gamma model fitted the data with the same linear model. 
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Figure E1:  Fit of the Loglogistic Model resulting in a BMD10 of 0.36 and a BMDL10 of 0.16 mg 
STC/kg b.w. per day.  
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Figure E2:  Fit of the Multistage Model, identical to the fit obtained for the other two versions of the 
Multistage Model as well as for the Weibull and Gamma model, resulting in a BMD = 0.36 and 
BMDL = 0.18 mg STC/kg b.w. per day.  
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ABBREVIATIONS 
aw  Water activity 
γ-GT  Gamma-glutamyltransferase 
ACAT  Acetyl-CoA cholesterol acetyltransferase 
AF  Aflatoxin 
AFB1,2  Aflatoxin B1,2 
AFG1,2  Aflatoxin G1,2 
AFM1  Aflatoxin M1 
AFQ1  Aflatoxin Q1 
AG  Azaguanine 
ALT  Alanine aminotransferase 
AOAC  Association of Official Analytical Chemists 
AST  Aspartate aminotransferase 
AVF  Averufin 
AVN  Averantin 
AVNN  Averufanin 
BMD  Benchmark dose 
BMD10  Benchmark dose for a response of 10 % extra risk 
BMDL  Benchmark dose lower confidence limit 
BMDL10  The lower 95 % confidence limit for a benchmark response of 10 % 
extra risk 
BMR  Benchmark response 
b.w.  Body weight 
CHO  Chinese hamster ovary 
CI  Confidence interval 
CONTAM Panel  EFSA Panel on Contaminants in the Food Chain 
CYP  Cytochrome P450 
DAD  Diode array detection 
DHDMSTC  Dihydrodemethylsterigmatocystin 
DHOMSTC  Dihydro-O-methylsterigmatocystin 
DHSTC  Dihydrosterigmatocystin 
DMSO  Dimethylsulphoxide 
DMSTC  Demethylsterigmatocystin 
ε  extinction coefficient or molar absorptivity 
EFSA  European Food Safety Authority 
ELISA  Enzyme-linked immunosorbent assay 
ESI
+  Electrospray positive ionization 
EU  European Union 
FAO  Food and Agriculture Organization 
FDA  Food and Drug Administration 
FLD  Fluorescence detection 
GC  Gas chromatography 
GES  Gastric epithelium cell 
GLDH  Glutathione dehydrogenase 
GSH  Glutathione 
HAVN  5-hydroxyaverantin 
HCC  Hepatocellular carcinoma 
HLA  Human leukocyte antigen 
HPLC  High-performance liquid chromatography 
HP-TLC  High-performance thin layer chromatography 
HPRT  Hypoxanthine–guanine phosphoribosyltransferase 
IARC  International Agency for Research on Cancer 
IL  Interleukin 
i.p.  Intraperitoneal Sterigmatocystin in food and feed 
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LC  Left-censored data/results / Liquid chromatography 
LC–MS  Liquid chromatography-mass spectrometry 
LC–MS/MS  Liquid chromatography-tandem mass spectrometry 
LDH  Lactate dehydrogenase 
LOD  Limit of detection 
LOQ  Limit of quantification 
Max  Maximum 
Min  Minimum 
MLs  Maximum levels 
MOE  Margin of exposure 
n  Number of samples 
n.a.  Not applicable 
NER  Nucleotide excision repair 
NOR  Norsolorinic acid 
n.r.  Not reported 
OAVN  Oxoaverantin 
OMSTC  O-methylsterigmatocystin 
OTA  Ochratoxin A 
P50  50
th percentile 
PBMC  Peripheral blood mononuclear cell 
PCNA  Proliferating cell nuclear antigen 
pDC  Plasmacytoid dendritic cell 
p.o.  Per os 
ROS  Reactive oxygen species 
s.c.  Subcutaneous 
SCE  Sister chromatid exchange 
SPE  Solid phase extraction 
STC, ST  Sterigmatocystin 
TDI  Tolerable daily intake 
TG  Thioguanine 
TLC  Thin-layer chromatography 
TNF-α  Tumour necrosis factor-alpha 
UDS  Unscheduled DNA synthesis 
UK  United Kingdom 
USA  United States of America 
UV  Ultraviolet 
VAL  Versiconal 
VERA  Versicolorin A 
VERB  Versicolorin B 
VHA  Versiconal hemiacetal acetate 
WBC  White blood cell 
XP  Xeroderma pigmentosum 
 